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Preface 
The molecular biology revolution of the 1960s has given rise to an enormous body of 
literature describing, in great detail, the inner workings of the cell. Over the course of the past 50 
years, and countless hours at the bench, biologists have used the implications of basic research to 
produce vaccines, antibiotics, and other therapies that have improved both the quality and 
duration of our lives. Despite these incredible advances, basic questions remain unanswered. In 
even the simplest model organism, hundreds of essential genes have never been studied. 
Moreover, the central dogma of molecular biology – DNA to RNA to Protein – is understood 
largely in terms of how the cell functions under ideal conditions. What happens when things go 
wrong? 
 This study seeks to characterize one of the cell’s contingency plans – a quality control 
measure for the eukaryotic ribosome. Today, despite the abundance of ribosomes in all cells, we 
are only beginning to understand the details of how they function, and the mechanisms that 
monitor their behavior. Recently, inactivated ribosomes were shown to be destroyed by the cell's 
own quality control measures, potentially preventing them from harming the cell. This system, 
dubbed 18S Nonfunctional rRNA Decay, is known to utilize a pair of ribosome-binding proteins 
to carry out its function. Yet the pathway still functions, albeit more slowly, in the absence of 
these two proteins, suggesting that other components must exist. The work discussed here is 
largely concerned with identifying these other factors, characterizing their activities, and 
determining how the 18S Nonfunctional rRNA Decay pathway impacts the health of the cell.  
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Chapter 1: 
Translation 
 The central dogma describes the process by which genetic information directs the 
synthesis of proteins. First, the sequence of a given gene, which is encoded in the form of DNA, 
is transcribed into RNA. The RNA sequence is then translated to produce protein. The process of 
mRNA translation is carried out by the ribosome, a macromolecular machine that couples the 
reading of the mRNA with the linear, ordered assembly of amino acids. This is a high-fidelity 
process capable of preventing most errors, and also dealing with those that arise. Both canonical 
translation and translation quality control mechanisms are promoted by a host of transiently 
associated ribosome binding factors. The complexity of translation allows multiple quality 
control events to take place, thereby preserving the integrity of the gene expression process and 
enabling detection of errors that do arise. 
 
Translation Initiation 
 The process of mRNA translation begins with an initiating phase that involves the 
binding of an mRNA and its associated proteins to a ribosomal small subunit. The resulting 
complex undergoes a series of intermediate steps before it becomes competent for large subunit 
recruitment and proceeds to 80S formation. This process utilizes a large number of proteins 
including complexes on the mRNA cap, mRNA tail, both ribosomal subunits, and individual 
initiation factors. A detailed overview of initiation was reviewed by Jackson et al. 2010, and is 
reiterated briefly below (Fig. 1.1). 
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Figure 1.1. Translation initiation. (Jackson et al, Nature 2010). 
 
 At the first step in initiation, a 40S ribosomal subunit is prepared for mRNA binding. 
Initially, the 40S is bound by three initiation factors: eIF3, which binds on the exterior of the 
ribosome near the E-site, eIF-1a, which binds the E-site itself, and eIF-1, which binds in the A-
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site. This leaves the P-site vacant for the binding of the Met-tRNA as part of the 
eIF2/tRNA(Met)/GTP ternary complex. Subsequently, eIF5 binds. At this point, a 40S subunit is 
prepared for interaction with the mature mRNA, and is referred to as a 43S complex, a name 
based upon its sucrose gradient sedimentation coefficient (Jackson, Hellen, & Pestova, 2010). 
 The next major initiation complex is comprised of the 43S complex bound to an mRNA. 
In preparation for translation, pre-mRNAs are subjected to nuclear maturation including the 
removal of intronic sequences via splicing, the addition of a 7-methyl-Guanine cap, 
polyadenylation, and the deposition of associated proteins (Matlin et al., 2007; Reed et al., 2002). 
During translation initiation, the cap is bound by the initiation factors eIF4G, eIF4E, and eIF4A, 
which together comprise the eIF4F complex. In addition to eIF4F, the cap is bound by eIF4B 
(von der Haar, Gross, Wagner, & McCarthy, 2004). The protein eIF4A is a DEAD-box helicase 
that helps resolve secondary structure within the 5` UTR of the mRNA during initiation (Rogers, 
Richter, Lima, & Merrick, 2001). Its activity is greatly enhanced by both eIF4B and eIF4G, and 
current work in the field has suggested the involvement of several other DEAD-box helicases, 
including Ddx3 and Ded1 (Tarn & Chang, 2009). Beyond its role in promoting the activity of 
eIF4A, eIF4G recruits the 43S complex via its interactions with eIF3 on the ribosome (LeFevbre 
et al., 2006). A 43S ribosomal small subunit complex bound to a mature mRNA comprises the 
48S preinitiation complex. 
 The small ribosomal subunit of a newly formed 48S complex scans the mRNA sequence 
in a 5`-3` direction until it reaches an AUG start codon. When the ribosomal P-site is positioned 
on the AUG, the proper pairing of Met-tRNA to the AUG is recognized by eIF1(Pestova et al., 
2002). This process is in contrast to the codon:anticodon pairing that occurs in the A-site during 
translation's elongation phase. Similar to the A-site proofreading mechanisms discussed below, 
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the P-site possesses mechanisms that allow faithful identification of proper AUG start codons. 
This ability is promoted by the initiation factors, especially eIF1, which also discourage the use 
of improper AUG codons (Donahue et al., 2000). Localization of purines at the -3 and +4 
positions relative to a true start codon provides one of the means by which the initiation factors 
can discriminate between these two possibilities (Pisarev et al., 2006). 
 Following start codon recognition, eIF5B is recruited along with a large ribosomal 
subunit. The protein eIF5B first activates the GTPase function of eIF2, triggering the hydrolysis 
of its bound GTP and the subsequent dissociation of eIF2 (Paulin et al. 2001). After this step, the 
60S subunit binds, allowing the eIF5B-mediated dissociation of the remaining eIF proteins, 
including, as a downstream event, eIF5B itself (Pestova et al. 2007).  The resulting complex, 
comprised of a large and a small subunit positioned at the start codon, now represents an 80S 
ribosome:mRNA complex capable of making the transition from initiation to translation 
elongation (Jackson et al., 2010). 
 
Translation Elongation 
 The elongation cycle begins following the clearance of eIF5B from the A-site. Once 
vacant, the A-site becomes available for insertion of eEF1A-bound aminoacylated tRNAs, which 
occurs stochastically until a proper codon:anticodon pair is formed (Stark et al. 1997).  At this 
point, eEF1A hydrolyzes its GTP and dissociates, allowing the tRNA to fully insert into the A-
site, positioning it in the peptidyl transferase center in a process called accommodation (Noble et 
al., 2008). As part of the tRNA selection process, the small subunit rRNA also detects proper 
codon:anticodon pairing via a process known as the kinetic proofreading function of the 
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ribosome . This proofreading step represents a separate round of selection based upon the proper 
orientation of the codon and anticodon, and can distinguish between cognate and near-cognate 
tRNAs with significantly higher fidelity than initial codon:anticodon pairing (Blanchard, 
Gonzalez, Kim, Chu, & Puglisi, 2004). The process is facilitated by rRNA itself as it surveys the 
codon:anticodon interaction, predominantly within the first two positions. Three bases in the 
small subunit RNA – G530, A1492, and A1493 – (using the E. coli numbering system) undergo 
conformational changes, rotating along the sugar-phosphate axis and forming hydrogen bonds 
with the tRNA and mRNA backbone.  Base G530 interacts with the anticodon at position 2, and 
with the mRNA at position 3. Base A1492 contacts position 1 of the mRNA’s minor groove, and 
A1493 contacts position 2, detecting the orientation of the mRNA as a measure of its pairing 
with the A-site tRNA. Despite the single contact point at position 3 by G530, quality control is 
almost entirely based on correct codon:anticodon pairing at positions 1 and 2, which permits 
imperfect pairing at position 3, or the “wobble” position.  Mutations in these bases have been 
found to affect disparate aspects of the ribosome’s kinetic proofreading function: proofreading in 
the A-site is greatly decreased in the case of A1492 mutation, whereas proofreading in the  P-site 
is affected by A1493 mutations (Ogle et al., 2001; Yoshizawa, et al., 1999). 
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Figure 1.2. The translation elongation cycle. Following large subunit recruitment, 
tRNAs are inserted into the A-site soichastically until proper codon:anticodon 
pairing occurs. Peptidyl transfer then proceeds, followed by ribosome progression 
to the next codon, and movement of tRNA-peptide from the A-site to the P-site. 
The cycles then restarts.  
 
If proofreading is successful, the peptidyl transfer reaction can proceed (Pape et al., 
1998). The rRNA itself catalyzes the dehydration synthesis reaction at the peptidyl transferase 
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(PTC) center of the large subunit, covalently linking the C-terminal of the P-site amino acid to 
the N-terminal of the A-site aa-tRNA (Ban et al., 2000). The mRNA then moves forward through 
the ribosome by three bases, thereby moving a new codon into the A-site, and moving the A-site 
and P-site codons into the P-site and E-site, respectively. This causes the tRNA in the A-site to 
tilt as it maintains contact with the tRNA at its base, without fully transferring its upper portion 
into the P-site. The process by which the tRNAs fully transfer from A to P to E is called 
translocation, and is driven by the GTPase EF-G (Rodnina et al., 1997; Valle et al., 2003). 
Interestingly, fungi possess an additional elongation factor not present in either 
prokaryotes or other eukaryotes – eEF3. Work on eEF3 has indicated that it is required for both 
binding of eEF1:Amino Acid:tRNA to the ribosome and exit of tRNA from the E-site (Triana-
Alonso et al., 1995). 
 
Translation Termination 
The elongation cycle will continue until the ribosome encounters a termination codon in 
the A-site. No tRNA codon matches the UAA, UAG, or UGA termination codon. Instead, the 
release factor protein eRF1 recognizes them, in part, via its NIKS motif. Additional work has 
demonstrated that the N-terminal region of eRF1 is also involved in stop codon recognition 
despite its distant location from the mRNA (Ito et al., 2002). The shape of eRF1 resembles that 
of a tRNA, consistent with its ability to insert into the A-site (Shin et al., 2004) (Fig. 1.3). 
The consequences of successful eRF1 binding include the release of the mRNA and 
ribosomal subunits, hydrolysis of the ester bond linking the C-terminal amino acid in the P-site 
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with its tRNA, and dissociation of tRNA and nascent peptide (Frolova et al., 2002; Song et al., 
2000).  
In addition to eRF1, its binding partner, eRF3, is required for canonical translation 
termination. Though eRF3 is not essential for termination in vitro, as part of its activity in vivo 
eRF3 greatly stimulates the activity of eRF1. Consistent with the structural similarity of eRF1 to 
tRNA, eRF3 resembles EF1A. These two proteins form a stable heterodimer and insert together 
into the A-site (Ito et al., 1998). Also consistent with its homology to EF1a, eRF3 is a guanine 
nucleotide exchange factor. Following stop codon recognition, eRF3 hydrolyzes GTP, triggering 
a dramatic conformational change in eRF1 and the subsequent release of the ribosome, mRNA, 
tRNA, and peptide. 
The activities of eRF1 and eRF3 are greatly stimulated by an factor, RliI (mammalian 
ABCE1) which is also involved in ribosome maturation, and translation initiation (Shoemaker, 
Eyler, & Green, 2010). This ATPase binds the eRF1:eRF3 to promote the process of termination 
and subsequent recycling of translation components (Fig. 1.3). Additionally, translation initiation 
factors eIF3/1/1A are required for recycling to finish (Shoemaker et al., 2010).  
9 
 
 
Figure 1.3. Translation Termination and Recycling.  
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rRNA Synthesis and Maturation 
 The eukaryotic ribosome is comprised of four long RNAs totaling 5 kb in length and 
more than 80 proteins, reaching a total mass of at least 3.3 megadaltons (Ben-Shem, Jenner, 
Yusupova, & Yusupov, 2010). The sheer size of the ribosome necessitates a complex synthesis 
and maturation process. rRNA processing alone involves the transcription of a long RNA 
precursor molecule, numerous cleavage and modification events, and the proper production of a 
complex three dimensional structure. This is all coordinated with the binding of a multitude of 
ribosomal proteins.  
The mature ribosome is a high-fidelity machine that possesses multiple independently 
functioning proofreading measures and quality control mechanisms. In its canonical function 
described above, the ribosome conducts translation with many initiation, elongation, and 
termination factors, underscoring the complexity of the translation process. Added to this, many 
transiently associated proteins promote the selective translation, or degradation, of mRNAs, 
allowing the ribosome to function as a highly flexible device for the control of gene expression.  
 
Ribsomal RNA Maturation 
 The eukaryotic ribosome consists of two distinct subunits, the 40S and 60S. The 60S 
contains the 25S, 5.8S, and 5S rRNAs, and the 40S contains the 18S rRNA. In S. cerevisiae, 
these four RNAs are encoded in the genome in the form of two tandem genes that together form 
a single rDNA repeat (Venema et al., 1999). The first RNA is a long operon called the 35S 
(Venema, J., Tollervey, 1999). It includes the 18S-5.8S-25S rRNAs plus two spacer regions, the 
ITS1 and ITS2, which separate the 18S from the 5.8S and the 3` end of the 5.8S from the 25S, 
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respectively. The 35S also contains flanking sequences – the 5` and 3` ETS. The 5S rRNA is 
encoded separately. The 35S and 5S rRNAs are transcribed by RNA polymerase I and RNA 
polymerase III, respectively (Venema, et al., 1999; Bernstein et al., 2004) (Fig. 1.4). 
 
Figure 1.4. Pre-rRNA Processing in S. cerevisiae. (Adapted from Bernstein et al. 
Eukaryotic Cell. 2004) 
 
In the S. cerevisiae genome, the rDNA genes are repeated 100 to 200 times, allowing 
large numbers of rRNAs to be produced in parallel. During log phase growth, an average yeast 
cell contains 2x105 ribosomes and doubles every 90 minutes, indicating a production rate of 
2,000 per minute (Warner, 1999). Production at this scale is possible, in large part, due to the 
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compartmentalization of the rDNA genes and maturation factors within a discrete organelle 
called the nucleolus. rRNA transcription and maturation, as well as a major portion of the 
ribosome assembly process, takes place there (Taddei, Schober, & Gasser, 2010). 
Transcription of the rRNA occurs slowly, taking as long as 6 minutes. It is followed by 
the very fast maturation of the rRNA, which occurs on the level of seconds (Kressler, Hurt, & 
Bassler, 2010). Early in the maturation process, the 3` ETS of the 35S rRNA is co-
transcriptionally removed by the endoribonuclease Rnt1 (Elela et al., 1996).  Next, 
approximately 70 small nucleolar RNAs (snoRNAs) direct the 2`-O-ribose methylation (-CH3) 
and pseudouridylation of the rRNA at various sites. The targets of pseudouridylation and 2`-O-
ribose methylation are entirely within the core conserved structure of the rRNA, and are 
especially prominent at functional rather than scaffolding sites, suggesting they should have an 
impact on ribosomal function (Bakin, Lane, & Ofengand, 1994). Despite the anticipated 
importance of the snoRNAs and the implication of snoRNA misregulation in various forms of 
cancer, determining specific functions for many of these modifications has proven difficult 
(Esteller, 2011). 
Following chemical modification, the 35S rRNA is cleaved at positions A0 and A1, 
thereby removing the 5` ETS, which is degraded by the nuclear exosome and the 
exoribonuclease Rat1. The resulting 33S is cleaved again at position A2 to form the 20S and 
27SA2 rRNAs. The former is exported from the nucleus where it is cleaved again, most likely by 
Nob1, to produce the 18S, a mature small subunit rRNA (Fatica, Tollervey, & Mensur, 2004). 
Meanwhile, the 27SA2, which contains the 5.8S and 25S rRNAs, is matured independently by 
the endoribonuclease  MRP, Rat1, and the exosome. Downstream cleavage events are mediated 
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by the exosome and unidentified endoribonucleases to form the mature 5.8S and 25S (Udem et 
al. 1973; Venema, et al., 1999) . 
snoRNA Structure and Function 
The general purpose of snoRNAs is to bring together an RNA target and the enzymes 
required for its site-directed chemical modification. Two functional categories of snoRNAs exist 
– the C/D box snoRNAs, which direct 2`-O-ribose methylation, and the H/ACA box snoRNAs, 
which direct pseudouridylation. The latter reaction entails the rotation of the uridine across the 
C3/C6 axis, producing a base that is unable to properly hydrogen bond to other nuclear bases 
(Charette & Gray, 2000). Both modifications are known to influence the folding and maturation 
of the ribosomal RNAs, though other functions may exist (Charette & Gray, 2000). 
The snoRNA classes are identifiable by sequence. A single snoRNA always encodes at 
least one set of highly conserved C and D boxes: RUGAUGA (R=purine) and CUGA, 
respectively. Often, a second set of less-conserved C and D boxes are also encoded, leading to an 
alternating order of C, D`, C`, D, with the symbol ` signifying the less-conserved sequences. A 
stem-loop structure is formed by inverted repeats at the 5′ and 3′ termini of the snoRNA, 
bringing the two internal and two terminal C and D boxes together.  
H/ACA snoRNAs also form a stem loop structure, though they are generally longer than 
C/D box snoRNAs and only contain single H and ACA guide sequences. Like the C/D box 
snoRNAs, the guide sequence is sufficient for nucleolar localization(Holley & Topkara, 2011).  
The snoRNAs function via their associated proteins. The proteins 15.5 K, Nop58, and 
Nop58 bind to C/D boxes, allowing subsequent binding of the enzyme Nop1, which conducts the 
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2`-O-ribose methylation. A different group of proteins binds the H/ACA snoRNAs: Cbf5, Gar1, 
Nhp2, Nop10, and the enzyme Cbf5 (human dyskerin), the latter of which actually performs the 
uridine isomerization reaction (Ganot, Bortolin, & Kiss, 1997; Henrase et al., 1998; Holley & 
Topkara, 2011).Though individual snoRNAs are not essential, their loss appears to have subtle 
effects on rRNA folding. Moreover, strains deficient in NOP1 or CBF5 deletions are lethal, 
suggesting that the complete loss of 2`-O-methyl or pseudouridine formation is harmful for the 
cell (Bachellerie, Cavaillé, & Hüttenhofer, 2002). 
 
Ribosome Assembly 
Production of the 40S and 60S subunits 
 The process of ribosome assembly, from rRNA transcription initiation to the completion 
of translation-competent 40S and 60S subunits, takes less than 10 minutes. The speed of this 
process is facilitated by the cotranscriptional production of the ribosomal small subunit. Some of 
the Rps (ribosomal protein small subunit) proteins actually bind and integrate with the 18S 
portion of the 35S rRNA, forming the initial structure of the small subunits at a very early point 
in production. Production of the larger 60S subunit is a bit slower, and begins following the A2 
cleavage of the 35S rRNA. After this point, the large and small subunit RNAs separate and 
integration of the large subunit ribosomal proteins begins (Pérez-Fernández, Román, De Las 
Rivas, Bustelo, & Dosil, 2007). 
 Biogenesis of the 40S subunit continues with the ordered assembly of UTP-A, UTP-B, 
and UTP-C complexes, which include ~20 non-ribosomal proteins that must be removed as the 
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subunit is matured (Pérez-Fernández et al., 2007). The addition and removal of the many 
ribosome maturation factors make the assembly process greatly resemble a factory with workers 
performing discrete tasks on an assembly line. After the A0, A1, and A2, cleavage events are 
complete, yielding the 20S pre-rRNA, the pre-40S composition goes through a major structural 
change. At this point, non-ribosomal proteins are removed and the complex is transported to the 
cytoplasm where other factors complete the maturation process, including the cleavage of the 
20S rRNA to the mature 18S (Schäfer et al., 2003; Schäfer et al., 2006). Hence, small ribosomal 
subunits enter the cytoplasm in an immature state, raising the possibility that immature small 
subunits could potentially attempt initiation. 
 The 60S subunit maturation process also utilizes a large number of transiently associated 
factors, though discrete maturation intermediates have not been as easily identified as those for 
the 40S subunit. Instead, there appears to be a continuous flow of proteins in and out of the pre-
60S, with various proteins present at some stages and still others present throughout the 
assembly process (Kressler et al., 2010). 
The 5S complex, which simply includes the 5S rRNA bound to Rrp5, integrates early into 
the large subunit, just after the cleavage and separation of  the 20S and the 27SA2 (Zhang et al., 
2007). Downstream, the removal of the Rix1–Ipi3–Ipi1 complex by the 550 kd AAA+ ATPase 
Rea1 serves to underscore the energy-intensive nature of ribosome assembly. The ring domain of 
Rea1 includes 6 ATPase domains, which are used to drive the movement of its tail domain in the 
manner of a lever. The leverage and power expenditure allow the removal of Rix1 and its bound 
counterparts from the pre-60S subunit (Ulbrich et al., 2009). The resulting complex is nearly 
ready for export by via the Mex67-Mtr2 pathway (Ansel et al., 2008). 
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Major alterations in pre-60S composition continue in the cytoplasm. The addition of the 
7S rRNA to the pre-60 particle occurs around the time of nuclear export, though incorporation 
does not appear to be required for the export process itself (Yao et al., 2007). In the cytoplasm, 
the 7S rRNA is further matured into the 5.8S (Ansel et al., 2008). The last large subunit protein 
to be added is Rpl10 (Hedges, West, & A.W. Johnson, 2005). Shortly after its incorporation, the 
60S reaches maturity. 
Catalytic Functions of the Ribosomal RNA  
Though the RNA serves largely as a scaffold for the binding of ribosomal proteins, it is 
also catalytic.  In its role as a ribozyme, the 25S rRNA directly participates in the transamination 
reaction that transfers the nascent peptide from the P-site tRNA to the A-site tRNA (Schmeing, 
Huang, Strobel, & Steitz, 2005). No ribosomal proteins are directly involved, though in bacteria, 
L27 does appear to be important for the function of the peptidyl transferase center (Maguire, 
Beniaminov, Ramu, Mankin, & Zimmermann, 2005). 
The small subunit rRNA also contributes to the proofreading ability of the ribosome. As 
discussed above, bases A1492 and A1493 contribute to A-site proofreading by hydrogen 
bonding to the minor groove of the mRNA. The A-site proofreading mechanisms alone are 
sufficiently selective that they would allow for an overall error rate of ~ 1 in 103 to 104, a 
significant proportion of the full ribosomal proofreading ability, which has an error rate of ~ 1 x 
106 (Battle et al., 2002; Johansson et al., 2008). 
 
 
17 
 
Ribosomal Protein Function 
 The crystal structure of the eukaryotic ribosome was only recently solved (Ben-Shem et 
al., 2010; Rabl, Leibundgut, Ataide, Haag, & Ban, 2011). This provided some of the first 
detailed structural information about the eukaryotic ribosomal proteins, including their location 
and intermolecular contacts. The eukaryotic ribosome is roughly 40% larger than the prokaryotic 
ribosome, and contains both RNA expansion sections and 25 proteins not found in eubacteria 
(Ben-Shem et al., 2010). Also distinguishing the eukaryotic ribosome is the degree of contact 
between ribosomal proteins. In the prokaryotic small subunit, 5 out of the 20 ribosomal proteins 
do not make any protein:protein contacts. Conversely, in the eukaryotic small subunit, most of 
the ribosomal proteins possess long C- or N-terminal tails that extend to distant locations on the 
subunit, making extensive contact with other proteins. Likewise, many of the eukaryotic 
ribosomal proteins that have direct counterparts on the prokaryotic ribosome have evolved C- or 
N-terminal extensions allowing protein:protein interactions (Rabl et al., 2011). 
Though we now have a great deal of structural information about the eukaryotic 
ribosomal proteins, their functions are not well understood. This is due in part to the difficulty 
inherent in studying essential proteins. Ribosomal proteins also present an additional challenge 
in that they function as part of a complex that also renders many mutations lethal. In the 
anecdotal examples of Rps30, Rps9, Rps26, and Rpl10, a PubMed search yields only a handful 
of papers. Moreover, these studies often simply report that a given ribosomal protein is 
implicated in a disease, or defines their extraribosomal functions, without providing insight into 
their mechanism on the ribosome. 
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Rack1 and Rps3 
 Despite our general lack of understanding about the functions of the ribosomal proteins, 
studies have elucidated the some of the activities of the proteins Rps3 and Rack1. Rps3 is present 
on both the prokaryotic and eukaryotic ribosome in essentially the same form (Rabl et al., 2011). 
It is located at the entrance to the mRNA channel where it functions as an mRNA helicase along 
with Rps4 and Rps5. These three proteins require the positively charged amino acids that extend 
into the mRNA channel for their helicase activities (Takyar, Hickerson, & Noller, 2005).   
 A great deal more information is available for Rack1. This non-essential, eukaryotic-
specific, ribosomal protein acts in a wide variety of gene expression pathways and promotes the 
ubiquitin mediated degradation of proteins (Nilsson, Sengupta, Frank, & Nissen, 2004; Rabl et 
al., 2011). The name Rack1 refers to both the human protein and the family of homologous 
proteins; however, the S. cerevisiae homologue of Rack1, Asc1, is the primary homologue 
discussed here. 
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A.        B. 
Figure 1.5. Rps3 contacts Asc1 via a long C-terminal tail and is situated at the 
mouth of the mRNA channel opposite Rps30. A. Asc1 is shown to the right of the 
picture in light gray. Rps3 is shown in dark gray with its C-terminal tail 
contacting Asc1. B. View of the small ribosomal subunit looking into the mRNA 
channel from the entry point. Rps3 and Rps30 are shown at the entry. Structural 
data from Rabl et al. 2011, viewed in PyMol. 
 
Like the other Rack1 orthologues, Asc1 is a WD40 repeat protein with a 7-bladed beta-
propeller structure (Coyle, Gilbert, & Doudna, 2009) (Fig. 1.2). The founding member of the 
WD40 family of proteins is the beta subunit of heterotrimeric G-proteins, a signaling molecule. 
The function of G-beta suggested a potentially similar role for Rack1, and it was accordingly 
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identified as a scaffolding protein in the PDE4D5- and Src signal transduction pathways. As a 
scaffold, Rack1 allows the simultaneous binding of multiple proteins, thereby promoting cross-
talk between substrates that do not interact directly (McCahill, Warwicker, B., Houslay, & 
Yarwood., 2002). As part of its role as a scaffold, Rack1, and specifically Asc1, are capable of 
forming homodimers. Each of the two Rack1 molecules in a given pair may bind discrete 
partners, thereby promoting interactions between proteins that do not bind each other directly. 
The ability to simultaneously homodimerize and also bind a second protein allows mammalian 
Rack1 to promote the Cullin complex  mediated ubiquitination of target proteins, leading to their 
degradation by the 26S proteasome (Liu et al.). 
Interestingly, Asc1 and Rps3 interact directly via the long C-terminal tail of Rps3 which 
is conserved between prokaryotes and eukaryotes (Fig. 1.5) (Rabl et al., 2011). The tail of Rps3 
contacts the WD4 domain of Asc1 which is implicated in mediating the dimerization of Asc1, a 
function critical for the ability of mammalian Rack1 to conduct ubiquitin mediated proteolysis  
 
Figure 1.6. Structure of Asc1 and the Asc1 heterodimer. (Yatime et al, J. Mol.      
Bio. 2011) 
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Rack1 was initially identified as a ribosomal protein by cryo EM (J. Sengupta et al., 
2004). On the ribosome, Rack1 promotes translation via both specific and general mechanisms: 
during initiation, Rack1 binds Protein Kinase C, leading to the phosphorylation eIF6 on the large 
subunit. This triggers the loss of eIF6 from the large subunit, thereby promoting 80S complex 
formation (Ceci et al., 2003). Rack1 also has the capability to promote the translation of specific 
transcripts by binding to the mRNA-associated factor Scp160. 
Though Rack1 clearly functions on the ribosome, it may also have extra-ribosomal 
functions. Certain mutations in the ASC1 gene partially or severely decrease the association of 
Asc1 with the ribosome, allowing the study of ribosome dependent, and independent functions. 
Strains harboring even the most potent of these mutants do not show a complete phenotypic 
overlap with ASC1 deletion strains, suggesting that Rack1 has functions both on and off the 
ribosome (Coyle et al., 2009). The functions for which ribosome binding is critical include the 
translational arrest and mRNA cleavage phenotypes in Nascent Peptide Dependent Translational 
Arrest (PDTA). In PDTA, Asc1 promotes a form of termination that releases the nascent peptide 
and triggers mRNA cleavage when the ribosome slows significantly or pauses during translation 
elongation. By detecting and resolving slow or stalled translation complexes, this system may 
represent a defense mechanism against improperly made mRNAs (Kuroha et al., 2010). The 
details of this process are described in the next section on translation surveillance mechanisms.  
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Translation Surveillance Mechanisms 
 In S. cerevisiae, translation  is monitored by several pathways that detect problems with 
ribsome:mRNA complexes. These pathways theoretically protect the cell from improperly made 
proteins and components of the translation complexes that are functioning incorrectly. Problems 
with translation can occur in all organisms, though the mechanistic details of the resolution 
mechanisms differs between eubacteria and eukaryotes. 
  
Translation Surveillance in Eubacteria 
 In E. coli and B. subtilis, mRNAs that lack a termination codon, or mRNAs that are 
translated by a ribosome which experiences an impediment to progression, are subject to the 
same type of quality control. In both cases, an RNA molecule called tmRNA resolves the stalled 
complex, acting on the mRNA, the nascent peptide, and the ribosome. As the name implies, 
tmRNA possesses structural features of both tRNA and mRNA. The tRNA-like portion of the 
molecule is aminoacylated with Alanine and bound by both Ef-Tu and an accessory protein, 
SmbP. In keeping with its structure, the tRNA-like portion of the molecule inserts into the A-site 
of the ribosome, while the mRNA portion inserts into the mRNA channel (Hallier et al., 2004). 
Due to the lack of codon:anticodon pairing, a mechanism exists to prevent kinetic proofreading 
mediated rejection of tmRNA. SmbP fulfills this role, apparently by occuping the A-site and 
interacting with bases 18S:1492 and 1493 (Nonin-Lecomte et al., 2009). After tmRNA insertion 
into the ribosome is complete, the nascent peptide is transferred to A-site alanine. tmRNA then 
extends the nascent peptide using its own internal open reading frame in a process called 
transtranslation. The extra amino acids added to the C-terminal of the nascent peptide are 
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recognized by various proteases, targeting the entire peptide for degradation (Tu, Reid, Zhang, 
Moritz, & Simpson, 1995). RNAseR (homologous to yeast Rrp44, a component of the exosome) 
was also implicated in the degradation of the mRNA, thereby precluding the possibility that a 
potentially errant mRNA will cause the formation of additional stalled complexes (Ge, Mehta, 
Richards, & Karzai, 2010). 
Beyond the degradation of aberrant mRNAs and their associated peptides, the tmRNA 
system appears to be important during both heat and cold shock (Fujihara et al., 2002). This 
suggests that problems with nascent peptide folding can also be resolved by tmRNA. 
 Despite the versatility of tmRNA, mutations in the rRNA that render the ribosome non-
functional are dominant negative. In 1990, the Noller lab demonstrated in bacteria that 16S 
rRNAs, mutated at G530, would produce small ribosomal subunits that killed the cell (Powers et 
al., 1990). These mutant subunits accumulate in the cell and also appear in polysomes, 
suggesting that they can complete initiation and 60S recruitment. Though this finding does not 
preclude the possibility that tmRNA rescues mutated ribosomes stuck during translation, it 
suggests that bacteria are unable to remove such ribosomes from the translation pool. As such, 
they  may repeatedly create new stalled complexes, sequestering mRNAs and interfering with 
normal gene expression (Powers et al., 1993; Muth, 2000). 
 
Translation-dependent mRNA Surveillance in S. cerevisiae 
 Eukaryotes and archea have not been found to possess tmRNA (Williams, 2000). Instead, 
protein-based systems have taken its place. Central to the function of the translation complex 
rescue systems is the heterodimer Dom34:Hbs1, a pair of proteins that closely resembles the 
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canonical release factors eRF1:eRF3. Both heterodimers structurally resemble EF-Tu:tRNA, 
consistent with the ability of all three pairs to insert into the A-site (Shoemaker et al., 2010). 
When Dom34:Hbs1 binds the A-site of a translating ribosome, there are multiple consequences: 
the P-site tRNA:peptide is released, the ribosomal subunits separate, and the mRNA is released. 
These events occur in a codon-independent manner, distinguishing the activity of Dom34:Hbs1 
from that of either EF-Tu:tRNA, which require the presence of a sense codon in the A-site, or 
eRF1:eRF3, which requires a stop codon in the A-site (Shoemaker et al., 2010). 
 Just as the tmRNA system promotes the degradation of the components of a stalled 
complex, Dom34:Hbs1 promotes the degradation of the mRNA, 18S rRNA, and nascent peptide 
of stalled complexes. These effects were discovered independently as part of the genetic analyses 
of Dom34:Hbs1 in three related pathways. First, the No-Go Decay (NGD) pathway was shown 
to degrade mRNAs with strong secondary structure or rare codons within the ORF. These 
structures apparently slow translation sufficiently to trigger the activity of Dom34:Hbs1, leading 
to the endonucleolytic cleavage of the mRNA (Doma et al., 2006). mRNAs encoding multiple 
lysine or arginine codons are also believed to slow ribosome progression, thereby triggering 
mRNA cleavage, translation termination, and degradation of the associated peptide. This process 
is named Nascent Peptide Dependent Translational Arrest (PDTA) (Kuroha et al., 2010). The 
Dom34:Hbs1 system also has a secondary activity that tmRNA does not: it promotes the 
degradation of mutant 18S rRNAs that are dominant negative in bacteria via the Nonfunctional 
18S rRNA decay pathway (Cole, LaRiviere, Merrikh, & Moore, 2009; LaRiviere, Cole, Ferullo, 
& Moore, 2006). 
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Figure 1.7. Translation-dependent mRNA surveillance mechanisms in S. 
cerevisiae and the corresponding references. Each pathway degrades the 
associated mRNA and is triggered by discrete mRNA mediated impediments: In 
No-Go Decay, the trigger is strong  mRNA secondary structure; in Non-Stop 
Decay the trigger is an empty A-site; and in Peptide Dependent Translation Arrest 
the trigger appears to be the translation of codons encoding positively charged 
amino acids. Dom34:Hbs1 function in each pathway. 
 
18S Nonfunctional rRNA Decay (18S NRD) 
 The experiments demonstrating the dominant effects of rRNA mutants paved the way for 
the same experiments in eukaryotes. To accomplish this, a robust system for working with 
eukaryotic rRNAs was established. Working in S. cerevisiae, multiple labs contributed to the 
development of a plasmid based system for ribosomal RNA expression. Though multiple 
iterations of the plasmid were created, the two systems relevant to this report are 2 micron 
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plasmids that encode the 35S rDNA repeat under either a constitutive Pgk1 promoter or a 
galactose inducible promoter (LaRiviere et al., 2006). Despite the fact that in vivo, the 35S rRNA 
is transcribed by RNA polymerase I, polymerase II-derived rRNAs support growth even when 
they are the only rRNAs in the cell (Venema, Dirks-Mulder, Faber, & Raué, 1995). 
 In order to detect the plasmid-derived rRNAs amid the endogenous rRNAs, sequence 
tags were inserted near the 5` ends of the 18S and 25S sequences (Beltrame & Tollervey, 1995; 
Musters et al., 1989). Importantly, these extra sequences do not appear to affect the ability of the 
rRNAs to conduct normal translation. The tags can be used for detection via northern blot with 
little to no background. 
 Initially, the constitutively expressed rRNA plasmids were tested for dominant negative 
effects. The dominant effects were not observed in bacteria until the mutant rRNAs reached 20% 
of the total, indicating that the same might be true in yeast. Yet, in a wild type yeast strain, the 
low abundance of the rDNA plasmid produced tagged rRNAs at roughly 2% of the total. To 
compensate for this, the strain YJV100 was used. This strain is a pol I deletion strain that 
remains viable due to the presence of ~10 chromosomal copies of the rDNA repeat under 
galactose-inducible promoters. Hence, YJV100 grows on galactose-containing medium and 
ceases growing on glucose, due to repression of the galactose-inducible promoter. Due to the low 
endogenous levels of rRNA expression in YJV100, when plasmid-derived rRNAs are expressed, 
their final concentration represents a significantly higher percentage of the total rRNAs in the 
cell – roughly 20%. Hence in YJV100, the dominant effect of a given rRNA mutation should be 
detectable. Moreover, the ability to turn off the expression of chromosome-derived wild type 
rRNAs makes it possible to grow this strain on plasmid-derived rRNAs alone. As such, it is 
possible to ask two questions: 1) Is a given rRNA mutation dominant negative? 2) Can cells 
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grow using a particular mutant rRNA, when it is the only rRNA in the cell? The subsequent 
experiments in YJV100 demonstrated that cells live when 18S:A1492C and 18S:G530U are 
present at high abundance, though neither mutant 18S is able to support growth on its own. This 
suggested that yeast possesses a mechanism for dealing with mutant 18S rRNAs. Follow-up 
experiments quantified mutant 18S rRNA abundance and found that in both cases, levels were 
greatly depleted at steady state, suggesting that cells may be degrading the deleterious rRNAs. In 
order to detect degradation, the same constructs were used in a pulse-chase assay. Following a 
brief induction, glucose was added and the stability of both the plasmid-derived 18S and 25S 
rRNAs was monitored over a 2-hour period. Though the wild type 18S and 25S were stable over 
this period, both of the mutant 18S rRNAs disappeared with a half-life of roughly 75 minutes. 
This established that nonfunctional rRNA decay (NRD) occurs in yeast (LaRiviere et al., 2006). 
 In an effort to define the trans-acting factors in NRD, strains lacking DOM34 and HBS1 
were tested for their ability to conduct NRD. Results showed that the rate of NRD is diminished 
by approximately half in the absence of either protein. This effect is not additive when the two 
deletions are combined, suggesting that both halves of the heterodimer are required. Moreover, 
the fact that 18S NRD still continues without Dom34 and Hbs1 indicates that other factors are 
promoting NRD independently (Fig. 1.8) (Cole et al., 2009). 
 
28 
 
 
Figure 1.8. Models for 18S NRD, NGD, and PDTA (not reflecting unpublished 
data). A. NRD - Small ribosomal subunits containing a mutant 18S:A1492C 
rRNA are targeted for degradation via the action of Dom34:Hbs1, and previously 
unidentified factors.  B. NGD - Dom34:Hbs1 promote the cleavage of the NGD 
substrate mRNA by unidentified nucleases. C. PDTA - mRNA cleavage by 
unidentified nucleases is promoted by Dom34:Hbs1 and Asc1. Fragments of all 
substrate RNAs are degraded by Xrn1 and the cytoplasmic exosome. 
 
 18S NRD substrates also accumulate in cytoplasmic foci called P-bodies. P-bodies 
contain translationally silenced mRNAs and a number of RNA degradation factors including 
decapping enzymes, and the major cytoplasmic 5`-3` exoribonuclease Xrn1. As such, they 
appear to represent a site used for the sequestration or degradation of nonfunctional ribosomes 
(Cole et al., 2009). 
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The discovery that mutant 18S rRNAs localize to P-bodies represents a second overlap 
between 18S NRD and the NGD pathway. No-Go mRNAs are cleaved in a Dom34:Hbs1 
dependent manner and also accumulate in P-bodies (Cole et al., 2009). These overlaps suggested 
that the NGD and NRD pathways may overlap. By extension, the Nascent Peptide Dependent 
Translational Arrest (PDTA) pathway may overlap as well. This possibility sets up the 
hypothesis that all stalled ribosome:mRNA complexes may be subject to degradation of the 
ribosome, mRNA, and nascent peptide.  
 
Translation-Independent Ribosome Degradation 
 In addition to the translation-dependent 18S NRD pathway discussed above, ribosomes 
are subject to translation-independent degradation. In yeast, three such pathways have been 
reported to degrade the large and small ribosomal subunits: 25S NRD, 60S Ribophagy, and 40S 
Ribophagy(Kraft, Deplazes, Sohrmann, & Peter, 2008; LaRiviere et al., 2006; Ossareh-Nazari et 
al., 2010). These pathways utilize a number of trans-acting factors that have not been examined 
for effects in NRD, NGD, NSD, and PDTA. 
 The 25S NRD pathway selectively detects and degrades mutant 25S:U2585A and 
25S:A2451G  rRNAs that are part of, apparently immature, 60S subunits (Cole et al., 2009; 
LaRiviere et al., 2006). These two bases are located in the peptidyl transferase center of the 60S 
and directly participate in the aminotransfer reaction, suggesting that mutations at this location 
may decrease the ability of the 60S to function properly. Consistent with this hypothesis, E. coli 
cells incorporate the equivalent mutant rRNAs, 23S:U2585 and 23S:A2451, into mature subunits 
that demonstrate a highly compromised capacity for producing protein. These mutant rRNAs 
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ultimately kill the cell via dominant effects when they are expressed at ~20% of the total 25S 
rRNAs in the cell (Youngman, Brunelle, Kochaniak, & Green, 2004).  In yeast, 25S:U2585A 
rRNAs are not dominant negative. Instead, they are selectively degraded with a half-life of 
approximately 80 minutes. Unlike the translation-dependent 18S NRD pathway, the application 
of the translation inhibitor cycloheximide does not decrease the rate at which 25S NRD occurs 
(Cole et al., 2009). This functional distinction between 25S and 18S NRD suggests that these 
pathways are distinct. Moreover, localization data indicate that mutant 25S rRNAs collect at the 
nuclear periphery, suggesting 25S NRD may represent a quality control measure for immature 
60S subunits (Cole et al., 2009). 
 Ribophagy is another translation-independent ribosome turnover pathway. During 
starvation, cells consume their intracellular organelles, including the peroxisomes, mitochondria, 
and ribosomes, via the process of autophagy (Kraft et al., 2008). The term “ribophagy” refers to 
one specific aspect of autophagy that is responsible for the degradation of the large and small 
ribosomal subunits. As part of ribophagy, both of the ribosomal subunits localize to the vacuole, 
apparently via discrete mechanisms. Though the proteins responsible for small subunit 
translocation are unknown, large subunit ribophagy is promoted by Doa1, Ubp3/Bre5, and 
Cdc48 (MacIntosh et al., 2011; Ossareh-Nazari et al., 2010; Kraft et al., 2008). Moreover, 
ribophagy requires the general autophagy proteins Atg7 and Pep4 (Ossareh-Nazari et al., 2010). 
The Doa1/Ubp3/Bre5/Cdc48 group is also involved in the ubiquitin mediated selection of 
cytosolic proteins for degradation by the 26S proteasome (Ossareh-Nazari et al., 2010). In this 
capacity, Doa1 functions as an adaptor protein, binding ubiquitin on ubiquitinated proteins and 
thereby promoting the Cdc48-mediated passage of these target proteins to the 26S proteasome 
(Ren, Pashkova, Winistorfer, & Piper, 2008). As part of this pathway, Ubp3 functions as a 
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ubiquitin protease, recycling the ubiquitin tag prior to proteolysis (Doelling et al., 2007). In 
ribophagy, the 26S proteasome appears to be expendable, suggesting that ribophagy is 
functionally distinct from these turnover events. One possible function for Doa1/Ubp3/Cdc48 in 
ribophagy is the promotion of ribosome translocation into the vacuole (Ossareh-Nazari et al., 
2010). 
 Like ribophagy, 25S NRD is promoted by the ubiquitin system(Fujii, Kitabatake, Sakata, 
Miyata, & Ohno, 2009a). A screen for factors involved in 25S NRD demonstrated that 
25S:U2585A rRNAs are stabilized in the absence of Mms1 and Rtt101, two members of the 
Cullin complex that function as E3 ubiquitin ligases (Fujii, Kitabatake, Sakata, Miyata, & Ohno, 
2009b). Though the target of ubiquitination is unclear, western blot data show that at least three 
ribosomal protein targets are ubiquitinated in an Rtt101 and Mms1 dependent manner.  
 Ubiquitin has also been implicated in the stability of wild type ribosomes.  Research on 
the essential E3 ubiquitin ligase Rsp5 has demonstrated that expression of dominant negative 
forms of the protein lead to widespread ribosome turnover (Shcherbik et al., 2011). Similarly, 
wild type rRNAs in an Rsp5 temperature-sensitive strain are uniformly degraded when the 
culture is raised to the restrictive temperature. Non-coding RNAs and mRNAs are also degraded, 
but to a far lesser extent, suggesting that Rsp5 is either directly or indirectly controlling ribosome 
stability (Shcherbik et al., 2011). 
 
RNA Damage 
 Damaged RNAs may be one of the targets of translation surveillance pathways discussed 
above. Though the effects of RNA damage were overlooked for many years due to the presumed 
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ease with which RNAs can be degraded, many reports over the past decade have demonstrated 
that RNA damage is common. Cellular metabolism in most cell types produces alkylating and 
oxidizing agents that chemically modify DNA and RNA. In humans, the accumulation of 
damaged RNAs correlates with the severity of neurological disease, suggesting that RNA 
damage is a very real threat to the health of our cells (Nunomura et al., 2009; Nonumura et al., 
2006). Presumably, RNA lesions may lead to miscoding, ribosome dysfunction, and other 
translation problems, potentially causing the translational stalling that triggers NGD, NRD, NSD, 
or PDTA.  
RNA Oxidation 
 RNA damage appears to play a role in human disease. Though no study has directly 
implicated damaged RNA as the causative agent of any illness, oxidized RNAs and decreased 
protein expression are correlated with diseases such as diabetes and Alzheimer’s disease 
(Nunomura et al., 2009). Contributing to the oxidation of RNAs in the central nervous system are 
the high prevalence of oxidation reactions relative to the rest of the body, high concentrations of 
redox-capable metals, and low concentrations of anti-oxidants (Nunomura et al., 2009). 
Furthermore, neurons in the central nervous system are bombarded by additional reactive oxygen 
species produced by the microglia that surround them (Block, Zecca, & Hong, 2007). 
 Several model systems support the oxidative stress hypothesis of neurological disease.  
For example, mice doubly deficient for the anti-oxidant enzyme superoxide dismutase 2 (Sod2) 
have extremely brief lifespans and display muscle weakness and other symptoms corresponding 
to amyotrophic lateral sclerosis (Nunomura et al., 2009). This matches well with the observation 
that neurons from patients with Alzheimer’s disease display highly oxidized RNAs including 
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rRNAs and mRNAs (Anderson, 2004). Testing in human leukocytes, among many other cell 
lines, indicates that RNA rather than DNA is the major target of oxidation in the cell (Shen, Wu, 
& Hazen, 2000). In vitro experiments in rabbit reticulocyte lysates demonstrated that oxidized 
mRNAs accumulate in heavier fractions and produce less protein, suggesting that ribosomes may 
stall on such mRNAs, leading to the accumulation of additional ribosomes (Fig. 1.9) (Shan, 
Chang, & Lin, 2007). Moreover, oxidized transcripts cause translation errors (Tanaka, Chock, & 
Stadtman, 2006). Accordingly, in the CNS neurons of Alzheimer’s disease patients, oxidized 
transcripts and malfunctioning ribosomes are correlated with a relative paucity of protein 
expression compared to that of healthy individuals (Nunomura et al., 2009). 
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Figure 1.9. Proposed model explaining the observation that oxidized mRNAs 
accumulate in heavier polysome fractions. A. The cannonical translation cycle. 
Following subunit dissociation, individual subunits will initiate again on the same 
or a new mRNA. B. Oxidized RNA bases may prevent proper codon:anticodon 
pairing, impairing translation and leading to additional stalling of upstream 
ribosomes. This could lead to an accumulation of oxidized mRNAs in heavier 
polysome fractions. 
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 Hence, endogenously produced, reactive oxygen species may promote disease via RNA 
oxidation. Though the mechanism by which RNA damage precipitates disease is unknown, the 
changes in protein level suggest that the cell may lose its ability to control gene expression at the 
level of translation.  
RNA Alkylation 
Cellular metabolism produces alkylating agents that modify DNA and RNA. Though 
these agents typically react weakly with the DNA, at physiological concentrations they promote 
mutagenesis (Taverna & Sedgwick, 1996). Examples of endogenous alkylating agents include S-
Adenosylmethionine, which is a common component of the methyl group transfer reactions in 
bacteria, and nitrosated amines, which can be formed from bile acids. Both examples are O-
alkylating agents (Drabløs et al., 2004). 
Alkylation damages both DNA and RNA in similar ways. Depending upon the particular 
agent, alkylation may occur on all oxygen and nitrogen atoms, producing a plethora of damaged 
species. Though the potential variety is vast, most alkylation damage is in the form of 7-alkylG 
in both DNA and RNA (Shooter, Howse, Shah, & Lawley, 1974) This modification is, generally 
speaking, not directly harmful to the cell. However, in DNA, such lesions are quickly removed 
via base-excision repair, thereby producing apurinic site intermediates that can be cytotoxic 
(Memisoglu et al., 2000). Alkylated RNAs are also repaired. The recent discovery of the 
oxidative human RNA demethylases AlkB and AlkBH3 suggests that the ability to clear 
alkylated RNAs provides a selective advantage for cells (S. Wu et al., 2011). Based upon the 
theorized ability of damaged RNAs to cause translation problems, it is also possible that the 
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translation surveillance mechanisms NGD, NSD, NRD, and PDTA may be responsible for the 
clearance of damaged RNA species (P.A. Aas et al., 2003). 
RNA repair may have implications for human health following exogenous RNA 
alkylation during chemotherapy. To destroy cancer cells, doctors often deliver alkylating agents 
such as Cisplatin, Oxiplatin, and Temodar (Takimoto & Calvo, 2008). These agents selectively 
damage fast-growing cells, thereby targeting the cancer cells while generally sparing healthy 
cells. Despite this partial selectivity, DNA and RNA of healthy cells are also damaged by 
chemotherapy agents. This raises the possibility that RNA damage may be relevant to the 
survival of healthy cells and cancerous cells alike. Accordingly, decreased expression of the 
RNA demethylase AlkB and AlkBH3 in cancer cells leads to increased apoptosis during 
Cisplatin treatment (S. Wu et al., 2011). 
 
UV Damage to RNA 
 Ultraviolet light damages RNA, producing photochemical modification, cross-linking, 
and oxidative damage. These products were originally detected in vitro using RNA from the 
tobacco mosaic virus, as well as poly(U), and poly(C). Damaged RNAs were enzymatically 
hydrolyzed and separated by chromatography to detect dimers and modified nucleotides.(Small, 
Tao, & MP, 1968). Researchers observed that UV treatment produced cyclobutane pyrimidine 
dimers, uridine hydrate, and cytidine hydrate (Miller & Cerutti, 1968; Singer, 1971). They also 
demonstrated that single-stranded RNA is more susceptible to UV damage than double-stranded 
RNA (Pearson & Johns, 1966). Essentially, these findings established that UV should modify 
RNA in a manner similar to DNA, likely preventing its proper function. 
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 The question of whether the UV exposures used in vitro are relevant for normal 
physiological conditions has also been addressed. UV-C, corresponding to wavelengths 200-290 
nm, was initially used in the RNA damage tests(Gambichler et al., 2006). These wavelengths are 
typically filtered by the ozone layer, such that it is mainly UV-B and UV- C that reach the 
earth(Gambichler et al., 2006). UV- B and UV-A have less energy than UV-C but reach the earth 
in higher amounts and can penetrate farther into tissue. A dose of UV-A/B relevant for human 
health is 704 ± 188 J/m2, which represents the minimum amount of energy needed to produce a 
sunburn (Gambichler et al., 2006). This is roughly the amount of energy a person would absorb 
during an hour of sun exposure in the northern hemisphere (Ambach & Blumthaler, 1993). A 
dose of physiologically relevant UV-B (specifically 600 J/m2) produces measurable 
impediments to reverse transcriptase in the 28S rRNA of cultured mammalian cells (Iordanov et 
al., 1998). Given preferential location of these impediments adjacent to pyrimidine nucleotides, 
these lesions are likely to be pyrimidine dimers. Hence, normal environmental exposure to UV is 
likely to produce pyrimidine dimers in RNA.  
 Evidence for UV-mediated RNA crosslinking has also been reported. Crosslinks between 
RNA and protein have been reported for many years as a tool to study the ribosome (Möller, 
Zwieb, & Brimacombe, 1978).  Moreover, RNA-RNA crosslinks have been shown to form in E. 
coli cells after UV-A irradiation. One major group of these cross-links include cytidine - 
pseudouridine bases (Ramabhadran, Fossum, & Jagger, 1976). UV-cross-linked tRNAs with 
these cross-links have lower rates of aminoacylation and produce less protein in translation 
assays (Ramabhadran et al., 1976).  
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Damaged RNAs Are Removed from Cells via Unidentified Processes 
 Despite the frequency with which damaged RNAs are formed, it is only recently that the 
impact of damaged RNAs has garnered much attention. In the past 10 years, an increasing 
number of reports  have demonstrated the turnover of damaged RNAs by unidentified pathways. 
Three examples in bacteria and plants are discussed below. In each case, cells treated with a 
genotoxic stressor caused widespread mRNA or rRNA turnover.  
 In the plant model system Z mays, leaf cells selectively degrade ribosomal RNAs 
following UV exposure (Casati & Walbot, 2004). Though the process is slow, occurring over the 
course of 16-24 hours, the selective turnover is clearly demonstrated and correlates with 
decreased protein expression. The loss of ribosomes is apparently compensated for by the 
subsequent increase in transcription of ribosomal protein genes. 
 Likewise, in A.thaliana, mRNAs are turned over following UVB exposure (Revenkova et 
al., 1999). This turnover is measured relative to non-coding RNAs, suggesting that the non-
coding RNAs are not degraded as quickly or are not degraded at all. This, in turn, suggests that 
translation may be required for the selective degradation of damaged RNAs. 
 
 To complement the studies of RNA turnover in plants, additional damaging agents in a 
variety of systems have triggered RNA turnover. In one example, E. coli cells damaged via 
hyberbaric oxygen treatment display widespread ribosome degradation. Here cells were grown in 
a hyperbaric chamber containing air plus 300 psi nitrogen or 300 psi oxygen. The mortality of 
the cells grown in the presence of high-pressure oxygen increased dramatically relative to the 
cells grown in high-pressure nitrogen (Harley, Flaks, Goldfine, Bayer, & Rasmussen, 1980). This 
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increase in cell mortality correlated with rRNA turnover, indicating that oxidative rRNA damage 
might contribute to cell death. 
 In conclusion, RNA damage appears to promote both cell death in a variety of organisms, 
and human disease. Though the mechanism by which this occurs is not yet clear, it is possible 
that damaged RNAs sequester translation factors and ribosomes, potentially leading to improper 
gene expression. 
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Chapter 2: 
Turnover of nonfunctional rRNAs requires ribophagy factors and the 
ribosomal protein Asc1 
 
Introduction 
Production of functional proteins depends upon accurate mRNA translation. Impediments 
to translation are known to slow, or potentially stall, ribosome:mRNA complexes, subsequently 
interfering with the formation of full-length peptides. A variety of events have been shown to 
promote such stalls, including oxidation of the associated mRNA, depurination of the rRNA by 
biological toxins, mutation of the rDNA, and impairment of ribosomal subunit maturation (Shan 
et al., 2007; Barbieri et al., 1992; Lariviere et al., 2006; Soudet et al., 2010). The variety of 
sources suggests that ribosome stalling may not be uncommon. Accordingly, at least four 
pathways are known to monitor the process of translation for the purposes of resolving stalled 
translation complexes. 
The process of No-Go Decay (NGD) selectively degrades transcripts that have strong 
secondary structures in the open reading frame or that encode a series of rare codons (Doma et 
al., 2006). These two features are believed to slow ribosome progression, subsequently triggering 
the observed endonucleolytic cleavage of the transcript. Non-Stop Decay (NSD) degrades errant 
mRNAs that lack a termination codon, leading to the formation of a stalled ribosome with the 
final 3 nucleotides of the mRNA in the P-site (L. N. Dimitrova, Kuroha, Tatematsu, & Inada, 
2009; Inada & Aiba, 2005). Such mRNAs are degraded by the exosome in a 3` to 5` manner 
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(Schaeffer et al., 2011). A third mechanism, Nascent Peptide Dependent Translational Arrest 
(PDTA) is triggered by mRNAs that encode serial arginine or lysine codons. It was initially 
hypothesized that PDTA causes ribosome stalling when positively charged lysine or arginine 
amino acids stick to the negatively charged peptide exit channel (Kuroha et al., 2010). PDTA 
entails dual consequences – endonucleolytic mRNA cleavage and degradation of the nascent 
peptide (Kuroha et al., 2010). Stalled complexes also have consequences for the ribosome vis a 
vis, the Non-Functional 18S rRNA Decay (18S NRD) pathway. This translation-dependent 
mechanism selectively degrades the 18S rRNA component of 40S subunits believed to be 
defective for proper codon:anticodon pairing (Cole et al., 2009; LaRiviere et al., 2006). 
Presumably, ribosomes stalled for a variety of reasons, including those discussed above, may 
also be subject to 18S NRD. 
In keeping with the common theorized triggers, these pathways may share common 
mechanisms. NRD, NGD, and PDTA are all promoted by the same trans-acting heterodimer, 
Dom34:Hbs1(Cole et al., 2009). In vitro experiments have shown that these two proteins insert 
into the ribosomal A-site, subsequently promoting the codon-independent release of the 
ribosomal subunits, mRNA, and tRNA-peptide (Shoemaker et al., 2010). Therefore, their activity 
is ideally suited for the remediation of immobile translation complexes.  
Recently, additional trans-acting factors have been identified in NSD and PDTA, 
suggesting that they may have roles in NRD and NGD. In PDTA, the ribosomal small subunit 
protein Asc1 (of the Rack1 family) was shown to promote the translational arrest phenotype 
(Kuroha et al., 2010). Moreover, in both PDTA and NSD, the associated nascent peptide is 
ubiquitinated, leading to its degradation by the 26S proteasome(Ito-harashima, Kuroha, 
Tatematsu, & Inada, 2007). In PDTA, this process is carried out by the E2 conjugase Ubc4 and 
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the E3 ubiquitin ligase Not4 as part of the Ccr4/Not4 complex. In NSD, the E3 ubiquitin ligase 
Ltn1 fulfills the same role with an unidentified E2 conjugase (Bengtson et al., 2010).  
 
Rack1 
 The H.sapiens and A.thaliana homologues of Asc1, known by the family name Rack1, 
have been the subject of numerous studies. Mechanistic analyses of Rack1 which have identified 
a number of regulatory mechanisms including phosphorylation, sumoylation, and protein:protein 
interactions (B. Y. Chang, Chiang, & Cartwright, 2001; Dell et al., 2002; Yang & Grégoire, 
2006). Figure 2.2 displays the phosphorylated tyrosines and proposed sumoylation sites.  
Sumo is a small, ubiquitin-like protein that is covalently attached to the lysine residues of 
certain proteins that contain consensus sumoylation sequences, as one aspect of the post-
translational modification process. Sumoylation has been proposed to alter protein:protein 
interactions, promote compartmentalization, and modify protein stability (Ullah et al., 2008). The 
proposed regulation of Rack1 by sumo is based upon the discovery of multiple examples of the 
sequence ψKxExxSP, called a “phosphor-sumoyl switch” that is predicted to be both 
phosphorylated on the serine residue and subsequently sumoylated on the lysine residue (Yang & 
Grégoire, 2006). The discovery of phosphor-sumoyl switches was based initially on the finding 
that the ψKxE sequence can be sumoylated, and that downstream serine residues can be 
phosphorylated (Melchior, Schergaut, & Pichler, 2003). Later investigations determined that 
sumoylation in phosphor-sumoyl switches can be dependent upon serine phosphorylation (Y. 
Hong et al., 2001).  
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The anticipated tyrosine phosphorylation sites on Rack1 represent residues conserved 
between Arabidopsis, flies, humans and yeast. In humans, these two residues, Y248, and Y246, 
are phosphorylated by the protein Src, leading to enhanced Rack1:Src binding. Despite the lack 
of tyrosine kinases in yeast, it has been suggested that under certain circumstances, 
serine/threonine kinases may also phosphorylate tyrosine residues. The combined availability of 
a potential kinase and the conservation of the two known regulatory sites suggest that Y248 and 
Y246 may alter Rack1 activity in yeast (Fig. 2.2B). 
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A.        
 
 
B. 
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C. 
Figure 2.1. Crystal structures of the eukaryotic ribosome, Rack1, and Dom34:Hbs1. A.Hbs1 
contacts Rps3 via its N-terminal domain (Adapted from Becker et al. 2011) B. Rack1 forms 
homodimers via its WD4 domain (Adapted from Sengupta et al. 2004). C. Rps3 interacts with 
Rack1 via its long C-terminal tail (Adapted from Rabl et al. 2011).  
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B.  
Figure 2.2. ASC1 mutational analysis schematic. A. The effect of various ASC1 mutations on 
ribosome binding is displayed (Adapted from Coyle et al. 2010). B. Analysis of ASC1 functional 
domains, and conserved structures (Adapted from Sengupta et al. 2004). 
 
Protein:protein, and ribosome interaction domains are conserved between Rack1 
orthologues. The two main interactions surfaces are on the opposing sides of the planar ring 
structure. On the ribosome, one plane faces the ribosome, and the other faces the cytosol (Coyle 
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et al., 2009). On the yeast Asc1 protein, a long loop faces into the cytosol, and represents one of 
the asymmetric features of the protein (Fig. 2.1A, C, D). Asymmetric features of WD40 repeat 
proteins are known to mediate protein binding, suggesting a possible function for the cytosolic 
loop. An additional asymmetric structure is the ribosome-facing “knob” structure which was 
initially suspected to mediate ribosome binding, a hypothesis that has since been disproven 
(Coyle et al., 2009). However, ribosome binding mutants have been developed, leading to the 
discovery that the interaction of Rack1 with the ribosome is critical for a number of Rack1’s 
functions, including its role in PDTA (Coyle et al., 2009; Kuroha et al., 2010).  
 
Ribophagy 
 Given the functional overlap between 18S NRD and the mRNA surveillance pathways, 
general ribosome turnover mechanisms may have implications for translation surveillance.  
Though endogenous ribosomal degradation pathways are not well understood, a number of 
proteins have been shown to promote the selective degradation of ribosomes during starvation in 
a process known as ribophagy (Kraft et al., 2008). Ribophagy represents one specific branch of 
the autophagy pathway and, therefore, relies on general autophagy proteins. Though the 
ribophagy proteins responsible for small ribosomal subunit degradation are unknown, several 
proteins that carry out large subunit degradation have been identified. These include the 
ubiquitin-binding protein Doa1, which functions as an adaptor protein for the AAA+ ATPase 
Cdc48. Doa1 is capable of binding to both the ubiquitin tag of ubiquitinated proteins and Cdc48, 
allowing the Cdc48-mediated passage of the target protein to the 26S proteasome where they are 
degraded. Indirect evidence in Arabidopsis suggest that the nuclease responsible for the rRNA 
degradation portion of ribophagy may be the endoribonuclease RNAse T2 (yeast Rny1), which 
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also appears to affect translation through the cleavage of tRNAs (MacIntosh et al. 2011; 
Thompson et al., 2009). Interestingly, application of the 26S proteasome inhibitor MG132 did 
not affect the rate of large subunit ribophagy, suggesting that ribophagy functions via an 
independent mechanism (Ossareh-Nazari et al., 2010). Accordingly, in ribophagy, both Cdc48 
and Doa1 appear to be important in the transport of ribosomes into the vacuole, where 
degradation events are carried out. 
In the current study, we present evidence that a subset of the factors involved in NSD, 
PDTA, and 60S ribophagy also promote 18S NRD. 
 
Results 
18S NRD shares a subset of factors with PDTA 
Recent work on translation surveillance and ribosome degradation pathways has 
implicated the involvement of several new proteins, raising the possibility that these factors 
could also have effects on NRD. To test this possibility, we conducted a survey of genes reported 
to act in PDTA, ribophagy, NSD, and endogenous rRNA turnover pathways, and tested the 
respective deletion strains for effects on mutant 18S:A1492C rRNA degradation. To expedite the 
process, we used a single timepoint assay similar to that used by van den Elzen et al. 2010, rather 
than the time course analyses used in our previous publication (Cole et al., 2009). For this assay, 
a gene deletion strain from the BY4741 knock-out collection and the isogenic WT strains were 
transformed with plasmids encoding galactose-inducible wild type 18S, or mutant 18S:A1492C 
rRNAs, known to be targeted by NRD. Also encoded on the plasmids is a wild type 25S rRNA, 
which is stable in the cell and can be used to normalize the 18S rRNA levels. Three individual 
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replicates of each transformed strain were grown to mid-log (OD600 = 0.5) in synthetic drop-out 
medium, in the presence of raffinose. rRNA expression was then induced for 90 minutes via the 
addition of galactose. We then harvested the cultures and subjected total RNA preparations to 
northern blot analysis. By probing for sequence tags integrated into the plasmid-derived 18S and 
25S rDNA genes, we were able to quantify the 18S and 25S rRNA levels in each sample. The 
18S:25S rRNA ratios were plotted relative to the levels observed in the isogenic wild type strain. 
We first validated the single timepoint assay by comparing the levels of mutant 18S 
rRNAs in the dom34Δ strain, which is known to produce a 2-fold decrease in the rate of 18S 
NRD in timecourse assays (Cole et al., 2009) (Fig. 2.3A and 2.3B). At both 45 minutes and 90 
minutes after induction of rRNA transcription, we observe levels of mutant 18S rRNAs in the 
dom34Δ strain roughly 2-fold higher than the levels in the WT strain. This demonstrates that 
even a partial loss of 18S NRD is detectable using both the timecourse and single timepoint 
assays (Fig. 2.3A).  
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Figure 2.3. Mutant 18S:A1492C destabilization in various deletion strains. A. 
18S NRD timecourse in WT and dom34∆ strains as previously demonstrated. 
Quantitation (top) of northern blot analysis (bottom). T0 18S:25S ratio is set to 1 
for both strains. B. Single timepoint analysis recapitulates timecourse data. Data 
for mutant 18S rRNA levels at 45 and 90 minutes post transcriptional induction in 
WT and dom34∆ cells. 18S rRNA levels are normalized to the WT 25S and 
displayed relative to levels of WT 18S level observed in the WT strain.  
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Figure 2.4. Gene deletion strains tested for effects on 18S NRD. Deletion strains 
transformed with WT or Mutant 18S rRNA constructs were subjected to Single Timepoint 
Assays. The abundance of WT or Mutant 18S rRNAs in each strain were determined by northern 
blot. Respective 18S rRNA levels were normalized to WT 25S rRNA levels in the same strain 
and plotted relative to the normalized, WT 18S rRNA levels in the WT strain.  
 
We then tested a number of strains deficient for PDTA, Ribophagy, and NSD factors for 
effects on 18S NRD.  In two of the three PDTA gene deletion strains, asc1Δ, and ubc4Δ, we 
observed higher levels of mutant 18S rRNAs. We also observed increased levels in doa1Δ and 
pep4Δ (Fig. 2.4). Based upon these initial data, we suspected that Asc1, Ubc4, Doa1, and Pep4 
might be involved in NRD. 
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Asc1 functions in parallel with Dom34 
Due to the observation that ASC1 or DOM34 deletion only leads to a partial effect on 
PDTA and NRD (Fig 2.4), we suspected that these two proteins might be functioning in parallel. 
To test this possibility, we constructed an asc1Δdom34Δ strain and analyzed its effects on NRD 
via a single timepoint assay. The mutant 18S rRNA levels in this strain were indistinguishable 
from WT 18S levels (Fig. 2.5A). These data suggest that in the absence of either Dom34 or 
Asc1, the other is still capable of promoting 18S NRD, and that in the absence of both, the loss 
of NRD is sufficiently severe that 18S NRD might be completely ablated. 
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Figue 2.5. Double deletion of ASC1 and DOM34 is synthetic for 18S NRD. 
WT, dom34∆, asc1∆, and dom34∆asc1∆ strains harboring WT (Left) or mutant 
(Right) 18S rDNA plasmids were assayed via A) single timepoint assay, or B) 
pulse-chase assay. In both experiments, the 18S:25S rRNA ratio in each lane was 
determined via northern blot, shown below the graph in A, and to the left of the 
graphs in B. In the single timepoint assay, the WT 18S:25S ratio in the WT strain 
is set to 1. In the pulse-chase analysis, the T0 18S:25S ratio (WT or Mutant) in 
each timecourse is set to 1. 
 
In the asc1Δ and dom34Δasc1Δ strains, mutant 18S rRNAs could potentially attain 
increased levels via an increase in production or a decrease in the rate of degradation. To 
distinguish between these two possibilities, we conducted a pulse-chase assay, and monitored 
mutant 18S rRNA stability over three hours (Figure 2.5B). In keeping with our previous study, 
our timecourse represents the chase portion of a pulse-chase assay ((Cole et al., 2009; LaRiviere 
et al., 2006). Here, strains harboring wild type or mutant 18S rDNA plasmid were grown to mid-
log in drop-out medium containing raffinose. rRNA transcription was then induced for 45 
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minutes via galactose addition, and shut off via glucose addition. The first timepoint was 
collected immediately after transcriptional repression and at 30 minute intervals thereafter. As 
with the single timepoint assay, levels of the plasmid-derived 18S and 25S rRNAs were 
determined via northern blot and plotted in the form of the 18S:25S ratio for each data point. 
Results of the timecourse demonstrate that at T0, mutant 18S rRNA levels are no lower than WT 
18S levels. Moreover, the rate of 18S NRD is decreased by roughly 2-fold in the dom34Δ and 
asc1Δ single deletion strains, consistent with the results of the single timepoint assay. Combining 
the deletions produces the previously observed synthetic effect, leading to a severe loss of 
mutant 18S rRNA degradation.  Again, these data suggest that Dom34 and Asc1 are both capable 
of functioning independently to promote 18S NRD, and raise the possibility that mutant 18S 
rRNAs may be fully stabilized in the dom34Δasc1Δ strain. 
 
In the absence of UBC4, 18S NRD is not detectable 
Data from the initial single timepoint assay shows that, in the absence of UBC4, the 
mutant 18S rRNA level is equivalent that of the WT 18S (Fig. 2.4). Again, to confirm that 
increased mutant 18S rRNA levels are due to a loss of degradation rather than increased 
synthesis, we conducted a pulse-chase assay. Given the high mutant 18S levels in this strain, we 
also decided to increase the resolution of the timecourse assay by extending its duration to 6 
hours. Results show that mutant 18S rRNA degradation was not detectable in the ubc4∆ strain 
over this period, suggesting that it is the loss of degradation that led to the high mutant 18S 
levels in the single timepoint assay (the same ubc4Δ data are depicted in both Fig. 2.6A and 
2.6B). We also considered the possibility that double deletion of UBC4 and either DOM34 or 
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ASC1 could potentially have a compensatory effect on the rate of 18S NRD, and thereby provide 
mechanistic insights into the role of UBC4. To this end, we developed both ubc4∆dom34∆ and 
ubc4∆asc1∆ strains, and ran pulse-chase assays to determine the rate of NRD in each strain (Fig. 
2.6A, 2.6B). Again, we failed to observe any loss of mutant 18S rRNAs. This suggests that 
UBC4 is required for one of the steps in the NRD pathway, and that it therefore operates at a 
level distinct from both Dom34 and Asc1. 
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Figure 2.6. 18S NRD is not detected in the absence of UBC4.  A) Wt, dom34∆, 
ubc4∆, and dom34∆ubc4∆ strains harboring WT 18S (left graph) or Mutant 18S 
(right graph) rDNA plasmids were subjected to pulse-chase analysis. The T0 
18S:25S ratio for each timecourse was set to 1. Northern blots of representative 
timecourses are shown on the far left. B) Pulse-chase analysis of Wt, asc1∆, 
ubc4∆, ubc4∆asc1∆ strains performed as in 3A. 
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The Ribophagy protein Doa1 is epistatic to DOM34, but not ASC1 
In addition to the overlap between 18S NRD and the other translation surveillance 
pathways, we also suspected a functional overlap with the ribosome degradation pathway, 
ribophagy. In order to test the effects of ribophagy proteins in 18S NRD, we assayed strains 
deficient for the reported ribophagy genes, ATG7, PEP4, BRE5, UBP3, and DOA1, as well as a 
the temperature-sensitive strain cdc48-3. Again we used our single timepoint assay to quantify 
the effects of each gene deletion/mutation on NRD. In the case of the CDC48 ts mutant, we grew 
cdc48-3 cells harboring both the WT 18S and mutant 18S rDNA plasmids to mid-log phase in 
the presence of raffinose, at the permissive temperature, 30o. We then added galactose and 
immediately split the cultures in half, leaving one group at the permissive temperature and 
transferring the other group to the restrictive temperature, 37o. After a 90-minute incubation, we 
harvested the cells and completed the northern blot analysis as described above.  
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Figure 2.7. DOA1 deletion confers a partial stabilization of mutant 18S 
rRNAs and is synthetic with ASC1 deletion. A) Wt, dom34∆, doa1∆, 
dom34∆doa1∆ strains harboring Wt 18S (Left) or mutant 18S (Right) rDNA 
plasmids were subjected to pulse-chase analysis. The T0 18S:25S ratio for each 
timecourse is set at 1. Northern blots of representative timecourses are shown on 
the far left.  B) Pulse-chase analysis of Wt, asc1∆, doa1∆, and asc1∆doa1∆ were 
performed as in 4A. 
 
Among this group of ribophagy-deficient strains, only the doa1Δ strain showed increased 
levels of the mutant 18S, suggesting an incomplete overlap between 18S NRD and ribophagy. 
The 2-fold effect of DOA1 deletion indicates that Doa1 is not absolutely required for 18S NRD, 
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similar to the effects observed in the asc1Δ and dom34Δ strains. This parallel suggested that 
Doa1 could be functioning on one side of the apparently bifurcated NRD pathway, either with 
Dom34 or with Asc1. To test this possibility, we developed doa1Δdom34Δ and doa1Δasc1Δ 
strains, and subjected them to pulse-chase analysis. Northern blot analysis showed that the 
additional loss of DOM34 in the doa1∆ background did not slow 18S NRD any further, 
suggesting that Doa1 and Dom34 affect a related step (Fig. 2.7A). However, in keeping with this 
hypothesis, the doa1Δasc1Δ demonstrated a synthetic decrease in the rate of 18S NRD, similar to 
the effect observed in dom34Δasc1Δ (Fig. 2.7B). Together, these data support the dual branch 
model for NRD and suggest that Doa1 functions with Dom34.  
In addition to DOA1, the ribophagy gene PEP4 also appears to promote 18S NRD. This 
increases the degree of overlap between ribophagy and 18S NRD established by the involvement 
of DOA1. However, the loss of ATG7 did not lead to an increase in mutant 18S rRNA levels, 
implying that auto/ribophagy can be functionally decoupled from 18S NRD (Fig. 2.4).  
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Table 2.1: Reported Pathway Involvement of Genes Selected for Our 
Analysis. Columns from left to right: 1. Gene name, 2. Known function annotated 
on the yeast genome database website 3. Pathways in which a given gene has 
been shown to be involved.  
 
Effects of increased Ubc4, Asc1, Dom34, and Hbs1 expression on NRD 
 As part of our effort to understand the mechanistic function for the 18S NRD pathway, 
we hypothesized that that some NRD proteins might function in a regulatory manner. In other 
PDTA NSD Ribophagy
RPL1B
Haploinsuff.
RPL6A
Haploinsuff. Other
UBC4 E2 Ubiquitin Conjugating Enzyme x x
ASC1 Euk. ribosomal small subunit protein, WD40 repeat family x x
PEX2 Interacts with Ubc4, E3 ligase x
UBC5 E2 ubiquitin conjugating enzyme, functionally redundant with Ubc4 x
NOT4 Non-Stop Decay E3 Ubiquitin ligase x
DOA1 Binds ubiquitin on modified proteins, functions as an adaptor protein for Cdc48 x x
PEP4 Involved in vacuole formation x
UBP3 Ubiquitin protease x
ATG7 Promotes autophagy x
BRE5 Interacts with Not4 x
VPS27 Indirect Doa1 interactor, promotes the sorting of proteins to Multivessicular bodies. x
NPL1 Cdc48 Adaptor on the ER x
LTN1 E3 Ubiquitin ligase x
RPN10 Component of the 26S Proteasome, binds ubiquitin x
UBP6 Ubiquitin specific protease in the 26S Proteasome x
LSM1 Part of the Lsm protein complex, involved in cytoplasmic mRNA degradation x
YCL001W-A Dom34 paralogue (dubious orf), alone or in combination with DOM34 deletion x
YCL001W-B Dom34 paralogue (dubious orf), alone or in combination with DOM34 deletion x
YLR456W Hbs1 interacting protein x
IRE1 Endoribonuclease, RNAse L homologue, (RNAse L Inhibitor, Rli1/ABCE1, binds Dom34:Hbs1.) x
HCR1 Binds Rli1 x
RNY1 tRNA Cleavage, endogenous rRNA degradation in A.thaliana x
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pathways, the loss of regulatory proteins can be compensated for by increasing the abundance of 
downstream factors. Generally, the ability of downstream factors to overcome the lack of an 
upstream regulator can be attributed to the inherent activity of the downstream proteins. Such 
activities are stochastically activated, albeit at a low frequency, in the absence of upstream 
factors. Therefore, by artificially overexpressing the downstream proteins, researchers increase 
the number of activation events, sometimes overcoming the lack of upstream regulatory proteins. 
Consistent with this previously used technique, we suspected that overexpression certain NRD 
proteins might overcome the loss of others, thereby providing insight into their potential 
regulatory activities.  
For these experiments, we developed epitope-tagged clones of the 18S NRD genes 
DOM34, HBS1, and UBC4, under the control of either the respective endogenous promoters or 
the strong ADH1 promoter. We also developed an epitope-tagged clone of the ASC1 gene under 
its own promoter. As a ribosomal protein, ASC1 is already highly expressed, precluding the 
possibility of finding a stronger promoter. Therefore we used the tagged ASC1 gene under its 
endogenous promoter for our overexpression studies. We expressed the FLAG-ASC1 in strains 
already possessing an ASC1 gene, leading to a 2-fold increase in Asc1 abundance.  Additionally, 
we were unable to clone DOA1, and were therefore unable to study the effects of DOA1 
overexpression.  
 We transformed each of the high or low expression plasmids into WT cells, then tested 
the levels of the tagged proteins via western blot (Fig. 2.8). We detected each protein using 
primary antibodies that target the epitope tags. As anticipated, our western blot data 
demonstrated that Dom34, Hbs1, and Ubc4 abundance increases when expressed under the 
ADH1 promoter. The increase in Dom34 and Hbs1 abundance was roughly 10-fold, whereas 
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Ubc4 abundance increased by approximately 4-fold. An additional consideration for the 
validation process is whether ASC1 levels are truly doubled when a second copy of ASC1 is 
present in the cell. Feedback regulation is a common mechanism for the control of gene 
expression, raising the possibility that Asc1 levels could remain constant despite the presence of 
a second ASC1 gene. Western blot data shows that FLAG-Asc1 levels are equivalent when 
expressed in either WT or asc1∆ strains. Because the WT strain harbors a chromosomal copy of 
the ASC1 gene, whereas the asc1∆ does not, this experiment serves to indirectly test the 
feedback regulation of Asc1 and infers that the overall abundance of the Asc1 protein is double 
when two copies of the ASC1 gene are present. As such, the data suggest that our FLAG-ASC1 
construct is a valid high-expression construct. Likewise, due to the ability of our DOM34, HBS1, 
and UBC4 construct to partially, or fully, complement their respective deletions, we believe that 
they represent viable tools for our study.   
We then used our single-timepoint assay and northern blot analysis to assess the ability of 
each construct to produce functional protein by testing their abilities to complement the 
respective deletion strains (Fig. 2.9). For this experiment, we transformed WT, doa1Δ, asc1Δ, 
dom34Δhbs1Δ, and ubc4Δ strains with an empty vector, or the respective low or high expression 
construct.  We then conducted a second round of transformations in which we delivered to each 
strain, already expressing the expression plasmids, our WT 18S rDNA plasmid or our 
18S:A1492C rDNA plasmid. The resulting strains possessed two plasmids: one NRD protein 
expression plasmid and one rDNA expression plasmid. This led to six possible combinations per 
strain: 1) WT rDNA/empty expression vector, 2) WT rDNA/endogenous expression construct, 3) 
Wt rDNA/high expression construct, 4) Mutant 18S rDNA/empty expression vector, 5) Mutant 
18S rDNA/endogenous expression construct, and 6) Mutant 18S  rDNA/high expression 
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construct. Three replicates for each strain/plasmid combination were then subjected to steady-
state NRD analysis (Fig. 2.9). As before, each culture was grown to mid-log in synthetic drop-
out media in the presence of raffinose. Galactose was then added for 90 minutes and cells were 
subsequently harvested and flash frozen. Northern blot analysis was used to quantify the ratio of 
plasmid-derived 18S:25S rRNAs. These ratios were then graphed relative to the wild type 18S 
levels observed in the WT strain harboring the empty vector control. The data demonstrated that 
co-expression of FLAG-DOM34, and HBS1-FLAG restored the ability of the dom34∆hbs1∆ 
strain to conduct 18S NRD. Likewise, our FLAG-ASC1 strain fully complemented asc1∆. The 
UBC4-HA construct, however, was only partially capable of complementation in the ubc4∆ 
strain. This suggests that the c-terminal HA tag may have impaired the function of UBC4, 
preventing its full activity in NRD. 
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Figure 2.8. Validation of Overexpression Constructs. Western blot data demonstrate increased 
expression of Dom34, Hbs1 and Ubc4 under the ADH1 promoter. Plasmid-derived FLAG-Asc1 
is present at equivalent levels with and without a second copy of the ASC1 gene. 
 
 In parallel with the complementation experiments, we  probed the genetic relationships 
between NRD protein genes by expressing the other, non-respective expression constructs in 
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each of the deletion strains. In other words, this experiment tested the possibility that 
overexpression of a given NRD protein might compensate for the loss of another.  
To assay each strain for changes in its ability to conduct NRD when another protein was 
present in high concentration, we also transformed each strain with our WT or mutant 18S rDNA 
plasmids. This led to the production of four variations for each strain: 1) WT rDNA/empty 
vector, 2) WT rDNA/high expression construct, 3) Mutant 18S rDNA/empty vector, and 4) 
Mutant 18S rDNA/high expression construct. Each strain was subjected to the single timepoint 
assay as before, and analyzed by both western and northern blot. Western blot data confirm that 
each of the expression constructs successfully produced increased levels of each of the NRD 
proteins, irrespective of the strain harboring the construct. However, northern blot data suggest 
that mutant 18S rRNA levels do not change in any of the NRD protein deletion strain, regardless 
of which overexpression construct is present. This suggests that the NRD proteins cannot be 
overexpressed as a means of compensating for the loss of the others (Fig. 2.9). However, an 
alternative possibility is that the degree of difference in expression levels between the 
endogenous and overexpression promoter constructs,  is insufficient to allow NRD proteins to 
compensate for the loss of others. 
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Figure 2.9.  Effect of NRD protein overexpression on the levels of mutant 18S rRNAs. Steady 
state analysis of strains harboring  either the empty vector, low-expression plasmid, or the high-
expression plasmid and the mutant 18S rDNA plasmid. Levels of mutant 18S and WT 25S 
rRNAs are analyzed by northern blot for each deletion strain (Left) and quantified in terms of the 
18S/25S ratio under each condition (Right).  
 
HBS1 and DOM34 have distinct genetic relationships with ASC1 
 The genetic data suggest that Dom34 and Asc1 function independently in NRD. If our 
current model is correct, Hbs1 and Asc1 should also function independently. As such, we 
predicted that 18S NRD would not be detected in an hbs1∆asc1∆ strain.  To test this hypothesis, 
we developed an hbs1∆asc1∆ strain and assayed its ability to conduct 18S NRD by single 
timepoint 18S NRD assay. We determined the level of mutant 18S rRNAs in each strain as 
before, and found that mutant 18S rRNAs are still destabilized even in the absence of both HBS1 
and ASC1, though only slightly so (Fig. 2.10).  
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Figure 2.10. Mutant 18S rRNA levels in hbs1∆asc1∆ strains. Steady state analysis of mutant and 
WT 18S rRNA levels in dom34∆asc1∆ and hbs1∆asc1∆ strains. 18S levels were normalized to 
the WT 25S levels in each strain and graphed relative to the levels of WT 18S rRNAs observed 
in the WT strain. 
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The remaining activity of 18S NRD in the hbs1Δasc1Δ strain, if any, is very low, 
suggesting that the results of our single timepoint could be due to technical error. Therefore, we 
increased the resolution of our data by running a timecourse assay in the hbs1Δasc1Δ strain. 
Unlike previous timecourses, we did not compare the rate of NRD in asc1∆, hbs1∆, and 
hbs1∆asc1∆ strains. Instead, we used a binary assay in which we simply asked whether 18S 
rRNAs are completely or paritially stabilized in this strain. Therefore, we transformed WT and 
hbs1Δasc1Δ cells with the mutant 18S rDNA plasmid only. We then ran, in triplicate, a 6-hour 
timecourse as previously described, taking timepoints every hour. Northern blot analysis of the 
mutant 18S rRNA levels, normalized to WT 25S rRNA levels, indicated that mutant 18S rRNAs 
are still destabilized in the hbs1Δasc1Δ strain, suggesting that 18S NRD is still active (Fig. 2.11).  
  
77 
 
 
 
Figure 2.11. 18S NRD still occurs in an hbs1∆asc1∆ strain. Mutant 18S rRNA stability in a 
timecourse experiment was determined by northern blot analysis and graphed according to the 
18S/25S ratio at each timepoint. For this experiment, the T0 timepoint was not set to 1, in order 
to emphasize the disparity between the rate of NRD in WT and hbs1∆asc1∆ strains.  
 
Previously reported NRD Factor Ski7 Probably Does Not Promote 18S NRD 
 In keeping with the data suggesting that HBS1 and DOM34 have distinct genetic 
relationships with ASC1, we also investigated the possibility that the Non-Stop Decay protein 
and HBS1 homologue, SKI7, could promote 18S NRD. Previously, Ski7 was implicated in NRD, 
due to the observation that mutant 18S rRNAs were synthetically stabilized in a ski7∆hbs1∆ 
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strain (Cole et al., 2009). If this hypothesis is correct, then a double ski7∆dom34∆ strain should 
display the same phenotype.  However, when we examined the rate of NRD via timecourse assay 
in a dom34∆ski7∆ background, we did not observe synthetic stability (Fig. 2.12). Instead, the 
dom34∆ski7∆ strain showed the same mutant 18S stability as the dom34Δ strain alone. Together, 
these data would initially suggest that SKI7 is epistatic to DOM34, but functions in parallel with 
HBS1. However, the synthetic sickness observed in hbs1∆ski7∆, together with the lack of any 
synthetic effect in the dom34∆ski7∆strain, suggests that the loss of 18S NRD in the hbs1∆ski7∆ 
strain is likely due to slow growth, rather than a loss of NRD. 
 
 
 
Figure 2.12. Mutant 18S rRNA timecourse analysis in SKI7 deficient strains. Timecourse 
analysis of mutant 18S rRNAs was conducted in dom34∆ski7∆, hbs1∆ski7∆, and the 
corresponding single deletion strains. Mutant 18S rRNA levels were detected by northern blot. 
Mutant 18S levels in each strain were normalized to WT 25s levels and the T0 timepoint for each 
timecourse was set to 1.   
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Previously Reported NRD Factor Xrn1 Is Not Required for 18S NRD 
 In a previous report, we presented genetic evidence that Xrn1 is involved in 18S NRD. 
Though our initial timecourse data suggested that the rate of 18S NRD is not diminished in an 
xrn1∆ strain, the additional loss of DOM34 led to a dramatic stabilization of mutant 18S rRNAS, 
potentially indicating that 18S NRD does not occur in this strain (Cole et al., 2009). Despite our 
consistent observation of this phenotype in multiple repeats of this experiment, the 
dom34∆xrn1∆ strain yields opposing results when the protocol is altered: under pulse-chase 
conditions, dom34∆xrn1∆ is synthetically sick, and mutant 18S rRNAs are highly stabilized. 
Conversely, when raffinose is excluded from the assay, the degree of difference in growth rate 
between dom34∆xrn1∆ and WT is far less, and mutant 18S rRNAs are degraded at a rate 
equivalent to the dom34∆ single deletion strain (Fig. 2.13).  
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Figure 2.13. Mutant 18S rRNA timecourse analysis in xrn1∆ cells in the presence or absence of 
raffinose. Timecourse analysis of mutant 18S rRNAs was conducted in xrn1∆ cells grown to 
mid-log in galactose-containing medium (diamonds) or raffinose-containing medium (squares). 
Transcription was then induced by the addition of galactose in the culture containing raffinose. 
Glucose was then added to both sets of cultures to shut off transcription. T0 was collected 
immediately following glucose addition and at the indicated time intervals thereafter. 
 
These data suggest that the loss of XRN1 in a dom34∆ background is not necessarily 
synthetic with respect to NRD, and may instead lead to mutant 18S rRNA stabilization as an 
indirect result of strain sickness during growth in raffinose. Moreover, the ability of a 
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dom34∆xrn1∆ strain to conduct 18S NRD at a fast pace indicates strongly that Xrn1 and Dom34 
do not represent all of the major factors in 18S NRD as initially suspected.  
Nevertheless, evidence does suggest the downstream involvement of Xrn1: in strain 
xrn1∆, a low molecular mass band is bound by the 18S probe, suggesting that at least one mutant 
18S degradation intermediate is degraded by Xrn1. This implies that Xrn1 may be involved in 
the cleanup of mutant 18S rRNAs that were already subjected to 18S NRD. 
 
Mutagenic analysis of ASC1 
 In order to better understand the mechanism by which Asc1 functions in NRD, we 
developed a number of ASC1 regulatory domain mutants expected to display decreased ability to 
conduct NRD. We first transformed either the empty vector, WT ASC1 clone, or the mutant 
ASC1 clones into an asc1Δ strain. The resulting strains were then transformed again with either 
the WT rDNA or Mutant 18S:A1482C rDNA plasmid. These strains were then subjected to a 
single timepoint 18S NRD assay as previously described.  Abundance of the WT or mutant 18S 
was determined via northern blot and plotted in terms of the 18S:25S ratio in each strain. This 
method allowed us to quantify the ability for each mutant ASC1 construct to complement the 
loss of the chromosomal ASC1 gene. The mutants we tested include mutations of the ribosome-
facing “knob”, the cytosolic “loop”, the knob’s central lysine residue, K282A, either one or both 
of the conserved tyrosine residues Y232, Y250, or Y232 Y250 (Fig. 2.2B). We also tested the 
ribosome binding mutants R38D/K40E, and D109Y (Fig. 2.16).  For each of the mutations we 
tested, we failed to observe any loss of complementation ability.  However, loss of the ribosome-
facing Knob structure appears to have actually improved the ability of Asc1 to promote NRD. 
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Moreover, the Y232F mutation also appears to promote the ability of Asc1 to conduct 18S NRD, 
regardless of the presence or absence of the Y250F mutation (Fig. 2.15). This suggests that 
phosphorylation of the two conserved tyrosine residues is not required, however phosphorylation 
of Y232 may play an inhibitory role. Likewise, though neither the loop or knob structrues appear 
to be required for NRD, the knob may have an inhibitory function.  
Despite the observation that the ribosome binding mutations affect the ability of Asc1 to 
promote PDTA, the same mutations do not appear to negatively impact the ability of Asc1 to 
conduct NRD (Kuroha et al., 2010).  This could indicate that PDTA is functionally distinct from 
18S NRD. 
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Figure 2.14. Complementation of asc1∆. Strain asc1∆ harboring either an empty vector, ASC1, 
ASC1 with the intron and snoRNA124 removed, or FLAG-ASC1 without the intron, was also 
transformed with the mutant 18S rRNA plasmid and subjected to single timepoint analysis. WT 
cells harboring the same empty vector or ASC1 plasmid was transformed with the mutant 18S 
rDNA plasmid and subjected to the same single timepoint analysis. Mutant 18S rRNA levels 
were normalized to WT 25S levels.  
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Figure 2.15. Structure based functional analysis of ASC1. asc1∆ cells transformed with either 
the empty vector, wild type ASC1 gene, or mutant forms of ASC1 suspected to promote 
protein:protein interactions, or to function as phosphorylation sites, were also transformed with 
the mutant 18S rDNA plasmid. Cells harboring both plasmids were subjected to single timepoint 
analysis. 
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Figure 2.16. Effect of ASC1 ribosome binding mutations on mutant 18S abundance. asc1∆ cells 
were transformed with either the empty vector, wild type ASC1 gene, or mutant forms of ASC1 
that have been shown to negatively affect the association of Asc1 with polysomes, as well as the 
mutant 18S rDNA plasmid. Doubly transformed cells were subjected to single timepoint 
analysis. 
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18S NRD depletes mutant 18S rRNAs from to the monosome fraction of polysome profiles. 
 Our model suggests that we could gain additional information about the behavior of 
mutant 18S:A1492C rRNAs, and by extenstion, 18S NRD, by looking at mutant 18S rRNA 
abundance in the polysome profiles of NRD deficient strains. We know that the loss of NRD 
proteins leads to a higher mutant 18S rRNA abundance, however whether this effect would be 
seen in monosomes or polysomes was unknown. Our model suggests that signal in the polysome 
fractions should be determined by the rate of ribosome run-off rather than the efficiency of the 
NRD pathway. This expectation is due to the fact that our model for NRD does not predict 
recycling of mutant 18S-containing small subunits following a stall. Otherwise, at higher 
concentrations, recycled mutant 18S-containing subunits could re-initiate on polysomes and raise 
levels within these fractions. Hence, we expected to see that in NRD deficient strains, the mutant 
18S signal would increase in monosome fractions, but not the polysome fractions.  
To test our model, we repeated the original polysome experiment, using dom34∆, asc1∆, 
and dom34∆asc1∆ strains. Briefly, we transformed WT, dom34Δ, asc1Δ, and dom34Δasc1Δ 
strains with the mutant 18S:A1492C rDNA plasmid, and grew these cells to mid-log in the 
presence of raffinose. We then induced mutant 18S transcription via the addition of galactose for 
90 minutes, in keeping with our steady state assay. We then added cycloheximide to our cultures 
to a final concentration of 100 mg/ml, harvested our cells on ice, and prepared cell lysates. 
Individual lysates were layered onto 5-50% sucrose gradients and spun in an ultracentrifuge. 
Individual fractions were then collected and subjected to northern blot analysis. After 
quantifying the total mutant 18S abundance in all fractions of the polysome profile, we observed 
an overall increase in mutant 18S signal in the three mutant strains. Hence, our experiments are 
ostensibly compatible with the previous single timepoint and timecourse assays. Moreover, the 
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major increase in signal seen in the mutant strains occurs exclusively with the monosome and 
monosome plus half-mer fractions, thereby supporting our model (Fig. 2.17B). This increase 
appears to be specific for the mutant 18S rRNAs as the methylene blue stain does not show a 
detectible increase in wild type 18S rRNAs in the corresponding fractions.  
One portion of our data set does not fit with our model: in the asc1∆ data set, there is a 
slight increase in mutant 18S signal within the polysome fractions. This may be explained by the 
general large subunit recruitment defect previously described in ac1∆ strains. This defect is 
apparently manifested in the polysome profile in the form of an increase in half-mer peaks 
behind each discrete polysome peak. Further experiments are needed to determine whether the 
increase in 18S abundance in the polysome pool is a general or specific effect. Likely, the proper 
experiment is to simply look at WT 18S rRNAs for changes in abundance within the same group 
of strains.  
 
Mutant 18S rRNA enrichment in monosomes is not retained under ribosome run-off conditions 
(Preliminary Data). 
Our model for 18S NRD suggests that mutant 18S-containing 80S ribosomes become 
stuck at AUG start codons. If this is correct, then the mutant 18S signal should be selectively 
retained under ribosome run-off conditions. To test whether this is correct, we set up an 
experiment that compared the monosome 18S rRNA signal in WT and dom34∆asc1∆ strains 
under ribosome run-off or standard conditions. We expected to observe that in both cases the 
mutant 18S rRNA abundance would not diminish, though the overall monosome and polysome 
fractions would be greatly reduced, signifying run-off has occurred.  
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To accomplish this, we split mid-log phase WT or dom34∆asc1∆ cultures in half. For 
each pair of cultures, we treated one with cycloheximide (CHX), according to the standard 
polysome protocol, and the other with DMSO. The lysate from CHX treated cells was 
maintained on ice for 20 minutes, while the run-off lysate was incubated at 30o for 20 minutes. 
Each extract was layered on top of a separate 5-50% sucrose gradient, subjected to 
ultracentrifugation for 3 hours, and separated into fractions.  
Preliminary data (N=1 for each of the 4 cultures) demonstrated that the original 
accumulation of the mutant 18S in the monosome fraction was lost during run off (Fig. 2.17C, 
middle). Interestingly, a loss of approximately 80% was consistent between both the wild type 
and the dom34∆asc1∆ strains. Also, this loss appears to have been selective for the mutant 18S, 
as the methylene blue staining did not show any gross perturbation in 18S:25S ratio in any of the 
strains, either with, or without CHX treatment. Still more, the run-off dependent loss of mutant 
18S signal was accompanied by a dramatic increase in the abundance of a sub-18S molecular 
weight band within the 40S pool in both strains. In the dom34∆asc1∆ strain, this low-mass band 
appeared at higher abundance than in the wild type strain. This increase correlates with the 
greater abundance of mutant 18S rRNA, originally in the monosome fraction. This suggests that 
the mutant 18S rRNAs may have been selectively degraded in lysates, even in the absence of 
both Dom34 and Asc1. Yet, to be certain that these effects are specific, WT 18S rRNA 
abundance should be tested under run-off conditions.  
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Figure 2.17. Polysome profile analysis in NRD deficient strains. A. WT cells expressing mutant 
18S rRNAs was grown to mid-log in galactose, then harvested and harvested and fractionated on 
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5-50% sucrose gradients as in a typical polysome analysis. Total RNA from individual fractions 
was purified and subjected to northern blot analysis. The A260 trace was recorded and plotted 
above the corresponding northern blot lanes. B. WT, dom34∆, asc1∆, and dom34∆asc1∆ strains 
harboring mutant 18S rDNA plasmids were grown to mid-log in galactose, then harvested and 
subjected to polysome analysis as above. Fractions were taken at shorter intervals than in 1A to 
increase the resolution. C. Replicates of the analysis in 1B are shown. Additional polysome 
analysis of WT and dom34∆asc1∆ cells not treated with CHX, and incubated at 30 degrees 
following lysis is shown in the WT run off and dom34∆asc1∆ run off graphs/northern blots. D. 
Mutant 18S rRNA signal normalized to the 25S rRNA signal in each lane was quantified and 
graphed. E. The average, normalized, 18S signal in monosomes or polysomes was determined 
for each strain and plotted on the chart. 
 
Implications of Rps3 involvement in NRD 
 The genetic data establishing a role for Asc1, and Dom34 on opposing halves of the NRD 
pathway raised the question of how, or if, both branches could be coordinately regulated. The 
possibility that both branches of NRD are regulated by an upstream factor is supported by the 
polysome profile run-off data (Fig. 2.17C). At the time this research was being conducted, the 
crystal structures of both the eukaryotic ribosome and Dom34:Hbs1 bound to the eukaryotic 
ribosome, had not been reported. Yet, as of the writing of this thesis, both structures have been 
solved, leading to the discovery that a single ribosomal protein, Rps3, binds both Hbs1, and Asc1 
(Becker et al., 2011; Ben-Shem et al., 2010; Rabl et al., 2011; Yatime, Hein, Nilsson, & Nissen, 
2011). The long, unstructured, c-terminal tail of Rps3 extends across the ribosome, where, on the 
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tetrahymena ribosome, it makes extensive contact with WD4 repeat number 4 of Rack1. The 
previously described function of WD4 in mediating the dimerization of Rack1 suggests that the 
Rps3 c-terminal tail may be regulating Rack1 by preventing its dimerization. Rps3 and Hbs1 
make contact via the long “ball and chain” domain of Hbs1. This n-terminal region extends 
across the ribosome to make contact with Rps3 (Becker et al., 2011). 
The Ben-Shem structure of the eukaryotic ribosome led to another important discovery 
about Rps3. In addition to contacting Hbs1 and Asc1, Rps3 is positioned at the entrance to the 
mRNA channel of the small subunit, suggesting that is ideally positioned to sense a decrease in 
ribosome translocation rate along the mRNA. As such, Rps3 is an excellent candidate for sensing 
ribosome stalling, and responding by regulating the activities of both Dom34:Hbs1, and Asc1.  
 To probe the potential regulatory activity of the Rps3 c-terminal tail on Asc1, we 
attempted to remove the final 46 codons of RPS3 which encode the unstructured portion of its c-
terminal tail. To accomplish this, we first developed a plasmid-based truncated RPS3 construct 
which includes both the upstream and downstream regions of RPS3. We then amplified, as a 
single 4kb product, the entire truncated RPS3 gene, plus a downstream LEU2 promoter/LEU2 
ORF/LEU2 3` UTR which is encoded on the plasmid. To provide a source of homology on the 3` 
end of the PCR product, we added 75 bp of homology to the 3`UTR of RPS3. This PCR product 
should be capable of integrating at the RPS3 locus, leading to the loss of the wild type RPS3 
gene, and subsequently incorporating both the truncated RPS3 gene and LEU2 gene. Following 
transformation of 5-20 µg of this construct, approximately 25 colonies appeared on leucine drop 
out media. The RPS3 locus from 10 colonies were sequenced  and shown to encode the Leu2 
gene in the correct orientation, and a non-truncated RPS3 gene. To ensure that the appearance of 
the wild type RPS3 gene was not the result of a technical error, we verified that RPS3 is 
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truncated in the actual PCR product used for transformation. The successful integration of the 
PCR product, and confirmation that RPS3 is truly truncated on it, suggests that technical errors 
are not preventing truncation of RPS3 on the chromosome. Instead, we propose that our inability 
to truncate the RPS3 indicates that it is lethal for the cell.  
To test whether the apparent lethality of a truncated RPS3 gene could be due to the loss 
of Asc1 regulation, we transformed an asc1∆ cell with the truncated RPS3 construct PCR. Again, 
among ten colonies capable of growing on SC-Leu media, we did not detect any cells with the 
truncated RPS3 gene. Another possibility not yet tested, is whether the apparently lethal effects 
caused by Rps3 tail truncation are brought about by removal of regulation of both Asc1 and of 
Hbs1. This could be easily tested by attempting the truncation of RPS3 in an hbs1∆asc1∆ strain. 
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Additional Testing of Suspected NRD Factors 
As part of our candidate survey for factors affecting 18S NRD, we examined deletion 
strains deficient for a variety of factors we suspected to be involved in NRD. Among these genes 
were the putative DOM34 paralogues, YCL001W-A and YCL001W-B. This pair of dubious 
ORFs are homologous to the N and C-terminal portions of DOM34, respectively, and could 
theoretically produce truncated forms of the Dom34 protein. However, we did not observe any 
significant increase in mutant 18S rRNA levels in the absence of either YCL001W-A or 
YCL001W-B alone, or in strains doubly deficient for either YCL001W gene and DOM34 (Fig 
2.18A). These data argue against a role for the YCL001W genes in NRD. 
We also suspected that the RNA endonuclease Rny1 might represent the nuclease in 
NRD, based upon the reported activity of its homologue Rnase T2 in endogenous rRNA turnover 
in Arabidopsis, and the observed specificity of Rny1 for rRNA in yeast (Thompson et al., 2009). 
Yet, again, we failed to observe any increase in mutant 18S rRNA levels in an rny1∆ strain (Fig. 
2.18B). 
As a third possibility, we noted the recent discovery that mammalian ABCE1, the 
homologue of yeast Rnase L Inhibitor, Rli1, binds mammalian Dom34:Hbs1 and promotes 
ribosomal subunit dissociation (Pisareva et al., 2011). This suggested that Rli1 might promote 
NRD. By extension, we also suspected that the yeast homologue of the promiscuous RNA 
endo/exonuclease RnaseL, which is repressed by Rli1, might represent the nuclease in 18S NRD. 
Blast analysis of the mammalian RnaseL amino acid sequence against the S. cerevisiae genome 
suggests that the closest homologue of RnaseL is Ire1. Though the essential nature of Rli1 
precluded the possibility of including it in our survey, we were able to test an ire1∆ strain and a 
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strain deficient for the Rli1 binding partner, Hcr1, for effects on NRD. In both cases, we did not 
observe any negative effect on mutant 18S rRNA levels, suggesting that Ire1 and Hcr1 are not 
involved in NRD (Fig. 2.18B). 
The involvement of the ubiquitin binding protein Doa1 in 18S NRD suggested that 
ubiquitin mediated proteolysis could be important for the pathway. To test this possibility, strains 
deficient for proteasome components, including Rpn10, Ubp3, and Ubp6, were tested for effects 
on NRD. None of these strains displayed increased levels of mutant 18S rRNAs, suggesting 
partial impairment of the proteasome does not negatively affect NRD, and arguing against its 
involvement (Fig. 2.18B). 
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Figure 2.18. Several genes suspected to promote 18S NRD do not affect mutant 18S 
rRNA levels. A. Deletion of the putative DOM34 paralogue genes YCL001W-A and YCL001W-
B do not lead to an increase in the level of the mutant 18S, either alone or in combination with 
dom34∆. B. Deletion of a variety of candidate genes, including the genes for the 
endoribonucleases Rny1 and Ire1, or the proteasome proteins Ubp3 and Rpn10, do not lead to a 
significant increase in mutant 18S levels. C. deletion of VPS27 does not affect levels of mutant 
18S rRNAs. 
 
Slow Growth Correlates with a Loss of 18S NRD 
 Slow growth is known to correlate with decreased translation (Petroulakis et al., 2004). It 
is therefore possible, that slow growing strains may have fewer translating ribosomes, and 
therefore, a compromised mechanism for the detection of mutant 18S rRNAs.  To test the 
possibility that the loss of 18S NRD in different deletions strains is an indirect effect of slow 
growth, we calculated the growth rates of each strain in synthetic complete media containing 
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either raffinose or galactose. Though certain strains have longer doubling times relative to the 
wild type strain, we suspect that these differences are sufficiently minimal that they are not the 
cause of the loss of NRD. In the case of dom34∆asc1∆, we do not observe synthetic slow growth 
relative to asc1∆. Also, in the case of doa1∆asc1∆, after an initial adjustment period, we observe 
only a mild synthetic slow growth phenotype (Fig. 2.19). In the ubc4∆ strain, which is 
completely deficient for 18S NRD, no slow growth is observed at all. 
 Conversely, three strains show severe slow growth which correlates with a loss of NRD: 
ctk1∆, hbs1∆ski7∆, and, when grown in raffinose, dom34∆xrn1∆. In the case of dom34∆xrn1∆, 
altering the carbon source triggered an increase in growth rate that subsequently reduced the 
degree of difference in growth rate relative to WT. Under these conditions, the 18S NRD defect 
disappeared, suggesting that growth rate rather than loss of NRD contributed to mutant 18S 
stabilization. 
 The strains ctk1∆ and hbs1∆ski7∆ also exhibit strong growth defects and apparent loss of 
18S NRD. However, this slow growth (>240 min) and loss of NRD is still apparent in 
hbs1∆asc1∆, even during growth in galactose. This precludes the possibility of decoupling slow 
growth from the rate of 18S NRD in this strain.  Likewise, the high mutant 18S levels in ctk1∆ 
correlate with extremely slow growth in raffinose (>8 hours), suggesting that the loss of NRD in 
this strain may be an indirect consequence of slow growth. 
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Figure 2.19: Growth rate analysis of strains in galactose and raffinose. 
Doubling times of various strains growing in SC medium containing 2% raffinose 
or 2% galactose. Cells growing in SC media for 24 hours were diluted to low 
density, then monitored via OD600 reading during their progression to high 
density. Three cultures/strains were used for growth rate calculations. Note: the 
initial doubling time of strain doa1∆asc1∆ is shown in black; however, this time 
decreases after 36 hours, leading to a 240 ± 17 min. doubling time shown in gray. 
Cells growing at the faster rate were used in timecourse and single timepoint 
analyses.  
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Materials and Methods 
Single Timepoint Assay:  
Strains harboring pSC40-Wt or pSC40-18S:A1492C plasmids were grown at 30o in SD-uracil, in 
the presence of 2% raffinose, to mid-log phase (OD600 = 0.5). Galactose was added to a final 
concentration of 2% to induce rRNA transcription, and cells were incubated for an additional 90 
minutes. OD600 was monitored during this time and pre-warmed medium was added as necessary 
to maintain OD600 = 0.5. Cells were then harvested by centrifugation and flash frozen on dry 
ice/EtOH. 
Pulse-chase Analysis: 
Pulse-chase analysis was performed as previously described (Lariviere et al. 2006). Strains 
harboring pSC40-Wt or pSC40-18S:A1492C plasmids were grown at 30o in SD-uracil with 2% 
raffinose to mid-log phase (OD600 = ~0.5). Galactose was added to a final concentration of 2% in 
order to induce rRNA transcription, and cells were incubated 90 minutes. Pre-warmed glucose 
was then added to a final concentration of 2% and timepoint T0 was immediately harvested. 
Samples were then flash frozen on dry ice/EtOH. Pre-warmed SD-ura with 2% glucose was 
added as necessary to maintain an OD600 of 0.5 for the duration of the timecourse. Timepoints 
were taken at specified intervals.  
 
Northern Blot Analysis: 
For each sample, 2 µg total RNA was separated on a 1% agarose-formaldehyde gel and 
transferred to a nitrocellulose membrane as previously described (Brown et al., 2004). Total 
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RNA was detected via staining with Methylene blue stain (Molecular Research). Membranes 
were hybridized with 32P-end-labeled probes FL125 (anneals to plasmid derived 18S rRNA) and 
FL126 (anneals to plasmid derived 25S rRNA) for 12 hr in ExpressHyb (BD Biosciences). 
Signals were visualized using a Typhoon Phosphorimager (Molecular Dynamics) and quantified 
via ImageQuant software (GE Lifesciences). 
 
Discussion 
Crosstalk between 18S NRD and other Pathways 
 Though the functional overlap between translation surveillance pathways has been 
recognized for some time, the extent of these similarities is unclear. Based upon the similar 
function of the PDTA and NRD pathways, as well as the common involvement of Dom34, we 
suspected that the PDTA factors Asc1, Ubc4, and Not4 might also function in NRD.  To test this 
possibility we assayed the levels of mutant 18S:A1492C rRNAs in asc1Δ, ubc4Δ, and not4Δ 
deletion backgrounds and observed a selective increase in mutant 18S rRNA levels in the asc1Δ 
and ubc4Δ strains. We interpret this increase as an indication that Asc1 and Ubc4 are involved in 
NRD.  These findings suggest a greater overlap between PDTA and NRD than previously 
observed. The lack of effect observed when the E3 ubiquitin ligase, Not4, is absent, suggests 
either that the mechanisms by which NRD and PDTA function may not overlap entirely, or that 
the potential degradation of the nascent peptide associated with an 18S:A1492C-containing 
ribosome does not influence 18S rRNA degradation. This latter possibility is not entirely 
unexpected given that the nascent peptide degradation and mRNA cleavage phenotypes in PDTA 
have not yet been shown to influence each other. 
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Though the data on Not4 are negative, the partner of Not4, the E2 ubiquitin conjugase 
Ubc4, is likely to be part of the 18S NRD pathway. Loss of UBC4 conferred a defect in NRD so 
severe that no measurable mutant 18S rRNA half life was detected over 6 hours, suggesting that 
Ubc4 may be essential for NRD. The activity of Ubc4 in the cellular ubiquitin system also sets 
up the expectation that ubiquitin modification is likely to play an important part in 18S NRD. 
This suggestion is consistent with several reports describing a role for ubiquitin in NSD, PDTA, 
and ribophagy. 
To further investigate the effects of the PDTA genes on NRD, we combined the ASC1 
and DOM34 deletions. This led to a strong synthetic stabilization of mutant 18S rRNAs, 
suggesting that Asc1 and Dom34 function independently in 18S NRD. This finding suggests a 
simple model for 18S NRD in which Asc1 and Dom34 promote parallel branches of the 
pathway.  
The reported activities of the Rack1 family, to which Asc1 belongs, suggest that S. 
cerevisiae Asc1 may function as part of the cell’s ubiquitin modification systems. When 
mammalian Rack1 takes on its homodimeric conformation, it becomes competent for its 
interaction with the Cullin complex. Together Rack1:Rack1:Cullin ubiquitinates the protein 
Hif1, leading to its proteolysis by the 26S proteasome (Lu et al.). Recently, the dimerization 
activity of Asc1 was also described, suggesting that its activity in ubiquitin modification 
pathways could also be conserved. If ubiquitination of a target protein occurs during NRD, the 
target of that modification is, as yet, unknown. Presumably, ribosomal protein on an 
18S:A1492C-containing ribosome would be a logical candidate. 
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Given the similarity inherent in the ribosome turnover phenotypes in NRD and 
ribophagy, we also suspected that ribophagy proteins might function in the 18S NRD pathway. 
Interestingly, only factors known to affect large subunit ribophagy have been discovered. 
Nevertheless, we tested the possible overlap with ribophagy by analyzing mutant 18S rRNA 
levels in strains deficient for the ribophagy genes BRE5, UBP3, and DOA1. Loss of DOA1 
conferred a partial stabilization of mutant 18S rRNAs, suggesting that Doa1 functions in NRD. 
The disparity between the large subunit specificity of Doa1 in ribophagy and effects on the small 
subunit rRNA in NRD suggests that either Doa1 is acting in a different fashion in NRD than it 
does in ribophagy, or that Doa1 promotes 18S NRD through the involvement of the large 
subunit. In support of the latter hypothesis, three lines of evidence have already suggested that 
large subunit recruitment is needed for degradation of 18S:A1492C rRNAs: 1) these mutant 18S 
rRNAs have been shown to appear in monosomes and polysomes, indicating that such small 
subunits are capable of recruiting a large subunit; 2) the NRD proteins Dom34:Hbs1 insert into 
the A-site; 3) addition of cycloheximide inhibits 18S NRD, but not the distinct, Dom34-
independent process, 25S NRD (Lariviere et al., Cole et al.). Together, these findings suggest 
that it would not be unlikely for Doa1 to act in NRD via an interaction with the large subunit.  
To elucidate the placement of Doa1 within the NRD pathway, we crossed strain doa1Δ 
with either dom34Δ or asc1Δ. We then conducted mutant 18S rRNA timecourse analyses in the 
resulting doa1Δdom34Δ or doa1Δasc1Δ strains, and observed a synthetic decrease in the rate of 
decay exclusively in the doa1Δasc1Δ strain. These data suggest that Doa1 functions with 
Dom34, and not with Asc1, thereby supporting our initial model and suggesting that Doa1 
functions with Dom34. Interestingly, in this configuration, WD40 repeat proteins are present on 
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both sides of the pathway, raising the possibility that Doa1 and Asc1 could function in a similar 
fashion.  
 In keeping with the theme of ubiquitin involvement in NRD, Doa1 possesses two 
ubiquitin binding domains, again raising the possibility that Doa1 and  Asc1 could promote the 
ubiquitin modification of a target protein as part of their functions in NRD. 
Additionally, though the potential synthetic interactions of pep4∆ with the other NRD 
proteins was not examined, the partial loss of NRD in the absence of this gene suggests that it 
may be a part of one of the two branches of the NRD pathway. Consistent with this is the 
observation that both Doa1 and Pep4 are involved in ribophagy, suggesting Pep4 may be 
functioning with Doa1 in NRD. 
 
Involvement of Hbs1 in NRD 
One model for 18S NRD provides an explanation for the different phenotypes exhibited 
by dom34∆asc1∆ and hbs1∆asc1∆ strains: Hbs1 may regulate the activity of Dom34 by 
promoting its function in NRD, making it less important for NRD than Dom34. A previously 
published in vitro study has established this regulatory activity for Hbs1, noting that Hbs1 
promotes the activity of Dom34, but is not required for the Dom34-mediated release of the 
ribosomal subunits from stalled translation complexes (Pisareva et al., 2011). Supporting this is a 
second study by Shoemaker et al. 2011, which also demonstrates that Hbs1 is dispensable for 
ribosome recycling. As such, our model suggests that in the absence of both Hbs1 and Asc1 
proteins, Dom34 continues to promote 18S NRD.  
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Involvement of Ski7 in NRD 
To clarify the apparent role for Ski7 in NRD, we tested the genetic relationship of 
DOM34 or HBS1 with SKI7, by combining the respective deletions.  Though we observed a 
synthetic effect in the hbs1∆ski7∆ strain, this effect did not repeat in the dom34∆ski7∆ strain. 
The simplest interpretation of these data is that in 18S NRD, Ski7 functions in parallel with Hbs1 
and serially with Dom34. The high degree of structural homology between Ski7 and Hbs1 would 
suggest that Ski7 is capable of binding Dom34 in place of Hbs1. However, this interpretation 
seems unlikely for a number of reasons. First, despite the publication of several global 
protein:protein interaction databases, Dom34 has not been reported to bind Ski7. Second, the 
deletion of DOM34 has the same effect on NRD as an HBS1 deletion (Cole et al., 2009). If Ski7 
can substitute for Hbs1, then loss of HBS1 or SKI7 should produce a partial effect on NRD that 
is less severe than the effect observed when DOM34 is deleted. A third problem with the above-
mentioned conclusion is that, if it were true, then loss of SKI7 and DOM34 should produce the 
same slow growth phenotype as double deletion of both SKI7 and HBS1, but this is not the case. 
Fourth, if Ski7 promotes NRD without biding to Dom34, then the deletion of Dom34 and ASC1 
should not completely shut off NRD because Ski7 would still be able to act. This is also not the 
case – 18S NRD is not detected in dom34∆asc1∆.  
As such, another explanation seems necessary. I propose instead that Hbs1, functioning 
without Dom34, may be functionally redundant with Ski7 in Non-Stop Decay. If this were the 
case, then Non-Stop Decay would continue, in an Hbs1-mediated manner, in a ski7∆ strain, 
potentially explaining why SKI7 deletion had little effect on NSD in the BY4741 background 
(Inada et al., 2005) whereas in the W303 background, loss of SKI7 decreased the rate of NSD 
(van Hoof et al. 2002)(van Hoof A, Frischmeyer PA, Dietz HC, 2002). In a strain doubly 
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deficient for SKI7 and HBS1, Non-Stop Decay would be severely diminished. The complete loss 
of Non-Stop decay could potentially cause cell sickness, leading to the observed slow growth 
phenotype and indirectly producing the deleterious effects we see on 18S NRD.  
Mutagenic Analysis of Asc1 
Though we were unable to identify structural features of Asc1 required for 18S NRD, the 
apparent gain of function produced by the knob deletion and Y232F mutations suggest that these 
sites may be responsible for the repression of Asc1 acitivity in NRD. Furthermore, the fact that 
the ASC1 ribosome binding mutations were fully capable of complementing the asc1Δ strain for 
its ability to conduct NRD suggests that Asc1 may function in an ribosome independent manner 
in NRD. Alternatively, these mutations might simply decrease ribosome binding affinity without 
abolishing it entirely. Such residual binding activity could be sufficient for NRD. 
The ability of mammalian and yeast Rack1/Asc1 to form homodimers suggests that this 
is another means by which Asc1 might be regulated in NRD (Fig. 2.1). In mammalian cells, 
Ser146, which is located on WD repeat 4 (WD4), is known to be phosphorylated, leading to 
Rack1 homo-dimerization. Once formed, homodimeric Rack1 facilitates the interaction between 
the cullin complex and their substrate, Hif-1alpha, which is subsequently ubiquitinated by cullin 
and degraded by the 26S proteasome (Y. V. Liu et al., 2007). In yeast, Ser146 is not conserved, 
initially preventing us from developing a dimerization-deficient Asc1 mutant. Nevertheless, 
following the completion of our Asc1 mutagenesis experiments, the crystal structure of 
dimerized Asc1 was published (Yatime et al., 2011). The structure revealed that, like its 
mammalian homologue, Asc1 dimerizes via its WD4 domain. This interaction requires major 
restructuring of the beta-pleated sheets that comprise WD4, allowing for a high degree of 
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protein:protein contact between both proteins. The Nilsson structure also implicated the highly 
conserved residue, His147, as a molecular switch, likely capable of promoting, or preventing, 
dimerization. As such, future studies of 18S NRD should consider mutation of His147 a major 
priority in the investigation of Asc1 function.  
The implication that Rack1 dimerization is required for its ability to promote the 
ubiquitination of target proteins provides an appealing mechanism by which Asc1 might act in 
NRD. In hypothesis, Asc1 might interact with, for example, Ubc4, to promote the ubiquitination 
of a ribosomal protein, thereby promoting the identification of the corresponding 40S subunit as 
a NRD substrate. 
 
 Polysome Profile Analyses 
 Previously, it was demonstrated that mutant 18S rRNAs appear in both the monosome 
and polysome fractions of a polysome profile in wild type yeast. Though the signal for the 
mutant 18S is low in the wild type strain due to deletion via the 18S NRD pathway, it is still 
detectable. The relative distribution of mutant 18S signal was shown to be very low in the 
polysome fractions, and high within the 40S and monosome fractions. The abundance in the 80S 
fraction suggests strongly that 40S subunits are capable of recruiting a large subunit. This is 
consistent with the fact that Dom34:Hbs1 binds the large subunit during NRD. Yet, a model is 
needed to explain the uneven distribution of mutant 18S rRNAs between mono and polysomes.  
One model that could explain this distribution proposes that mutant 18S-containing 40S 
subunits stall immediately following the completion of translation initiation, right at the shift to 
elongation phase. This is based upon the observation that base 18S:A1492 is needed for kinetic 
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proofreading in the A-site, an event which is not known to occur prior to translation elongation 
phase (Yoshizawa et al., 1999). As such, even mutant 18S-containing ribosomes should have an 
intact P-site, capable of conducting codon:anticodon pairing between the Met-tRNA and the 
AUG start codon during initiation. Only after the recruitment of the large subunit, and transition 
to elongation phase, would the ribosome require the use of the mutant A-site. It is at this point, 
the first attempted A-site mediated codon:anticodon pairing, that the 18S:A1492 mutation could 
reasonably be expected to cause translation problems via the creation of a translational stall. 
This model sets up the expectation that most of the mutant 18S rRNA signal should 
appear in the fractions corresponding to a full ribosome plus a half-mer, thereby accurately 
explaining the data. If correct,  the model suggests that a mutant 18S-containing 80S complex 
could initiate on a polyribosome. By stalling on the start codon, it would prevent the formation of 
additional 80S ribosomes, leading to a net loss of ribosomes on the transcript as the downstream 
ribosomes run off. This would have the effect of converting a poly-ribosome into a monosome. 
Moreover, by blocking the start codon, no other 40S subunits would be able to complete 
initiation via the recruitment of the large subunit. Instead, all upstream 40S subunits would be 
expected to stall behind the stalled ribosome. The combination of downstream ribosome run-off, 
and the blockade of initiating 40S subunits, would promote the conversion of mutant 18S-
containing 80S ribosomes into monosomes plus a half-mer. The only mutant 18S signal expected 
to be present in the polysome fractions would represent mutant 18S-containing small subunits 
that had very recently initiated on an existing polysome. Hence, mutant 18S signal is expected be 
highest within the 1.5-mer fractions and much lower, but evenly distributed, across the polysome 
fractions. Within the 40S pool there should also be mutant 18S signal, though the abundance of 
this signal is not addressed by our model. Overall, this model accurately describes the polysome 
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profile data, while taking into account the known role and activity of the 40S subunits that 
contain mutant 18S:A1492C rRNAs. 
In addition to generally supporting our data, these polysome experiments suggest that 
shutting down 18S NRD via DOM34 and ASC1 double deletion, yields its major effects on 
mutant 18S abundance within the pool of translating ribosomes. This is an important distinction 
due to the fact that the mutant 18S signal could have conceivably increased exclusively within 
the free 40S pool. Quantification of the signal within the free 40S fractions is difficult because 
there is no 25S with which to normalized these signals. This means that loading errors, among 
other problems, could easily disrupt the quantification process in these fractions. Hence, our data 
do not exclude the possibility that mutant 18S rRNA abundance could increase in free 40S pool. 
However, the indication that NRD proteins do yield their effect on the translation pool 
contributes significantly to our understanding of this process.  
An additional consideration not apparent from this study is that the enrichment of mutant 
18S:A1492C in monosomes could be specific to this mutation. In the case of an endogenously 
produced stalled ribosome, the offending ribosome could conceivably be present at any location 
on the transcript. For example, much of our data suggest that PDTA, NSD, and NGD are all 
functionally related, and indeed, could even represent the same pathway. As such, the fact that 
offending string of lysine or arginine codons in PDTA transcripts is in the middle of the 
transcript serves to underscore the fact that both Asc1 and Dom34 are still capable of acting on 
these transcripts (Kuroha et al). Therefore, the enrichment of 18S:A1492C rRNAs in the 
monosome fraction of polysome profiles is likely to be specific for this particular mutant. 
Therefore, the important finding here is not that mutant 18S signal is enriched in the monosome 
fraction, but rather the fact that it is enriched within the pool of translating ribosomes. 
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Unlike the polysome profile data set, the run-off data may offer additional insights into 
NRD beyond the confirmation of our model. Assuming for a moment, that the run-off data set 
were to be repeated successfully, and also that this effect is selective for the mutant 18S, as 
suggested by the methylene blue stain, this data set may imply the activity of a NRD factor 
upstream of Dom34 and Asc1. The selective degradation of mutant 18S rRNAs in NRD indicates 
that a mechanism exists to discriminate between wild type and mutant 18S rRNAs. The ability of 
Dom34:Hbs1 to bind to the ribosome, and the presence of Asc1 on the ribosome, suggest that 
these factors could be responsible this discrimination event, or, that this step occurs prior to their 
involvement. The possibility that discrimination occurs down-stream of Dom34 and Asc1 
activity is not supported by the data, due to the fact that wild type 18S rRNAs are not subject to 
Dom34 and Asc1-mediated degradation. Moreover, the discrimination step is highly unlikely to 
exist in parallel to Dom34 and Asc1, due to the fact that, in the absence of both proteins, 18S 
NRD does not occur.  A parallel discrimination event would bypass the need for Dom34:Hbs1 
and Asc1 involvement, which, as demonstrated by the lack of detectible NRD in dom34Δasc1Δ, 
is clearly not the case. Therefore, the discrimination step must be conducted by Dom34:Hbs1 and 
Asc1, or, it must occur upstream of them. Given the run-off data (though it is preliminary), we 
observe evidence that that discrimination between wild type and mutant 18S rRNAs still exists in 
the absence of both Dom34 and Asc1. This suggests that discrimination occurs upstream of 
Dom34 and Asc1. One candidate for the upstream discrimination factor is Rps3, which is 
discussed below. 
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NRD Protein Overexpression Studies 
 Our overexpression studies attempted to detect redundant roles for the known 18S NRD 
proteins or their potential ability to regulate each other. Although complementation data 
suggested that these constructs represent valid tools for overexpression, the lack of ability of any 
of the proteins to functionally compensate for the loss of others has three possible explanations: 
1) The endogenous levels of each NRD protein may be saturating; 2) 18S NRD proteins may not 
regulate the others; or 3) the overexpression constructs do not produce a sufficient increase in 
protein level to produce a detectable change in phenotype. This latter possibility is credible, at 
least in the case of the UBC4 and ASC1 overexpression constructs, for which we observed a 
only a 4-fold or 2-fold increase, respectively. The theoretical 2-fold increase for ASC1 is based 
upon the fact ASC1 is simply present in a second, identical copy during “overexpression,” which 
could lead to an additional 200k copies of Asc1, according to the O’Shea and Weissman GFP-tag 
database (Huh et al., 2003).  In the case of the high expression UBC4-HA construct, we observed 
only a 4-fold increase over the levels produced by the endogenous UBC4 promoter construct. 
This increase in expression is 2.5-fold less than the 10-fold increase produced by high expression 
DOM34 and HBS1 constructs. This disparity is not entirely surprising, given that, under its 
endogenous promoter, Ubc4 has been reported to reach 14k copies per cell, whereas Dom34 and 
Hbs1 are present at roughly 2-3k copies. This suggests that, when switched to the ADH1 
promoter, all three genes are expressed at the level of the Adh1 protein, which would represent a 
larger change for Dom34 and Hbs1 than for Ubc4. Hence, the UBC4 gene might be more 
effectively overexpressed under a stronger promoter. 
 With respect to Dom34 and Hbs1 overexpression, the simplest explanation for their lack 
of ability to compensate for the loss of other NRD proteins is that they may be saturating, even at 
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low abundance. This would explain why, even at 10 times the normal abundance, they failed to 
promote NRD in the absence of Asc1. If this were not the case, then the increased concentration 
of these two proteins would likely have led to an improved rate of detection and degradation of 
mutant 18S rRNAs. 
 
Implication of ESCRT complex involvement in NRD 
 The major pathway for the breakdown of cellular components is mediated by the 
lysosome. In yeast, proteins from the cell surface and other compartments arrive at the lysosome 
via invagination of the membrane or via direct transfer across the endosome membrane. Cell 
surface receptors contained in endosome membranes are selectively incorporated into smaller 
endosomes by an additional invagination process. As the outer endosome membrane becomes 
filled with smaller internal bodies, it becomes a multivesicular body (MVB). Three protein 
complexes produce MVBs: the Endosomal Sorting Complex Required for Transport (ESCRT) I, 
II, and III. The protein Vps27 initially recruits the ESCRT-I complex, which then recruits 
ESCRT-II, which, in turn, is believed to recruit ESCRT-III. The process of MVB formation and 
lysosome-mediated protein degradation was reviewed by Hurley et al. and is summarized below 
(Hurley, 2008). 
 The monoubiquitination and polyubiquitination of protein targets lead to their 
incorporation into MVBs via activity of Vps27:Hse1 (Hirano et al., 2006). This heterodimer 
binds both ubiquitin and ESCRT-I to promote the recruitment process. Furthermore, Vps27:Hse1 
also recruits the E3 ubiquitin ligases and deubiquitinating enzymes that function, in some 
capacity, to promote this process. Together, Vps27 and the Tom proteins sequester ubiquitinated 
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protein cargo into defined areas along the outside of the endosome membrane. These areas are 
then coated in clatherine, leading to their subsequent incorporation into the MVB. Downstream, 
the acidification of the lysosome contributes to the degradation of the encapsulated materials 
(Hurley, 2008). 
 The MVB system may be involved in 18S NRD. The initial clue suggesting this 
connection came from genetic data indicating Doa1 involvement in NRD. Doa1 functions in at 
least two major pathways that involve the ubiquitin-mediated selection of target proteins for 
degradation by the 26S proteasome or their sequestration into MVBs (Qiu et al., 2010; Ren et al., 
2008). Moreover, Doa1 is also involved in the transport of wild type ribosomes into the vacuole 
during ribophagy (Ossareh-Nazari et al., 2010). The established overlap between 18S NRD and 
ribophagy supports the possibility that ribosomes may move into a membrane-bound 
compartment, such as an MVB, in a Doa1-dependent manner as part of 18S NRD. However, our 
data suggest that the Vps27 protein is not required for this process (Fig. 2.18C) . This argues 
against a role for MBVs in NRD, raising the possibility that another membrane-bound 
compartment is used, or that sorting into MVBs can occur in a Vps27-independent manner. 
A Model for 18S NRD 
 The genetic evidence for Ubc4, Doa1, and Asc1 involvement in NRD allows us to 
partially outline their locations in the pathway (Fig. 2.20). First, Dom34 and Asc1 appear to 
function independently at the same level, thereby establishing parallel branches at their step of 
the pathway. Given the suggestion that Doa1 is epistatic to Dom34, we have grouped them 
together. In vitro data suggest that Hbs1 has a stimulatory effect on Dom34 but is not essential 
for its activity (Pisareva et al., 2011). Hence, we have placed Hbs1 above Dom34. In the case of 
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Doa1, our data do not indicate whether it functions upstream or downstream from Dom34; hence 
our model is ambiguous about these two possibilities. 
 
B. 
Figure 2.20. A model for 18S NRD. A. Pathway diagram including Ubc4 and an 
anticipated, associated, E3 ubiquitin ligase and Rps3. The activities of both Rps3 
and the E3 ligase are inferred based upon known physical interactions, but have 
not been demonstrated in NRD. B. Diagram of the ribosome displaying 
schematically the interactions between Hbs1, Rps3, and Asc1. 
 
The severe decrease in 18S NRD activity in the absence of UBC4 suggests that Ubc4 is 
required at its level in the pathway. While it is clear that Ubc4 functions at a level distinct from 
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Dom34, Doa1, and Asc1, the data, again, do not allow us to establish order. For the purposes of 
simplicity, we have placed it upstream, though multiple other possibilities exist. 
In an effort to gain additional insight into the order of the pathway, and potential 
functional redundancy within the system, we overexpressed different NRD proteins in the 
absence of others. We expected that functionally redundant proteins might compensate for the 
loss of others, or that certain proteins might, when overexpressed, overcome the loss of an 
upstream regulator. To test this possibility, we developed high expression ADH1 promoter 
fusion constructs for DOM34, HBS1, and UBC4. Because the endogenous ASC1 promoter is 
already highly efficient, we simply expressed FLAG-ASC1 under its own promoter. For each of 
these four proteins, we observed partial or full complementation in the respective deletion 
backgrounds, but no evidence that they are capable of compensating for the loss of other NRD 
proteins. This suggests that endogenous NRD protein levels may be saturating, or that these 
constructs did produce quantities of protein sufficient to detect dosage compensation (data not 
shown).  
 The two major ambiguities inherent in our data set allow for four possible configurations 
of the 18S NRD pathway: Ubc4 could function above or below the Asc1/Dom34 branches, and 
the two branches either converge again at the end opposite Ubc4, or they remain separate for the 
remainder of the pathway. 
The dual branch model for NRD also raises the possibility that the Asc1 and Dom34 
branches could be coordinately regulated by an upstream factor. In consideration of this 
possibility, we note that both Asc1 and Hbs1 directly interact with Rps3, which in turn directly 
interacts with the mRNA at the entrance to the mRNA channel. As such, Rps3 is ideally 
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positioned to function as a sensor of ribosome translocation along the mRNA, and could 
potentially function as a regulator of both branches of the NRD pathway. Interestingly, the tail of 
Rps3 directly interacts with WD4 of Asc1, the WD40 repeat involved in Asc1 dimerization, 
thereby suggesting a potential mechanism by which Rps3 could regulate Asc1. 
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Chapter 3: 
 Testing the endogenous functions of 18S NRD 
 
Introduction 
 To date, 18S NRD has been shown to degrade synthetic, mutant rRNAs expressed from 
plasmids. Though it is conceivable that yeast may naturally develop an 18S:A1492, 18S:1493, or 
18SG530U mutation, the existence of the complex NRS system suggests that a more general 
trigger for translational stalls is likely to exist. One likely function is the detection of improperly 
or incompletely made small subunits. A second possibility is that NRD/NGD deletes partially 
degraded or damaged mRNAs. In rare cases, NRD may also ameliorate the toxic effects of 
ribosome-inactivating toxins released by microorganisms. 
 
18S NRD serves as a quality control measure for translating ribosomes 
 The production of ribosomes is complex and requires the involvement of a large number 
of assembly factors, nucleases, small accessory RNAs, and chemical modifications. All of this 
takes place quickly and requires the correct localization and transfer of the pre-ribosomal 
subunits. The complexity of this process implies that even minor errors may contribute to the 
production of a nonfunctional ribosome.  This suggests that mutations in ribosome assembly 
proteins could lead to widespread ribsome/translation problems. In a recent publication, Soudet 
et al. demonstrated that defects in 20S maturation promote the formation 20S-containing, but 
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otherwise mature, small ribosomal subunits that attempt to conduct translation initiation. These 
subunits appear in polysome profiles predominantly in the monosome fraction, and appear to 
cause widespread problems with translation as evidenced by altered polysome profiles and slow 
growth (Soudet et al.). The loss of Dom34 and Hbs1 in this strain background has the surprising 
effect of relieving the slow-growth phenotype. Despite the observation that Dom34 and Hbs1 
promote cell growth when ribosome assembly is altered due to ribosomal protein 
haploinsufficiency, in this instance, the opposite appears to be true (Bhattacharya et al.). Here, 
the authors propose that a mild decrease in the rate of 20S processing leads to the accumulation 
of incompletely synthesized small subunits, which attempt translation. These immature small 
subunits are apparently degraded by Dom34:Hbs1 even though, given additional time, they 
might reach full maturation. Hence, in this case, the deletion of these immature small subunits by 
Dom34:Hbs1 appears to be detrimental to the cell. 
 In a second example, Dom34:Hbs1 were also shown to promote the growth of cells 
deficient for one copy of the Rps6A gene (Bhattacharya, McIntosh, Willis, & Warner, 2010). 
The deletion of one copy of a ribosomal protein gene is anticipated to lead to a decrease in the 
corresponding protein, potentially leading to a defect in ribosome production. The slow growth 
of such strains supports this hypothesis. Interestingly, the loss of Dom34 or Hbs1, which 
normally does not affect the growth of WT cells, decreases the growth rate of RPS6A 
haploinsufficient cells, suggesting that the NRD pathway is somehow active in the protection of 
the cell against the deleterious effects of this ribosome production defect. 
Data discussed below supports the Soudet et al 2010, and Bhattacharya et al. 2010 data 
sets by providing direct evidence of rRNA degradation during ribosomal protein 
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haploinsufficiency. It also contributes to the identification of additional endogenous roles for 18S 
NRD, including protection from genotoxic stress and translation inhibitors. 
 
18S NRD may protect the cell from damaged RNAs 
Damaged RNAs represent a theoretically common impediment to canonical translation, 
potentially leading to their removal from the cell by NRD/NGD. Cells continually produce 
endogenous alkylating and oxidizing agents via cellular metabolic processes, creating a constant 
source of hazardous RNA-damaging chemicals. The discovery in mammalian cells of the 
oxidative RNA demethylases, AlkB and AlkBH3, suggests that the alkylation of RNA has 
negative implications for the health of the cell (Drabløs et al., 2004). Oxidized mRNAs show 
apparently normal polysome association; however, at levels corresponding to the degree of 
oxidation, they lead to the formation of incompletely synthesized peptides (Tanaka et al., 2006). 
These truncated peptides suggest that oxidized mRNAs cause translational stalling, the theorized 
trigger for NRD/NGD.  
In Arabidopsis, wild type plants display widespread mRNA turnover following UV 
exposure, a phenotype lost in strains lacking the RPS27A gene. Loss of this gene also triggers 
sensitivity to the alkylating agent MMS, which is capable of forming adducts on both DNA and 
RNA. These phenotypes are reminiscent of the mRNA degradation events observed in NGD, 
suggesting Rps27A might act in NGD or 18S NRD (Revenkova et al., 1999). In yeast, the RPS27 
genes encode a pair of highly similar copies of the small subunit protein Rps27, which is located 
on near the mRNA channel. This location suggests that Rps27 is potentially able to directly bind 
the associated mRNA, as well as the rRNA, making it suitable as a sensor of translation stress or 
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potentially as a nuclease, though its structure does not imply this activity. Similar to the yeast 
genes, in A.thaliana, there are four Rps27 genes: -A, -B, -C, and Ψ. These genes differ at the 
same amino acid shown to be variable in yeast, with the exception of Ψ, which is divergent at an 
adjacent residue. In yeast, Rps27A is apparently the closest orthologue to the Arabidopsis 
Rps27A. This suggests that a yeast rps27a∆ strain might display defects for NRD and NGD, 
whereas an rps27b∆ strain might not. 
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18S NRD may protect the cell from eukaryotic ribosome-targeting antibiotics 
Cycloheximide (CHX) is a ribosome-inactivating toxin produced by the bacterium 
Streptomyces griseus. It specifically targets the eukaryotic ribosome, essentially locking the large 
and small subunits together (Baliga et al., 1969,,Obrig et al., 1971). Even at low concentrations, 
CHX is cytotoxic to most eukaryotic cells. Due to the opposing activities of CHX and 
Dom34:Hbs1, we theorized that CHX-bound ribosomes might be resolved by Dom34:Hbs1, 
either by releasing them or by degrading them via the 18S NRD pathway. If correct, we 
anticipated that cells deficient for NRD would be killed at a lower concentration of CHX. 
 
Results 
Ribosomes in RPS27B deficient cells are targeted for degradation by Dom34, correlating with 
faster cell division. 
The discovery that 18S NRD may function to delete incompletely synthesized ribosomes 
occurred indirectly, as part of the search for new 18S NRD factors. As of 2009, Dom34 and 
Hbs1 were the only known 18S NRD factors. The continued activity of the 18S NRD pathway in 
the absence of both proteins implied the existence of additional factors, prompting us to 
investigate new candidate genes. This search led us to examine the potential role for RPS27A 
and RPS27B, two factors that were implicated in a NGD-like process in Arabidopsis (Casati et 
al.). To test the involvement of the RPS27 genes in NRD, we assayed the two deletion strains for 
effects on NRD using a single timepoint assay and northern blot analysis. We also tested 
rps27a∆dom34∆ and rps27b∆dom34∆ strains in order to detect potential synergistic effects. Our 
results demonstrated that mutant 18S rRNAs were not stabilized in the absence of either RPS28A 
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or RPS27B. Surprisingly, the stabilizing effect on mutant 18S rRNA seen in the absence of 
DOM34 was slightly diminished in strains lacking either RPS27A or B. This effect was stronger 
in the dom34∆rps27b∆ strain than in the dom34∆rps27a∆ strain (Fig 3.1.)  
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A. 
 
B. 
Figure 3.1. 18S rRNA levels in rps27A∆ and rps27b∆ deletion strains. Strains rps27a∆ or 
rps27b∆ were crossed with dom34∆ and subjected to single timepoint analysis. 18S/25S ratios 
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were plotted, and representative northern blot data are shown below (A). The single rps27a∆ and 
rps27b∆ strains were subjected to timecourse analysis. 18S/25S ratios were plotted and T0 ratios 
for each timecourse were normalized to 1 (B). 
The data displaying WT 18S rRNA levels in the rps27a∆/b∆ strains provide some insight 
into the mutant 18S data set. Surprisingly, in the single timepoint data set, WT 18S rRNAs were 
dramatically destabilized in the rps27b∆ strain, but not the rps27a∆ strain. This destabilization 
correlates with slow growth and reported sensitivity of the rps27bΔ strain to various sources of 
genotoxic stress (Jelinsky, Estep, Church, & LD, 2001). This strong destabilization was 
significantly, but partially, relieved by the additional deletion of DOM34. This suggests that 
Dom34 may be subjecting many of the small subunits in these cells to 18S NRD. Timecourse 
analysis of WT 18S rRNAs in this strain suggests that WT 18S rRNAs only represent 50% of the 
total seen in WT or rps27a cells, but that this population is stable.  This agrees with the 
hypothesis that a large percentage of the 18S rRNAs in the rps27b∆ strain are degraded.  
  
18S NRD deficient cells are sensitive to 4-nitroquinoline 
 To test whether NRD protects the cell from damaged RNAs, we compared the growth of 
NRD-deficient and wild type strains during application of genotoxic  chemicals thought to 
damage RNA. Specifically, we applied the same genotoxic chemicals used in the Genomic 
Phenotyping database prepared by the Samson lab to a variety of strains (Said, Begley, 
Oppenheim, Lauffenburger, & Samson, 2004). These chemicals include 4-nitroquinoline-N-
oxide (4NQO), a UV mimetic that also produces oxidative damage; an oxidizing agent, tert-
Butyl hydroperoxide; and the alkylating agent MMS. We theorized that certain chemical lesions 
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may lead to translational stalling, thereby triggering their resolution by the NRD/NGD pathways. 
As such, the loss of NRD proteins would be expected to promote strain sensitivity to certain 
chemicals. 
 To assay our deletion strains, we chose to conduct halo assays, an experimental system in 
which a lawn of cells is plated out, and then a disk of paper containing a defined quantity of a 
chemical agent is placed in the center of the plate. The drug then diffuses from the disk, creating 
a concentration gradient on the plate. The quantity of each damaging agent applied to the disk is 
titrated to produce a zone of growth inhibition that is easily measured. Different strains may 
show variable areas of growth inhibition or “halos,” thereby providing a quantifiable measure of 
their sensitivity to the damaging agent. 
 It was previously reported in the high throughput Genomic Phenotyping database that 
both dom34∆ and hbs1∆ strains are sensitive to oxidative damage by tert-butyl hydroperoxide 
(Said et al., 2004).  Strain asc1∆ was also reported to be sensitive to MMS and 4NQO. Like the 
Samson lab, we observed that asc1∆ is sensitive to 4NQO; however, we did not detect any 
sensitivity to MMS. Likewise, for the dom34∆ and hbs1∆ strains, we did not observe the 
reported sensitivity to any of the damaging agents. The differences between these two data sets 
suggest that differences between the W303 strain background used in the Samson data versus the 
BY4741 strain background used in our lab may be affecting the outcome of the experiments. 
 Nevertheless, we continued to test our hypothesis by examining the effects of damaging 
agent treatment on the double mutants dom34∆asc1∆, in which 18S NRD is not detectable, and 
hbs1∆asc1∆, which still conducts NRD, albeit at a slower rate than either of the corresponding 
single deletions. We found that for 4NQO treatment, dom34∆asc1∆ showed synthetic sensitivity 
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whereas hbs1∆asc1∆ did not. This correlates with the apparently complete shut-off of NRD 
observed in dom34∆asc1∆, but not in hbs1∆asc1∆ (Fig. 3.2). 
 
Figure 3.2. 4NQO sensitivity of dom34∆asc1∆ and hbs1∆asc1∆ strains. Both single and double 
deletions strains were subjected to halo assays in the presence of 25 µg 4-nitroquinoline-n-oxide 
which was placed onto the watman paper disk. The relative area of growth inhibition for each 
strain was plotted.  
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18S NRD-deficient cells are sensitive to translation inhibitor Cycloheximide (CHX). 
 Given that CHX prevents translocation of the eukaryotic ribosome by essentially locking 
the large and small subunits together, we theorized that CHX-treated ribosomes would resemble 
NRD targets. As such, the ability of the NRD pathway to resolve stalled ribosome complexes 
should protect cells from the activity of this drug. To test this hypothesis, we conducted halo 
assays in strains deficient for DOM34, ASC1, or both genes, and compared the area of growth 
inhibition to that of the isogenic wild type strain (Fig. 3.3). Strains deficient for DOM34 or 
HBS1 did not display any sensitivity to CHX in halo assays, although deletion of ASC1 led to a 
~40% increase in halo area. Both dom34∆asc1∆ and hbs1∆asc1∆ strains showed synthetic 
sensitivity to CHX, consistent with the synthetic effect in NRD previously observed in both 
strains. In these strains, loss of NRD correlated with CHX sensitivity. However, this correlation 
does not always apply: strain ubc4∆ showed no sensitivity to CHX despite its apparent complete 
lack of ability to conduct 18S NRD. This difference may reflect differences in the level at which 
Dom34, Asc1, and Ubc4 function in NRD.  
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Figure 3.3. CHX sensitivity of dom34∆asc1∆ and hbs1∆asc1∆ strains. The dom34∆asc1∆, 
hbs1∆asc1∆ strains, and corresponding single deletion strains were subjected to halo assay in the 
presence of 7.5 µg cycloheximide placed onto the watman paper disk. The relative area of 
growth inhibition for each strain was plotted. 
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 Our doa1∆ and ubc4Δ strains also showed a CHX sensitivity equivalent to the WT strain, 
consistent with the effect seen in dom34∆ and hbs1∆ strains. Given the genetic evidence that 
Doa1 is epistatic to Dom34, this is not surprising. Also, based on previous results, it would 
certainly stand to reason that synthetic sensitivity to CHX would be observed in doa1∆asc1∆, but 
not in doa1∆dom34∆. Again, this hypothesis is based upon the previously established synthetic 
loss of NRD in doa1∆asc1∆ but not doa1∆dom34∆. These possibilities have not yet been tested. 
The sensitivity of NRD deficient strains to alkylating and oxidative damaging agents was also 
tested (Fig. 3.4). The halos of the assayed strains were highly similar, suggesting that the tested 
strains are not sensitive to damage by MMS or tert-butyl hydroperoxide. 
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Figure 3.4. MMS and TBH sensitivity of dom34∆asc1∆ and hbs1∆asc1∆ strains. The 
dom34∆asc1∆ strains, hbs1∆asc1∆ strains, and corresponding single-deletion strains were 
subjected to halo assays in the presence of either 5µl Methylmethanesulfonate or 1.5 µl of 70% 
tert-butyl hydroperoxide pipetted directly onto the watman paper disk. The relative area of 
growth inhibition for each strain was plotted. 
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Materials and Methods 
Single Timepoint Assay:  
Strains harboring pSC40-Wt or pSC40-18S:A1492C plasmids were grown at 30o in SD-uracil, in 
the presence of 2% raffinose, to mid-log phase (OD600 = 0.5). Galactose was added to a final 
concentration of 2% to induce rRNA transcription, and cells were incubated for an additional 90 
minutes. OD600 was monitored during this time and pre-warmed medium was added as necessary 
to maintain OD600 = 0.5. Cells were then harvested by centrifugation and flash frozen on dry 
ice/EtOH. 
 
Pulse-chase Analysis: 
Pulse-chase analysis was performed as previously described (Lariviere et al. 2006). Strains 
harboring pSC40-Wt or pSC40-18S:A1492C plasmids were grown at 30o in SD-uracil with 2% 
raffinose to mid-log phase (OD600 = ~0.5). Galactose was added to a final concentration of 2% in 
order to induce rRNA transcription, and cells were incubated 90 minutes. Pre-warmed glucose 
was then added to a final concentration of 2% and timepoint T0 was immediately harvested. 
Samples were then flash frozen on dry ice/EtOH. Pre-warmed SD-ura with 2% glucose was 
added as necessary to maintain an OD600 of 0.5 for the duration of the timecourse. Timepoints 
were taken at specified intervals.  
Northern Blot Analysis: 
For each sample, 2 µg total RNA was separated on a 1% agarose-formaldehyde gel and 
transferred to a nitrocellulose membrane as previously described (Brown et al., 2004). Total 
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RNA was detected via staining with Methylene blue stain (Molecular Research). Membranes 
were hybridized with 32P-end-labeled probes FL125 (anneals to plasmid derived 18S rRNA) and 
FL126 (anneals to plasmid derived 25S rRNA) for 12 hr in ExpressHyb (BD Biosciences). 
Signals were visualized using a Typhoon Phosphorimager (Molecular Dynamics) and quantified 
via ImageQuant software (GE Lifesciences). 
Halo Assays: 
WT and the corresponding mutant cells were grown to mid-log (~OD 0.5) in YPD medium, then 
spun down to collect the cells, and resuspended in 150 ul YPD medium. Cells were then spread 
evenly on plates consisting of exactly 25 ml of YPD/Agar, and set at 30o for one hour until dry. 
Sterile whatman paper disks were then placed in the center of the plate, and drugs were added in 
the indicated quantities. Cells were then grown for ~16-32 hours until a clear zone of growth 
inhibition was established. Plates were then digitally photographed, and the area of growth 
inhibition was measured using software.  Damaging agent amounts added to whatman paper 
disks are as follows: 5µl Methylmethanesulfonate, 1.5 µl of 70% tert-butyl hydroperoxide, 7.5 
µg cycloheximide, 25 µg 4-nitroquinoline-n-oxide. 
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Discussion: 
 These experiments test a number of proposed functions for the 18S NRD pathway, 
including the turnover of immature ribosomes, and degradation of damaged RNAs. The initial 
experiments on the Rps27 proteins was initiated based upon the suggestion that a subset of the 
Arabidopsis Rps27 proteins could promote a NGD like process. Though we do not observe 
evidence of any effects on 18S NRD, the dramatic lack of wild type 18S rRNAs in the rps27b∆ 
background, and the subsequent, partial restoration of their levels when DOM34 is deleted, are in 
keeping with the conclusions of Bhattacharya et al. This group demonstrated that DOM34 and 
HBS1 promote cell growth when certain small subunit ribosomal protein genes are absent from 
the cell. This indirectly implies that Dom34:Hbs1 may recognize improperly assembled small 
subunits. The translation-dependent nature of 18S NRD also suggests that such improperly 
assembled, but otherwise wild type ribosomal subunits may be attempting translation initiation. 
Our other work, demonstrating a selective increase in NRD substrates in the monosome fraction 
also suggests that immature small subunits that attempt initiation may successfully proceed to 
recruit a large subunit recruitment prior to triggering the effects of Dom34:Hbs1. These 
suggestions are both supported by the data presented by Soudet et al. which demonstrates that 
immature, but otherwise wild type small subunits can attempt initiation, leading to their 
degradation in a Dom34 dependent manner. Unlike the Soudet et al. dataset which deals with an 
analogous, but distinct situation, in the rps27b∆ background, Dom34 in its normal function, 
appears to be rescuing the cell from the detrimental effects of incompletely or improperly made 
small subunits. This helps establish the previously theorized role for Dom34:Hbs1 as a final 
round of quality control for wild type ribosomes. 
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 Our data set also includes a preliminary investigation of the effects of genotoxic 
chemicals on cell growth in the absence of 18S NRD. Though we observe a significant, 
detrimental effect of these chemicals on cell growth, the NRD pathway only appears to have a 
mild protective effect on cells. It is currently unknown whether 4NQO directly damages RNA, 
though the chemical structure of RNA is sufficiently similar to that of DNA that it would not be 
unreasonable to expect that it produces similar lesions on RNA. Nevertheless, a thorough 
investigation of the effects of 4NQO on RNA is necessary before any credible claims can be 
made about the mechanism by which Dom34, Hbs1 and Asc1 protect the cell from 4NQO. 
However, it is worth noting that there has never been any published work reporting the detection 
of a role for Dom34 in DNA damage repair, and that, conversely, its role in RNA metabolism is 
quite clear. Moreover, unpublished data from Roy Parker's lab and Rachel Green's lab argue 
against changes in the transcriptional and translational profile of cells in the absence of DOM34. 
This suggests that indirect effects of DOM34 deletion on the expression of DNA damage repair 
genes are minimal. In light of these data, the possibility that NRD protects the cell from 4NQO-
damaged RNAs remains credible. Future testing of the ubc4∆ strain should serve to further test 
this possibility. 
 Finally, our data also suggest that 18S NRD may counteract the detrimental effects of 
cycloheximide on the cell. Dom34, Hbs1, and Asc1 may or may not directly release ribosomal 
subunits that have stopped during elongation due to the activity of CHX, however this is 
certainly a possibility. Alternatively, these three proteins could simply act on wild type 
ribosomes, thereby increasing the pool of free ribosomal subunits which may be limiting at 
increasing concentrations of CHX.  
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 Ribosomal processing defects as tools for studying NRD: 
The Soudet paper demonstrated the Dom34:Hbs1-mediated degradation of 20S-
containing small subunits, suggesting that the strains mutant for 40S production could potentially 
provide important new information about 18S NRD. Specifically, the data implies that the 
subcellular localization of small ribosomal subunits in maturation deficient strains, would 
correspond to the location where NRD takes place. Perhaps this compartment is simply P-bodies, 
as previously observed, or perhaps P-bodies are a downstream location. One alternate possibility 
is that these 20S rRNAs could be present in the vacuole in the same manner observed in 
ribophagy. Another appealing possibility is that these strains could be used to look for 
spontaneous suppressors. Presumably, the up-regulation of 18S NRD proteins could lead to 
faster growth, allowing for a selection mechanism. Alternatively, it might be possible to use an 
anagous process to find large subunit defects that led to an analogous, translation-depenedent 
process for the large subunits. Along these same lines, the Bhattacharya paper suggests that RplX 
haploinsufficient might also represent an equally facile tool. 
 
Implications of 18S NRD in protecting the cell from antibiotics and damaging agents: 
Though we are not the first group to discover that NRD protein deficient strains are 
sensitive to genotoxic stress, we are the first to combine these previously decoupled deletions to 
show that they produce a synthetic effect. The sensitivity to 4NQO observed in dom34∆asc1∆ 
suggests that Dom34:Hbs1, could potentially be directly protecting the cell from 4NQO 
mediated RNA damage. Though 4NQO should also damage DNA, Dom34:Hbs1 has not been 
shown to have activity within the nucleus. Moreover, it’s well characterized activities in NRD, 
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NGD, and NSD suggest that its synthetic effect with ASC1 deletion in protection from 4NQO 
likely represents a defect in an RNA degradation pathway.  Yet, barring direct evidence that 
4NQO damages RNA, and that it is the RNA damage, rather than DNA damage, that is the 
causative agent behind the increase in cell death in dom34Δasc1Δ, we cannot draw any hard 
conclusions regarding the mechanism by which NRD protects the cell from 4NQO. 
 The sensitivity disparity between dom34∆asc1∆ and hbs1∆asc1∆ is also interesting. One 
potential explanation for this difference is the continued activity of Dom34 in the absence of 
Hbs1. In vitro, the loss of Hbs1 can be compensated for by increasing the concentration of the 
Dom34 homologue, Pelota (Pisareva et al., 2011). This suggests that the same may be true in 
vivo, potentially leading to a compensatory up-regulation of the DOM34 gene or simply residual 
activity by the Dom34 protein. 
 Also of interest is the fact that NRD deficient cells are not susceptible to increased killing 
by oxidative or alkylating damaging agents. This lack of effect suggests that 18S NRD may not 
be capable of detecting or degrading oxidized or alkylated RNAs. Instead, NRD may only 
function to detect specific chemical modifications such the bulky lesions produced by 4NQO. 
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Chapter 4:  
Prospectus 
 When this phase of the 18S NRD project was initiated, the role of Dom34:Hbs1 in NRD 
and NGD had already been identified. Despite their involvement, it was clear that other proteins 
contribute to 18S NRD, due to the continued degradation of mutant 18S:A1492C rRNAs in the 
absence of either protein. We were particularly interested in finding the other NRD proteins 
because we wanted the ability to completely shut off the pathway. We anticipated that NRD 
deficient cells might show phenotypic effects, such as sensitivity to chemicals that damage 
nucleic acids. The identification of such phenotypes could potentially allow us to identify 
endogenous functions and targets of the NRD pathway. To find the additional NRD proteins, we 
tested a number of candidate gene deletion strains for loss of 18S NRD. 
 Initial attempts to find new 18S NRD factors focused on the two dubious ORFs that 
represent the original DOM34 gene on chromosome XIV. These two ORFs, YCL001W-A and -
B, are homologous to the 5` and 3` portions of the DOM34 gene, suggesting that they might 
function in 18S NRD. To test this possibility, we examined mutant 18S:A1492C stability via 
timecourse and single timepoint assays, in strains ycl001w-A∆, ycl001w-b∆, and in the double 
mutant strains ycl001w-A∆dom34∆, ycl001w-b∆dom34∆. We did not observe any stabilization 
of the mutant 18S rRNAs in the single ycl001W∆ strains, or any synthetic effect when they were 
combined with dom34∆, arguing against any role for these two genes in NRD. 
 We also tested the role of two ribosomal small subunit proteins, Rps27a and Rps27b, for 
effects in NRD. These two proteins were implicated in a NGD like process in plants, suggesting 
that they might be involved in NRD/NGD in yeast (Casati et al., 2004). Though we did not 
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observe any stabilization of mutant 18S rRNAs in the absence of either protein, we did notice 
that WT 18S rRNAs were low in abundance in the rps27b∆ strain, which has a slow growth rate. 
Further loss of DOM34 in this strain led to a partial rescue of the WT 18S rRNA levels, but also 
made the cells grow slower still. These data support the conclusions of Bhattacharya et al. which 
indicated the same genetic interaction between DOM34 and RPS27B, as well as the synthetic 
sickness of the rps27b∆dom34∆ strain.  
 A simple model that could explain this data: In the absence of RPS27B, many of the cell's 
40S subunits could be improperly/incompletely manufactured. These immature small subunits 
could be detected by Dom34, via the 18S NRD pathway, leading to their clearance from the cell, 
and decreasing cell sickness due to translation problems. A recent report by Soudet et al. 2010, 
described a similar role for Dom34 in the clearance of incompletely manufactured small subunits 
which attempt initiation. Our data on RPS27B supports the Soudet et al. data set, providing 
additional evidence that one endogenous function for Dom34, and by extension, Hbs1, is the 
deletion of improperly made small subunits. Interestingly the phenotypic rescue of the rps27b∆ 
strain by DOM34 deletion, was partial, just as we had seen before in our 18S NRD assays. This 
again suggested that a second, as yet unidentified protein, was deleting the 18S rRNA component 
of small subunits. 
 
The role of Asc1 in NRD 
 We later learned of the involvement of Asc1 (Rack1) in a NRD related process - PDTA. 
The previously described involvement of Dom34 in PDTA, as well as the newly discovered role 
for Asc1, suggested that Asc1 was also likely to be involved in 18S NRD. Accordingly, our 
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results show that Asc1 promotes 18S NRD , and that it acts in parallel with Dom34. The lack of 
NRD observed in the absence of both protein suggests that Asc1 represents the other half of the 
18S NRD pathway. 
 Asc1 is a eukaryote specific ribosomal protein involved in a multitude of processes in the 
cell. In a number of pathogenic organisms, Rack1 function is required for virulence. It is also 
involved in general translation, the selective translation of a number of different transcripts, 
ubiquitin mediated proteolysis, signal transduction, and the small subunit rRNA turnover we 
observe in 18S NRD. The activities of Asc1 in translation and its localization to the ribosome 
suggest that it would function while ribosome-bound in 18S NRD. Despite our expectation, 
ASC1 mutations shown to decrease the association of Asc1 with the ribosome in polysome 
profiles, had no negative effect on NRD. In fact, single timepoint analysis suggests that these 
mutations could even promote Asc1 activity. These data suggest that Asc1 functions off the 
ribosome in NRD.  
 We gathered additional clues about the mechanism of Asc1 activity by mutating two 
other putative regulatory domains - deletion of the ribosome facing "knob" and the Y to F 
mutation of the two proposed sumoylation sites. The knob deletion was shown to be irrelevant 
for ribosome binding activity, suggesting that decreased ribosome association is not the reason 
for this potential gain of function activity. However, the decrease in mutant 18S rRNA levels 
observed in the presence of the two ASC1 tyrosine mutants suggests that regulation of Asc1 by 
sumoylation, or another ubiquitin like modifier, may occur. 
 Studies on the mammalian homologue of Asc1, Rack1, indicated the ability of Rack1 to 
dimerize (Yatime et al., 2011). However, the residues responsible for Rack1 dimerization are not 
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conserved in yeast, precluding our ability to test the effects of Asc1 dimerization mutants on 18S 
NRD. Following the completion of this work, the existence of Asc1 homodimers was confirmed, 
and two crystal structures were determined (Yatime et al., 2011). Based upon these structures, 
the homodimerization process was proposed to be mediated by, or require, His147. As such, the 
future testing the ability of ASC1:H147 mutant to promote NRD will likely provide important 
information about the mechanistic basis of Asc1 involvement. 
The roles of Ubc4 and Doa1 in NRD 
 The initial data suggesting Asc1 involvement in NRD set up the expectation that one of 
the previously reported Asc1 binding partners could facilitate Asc1's activity in NRD. We 
therefore looked for factors known to physically associate with Asc1 and screened a number of 
them for effects on NRD. This led to the discovery of Ubc4, and Doa1, two Asc1 binding factors 
implicated in PDTA and Ribophagy. The identification of these two proteins strengthened the 
growing connections between PDTA, NRD, and the other translation surveillance pathways 
NGD, and NSD. All of these pathways are facilitated by Dom34:Hbs1, and growing evidence 
suggests that the associated nascent peptides are also targeted for degradation via the ligation of 
a ubiquitin tag. Hence, what is true for one pathway is often true for the others. This has led to 
the suggestion that these pathways may, to a large extent, be coupled. 
 The implication that Doa1, which specifically affects large subunit ribophagy, is involved 
in small subunit rRNA turnover suggests that Doa1 may also exert its influence on 18S NRD via 
interaction with the large subunit. This is certainly not unreasonable given the requirement for 
large subunit recruitment prior to 18S:A1492C detection, as well as the A-site binding activity of 
Dom34:Hbs1. Moreover, the Bhattacharya et al. dataset suggest that Ubc4, Asc1, and Doa1 all 
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promote cell growth, specifically during large subunit ribosomal protein haploinsufficiency. 
Hence, it is possible that certain NRD proteins could function through large subunit interactions.  
 In considering 60S involvement in NRD, it is important to note that a translation 
dependent 25S rRNA decay pathway, analogous to 18S NRD, has not yet been detected.  It is 
entirely possible that such a pathway exists. An equally intriguing possibility, given what we 
know about Asc1, Doa1, and Ubc4, is that the large subunit might be degraded via 18S NRD 
when it becomes paired with a nonfunctional small subunit. In the future, it will be important to 
determine if this occurs. 
 Similar to the possibility that a mutant 18S-containing small subunit could prompt the 
degradation of the associated large subunit, it is also possible that a mutant 18S containing small 
subunit could promote the degradation of the entire complex, including the nascent peptide, 
mRNA, large subunit, and tRNA. Moreover, ribosomes upstream of a stalled 80S complex 
would eventually encounter the stalled ribosome, leading to the production of additional stalled 
complexes (Akimitsu, Tanaka, & Pelletier, 2007). This suggests that a single ribosome stalling 
event could promote the NRD-mediated degradation of all of the associated upstream ribosomes. 
Among this group of potential secondary targets, the degradation of the associated tRNA is a 
particularly appealing. One previous report demonstrated that Dom34:Hbs1 triggers tRNA-
peptide release rather than the separate release of the two which normally occurs during 
cannonical termination (Shoemaker et al., 2010). If the nascent peptide is subject to selective 
degradation as part of 18S NRD the way it is in PDTA and NSD, this mechanism could also 
clear the associated tRNA from the cell. (Conversely, this also suggests that tRNA-mediated 
translational stalling could be physiologically relevant, and that Dom34:Hbs1 might be 
responsible for the deletion of such a molecule.) As such, a global translation complex 
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degradation mechanism would preclude the need to evolve independent quality control devices 
capable of distinguishing between an mRNA/tRNA/rRNA/ribosmal protein/peptide mediated 
stall. Hence, the data suggesting significant overlap between NRD, NGD, PDTA and NSD, 
pathways certainly seem to make logical sense in that it suggests a relatively simple means for 
dealing with improperly functioning translation complexes. Nevertheless, several lines of 
evidence have demonstrated that NSD, NDG, and NRD can all be decoupled, indicating that 
discreet detection and degradation mechanisms do exist (Pisareva et al., 2011; D. Schaeffer & 
Hoof, 2011).  Together, these observations would seem to suggest that an indiscriminant global 
translation complex degradation process is unlikely, and that instead, combinations of 
translational stall induced tRNA/mRNA/rRNA/nascent peptide/ribosomal protein degradation 
events may overlap in more subtle ways. 
  Following our analysis of Asc1, we tested the roles of Ubc4 and Doa1 in NRD, by 
crossing the two respective deletion strains to either dom34∆ or asc1∆, which appear to represent 
separate halves of the NRD pathway. Timecourse assays reveals that in the absence of UBC4, 
18S NRD is not detectible over a 6 hour period, and that the additional loss of DOM34, or 
ASC1, does not alter this apparent complete stabilization. The loss of mutant 18S degradation in 
the ubc4∆ strain suggests that Ubc4 is essential for 18S NRD. Loss of DOA1 however, produced 
a partial stabilization of mutant 18S rRNAs, suggesting that it functions in parallel with other 
factors. The synthetic stabilization observed in doa1∆asc1∆ but not doa1∆dom34∆, indicates that 
Doa1 functions with Dom34, and in parallel with Asc1. The phenotypes were similar to the rate 
of NRD, and degree of mutant 18S stabilization, observed in the dataset comparing the rate of 
NRD in dom34∆, asc1∆ and dom34∆asc1∆. As such, we developed a model for 18S NRD in 
which Dom34:Hbs1 functions with Doa1 in one branch of the 18S NRD pathway, opposite Asc1. 
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Ubc4 either functions in both branches of the pathway, or at a different level where the NRD 
pathway exists as a single branch. Interestingly, under this configuration there are WD40 repeat 
proteins on both sides of the pathway, raising the possibility that Doa1 and Asc1 could have 
similar functions. 
 
Implications of Ubiquitin Involvement in NRD 
 Though we established a general framework by which the NRD proteins promote the 
degradation of mutant 18S rRNAs, we did not determine the mechanistic basis for their 
involvement. However Asc1, Doa1 and Ubc4 have all been the subject of other studies, allowing 
us to speculate on the means by which they could promote NRD. With the exception of Dom34 
and Hbs1, all of the NRD proteins have been shown to function as part of the cellular ubiquitin 
systems. Rack1 promotes ubiquitin mediated proteolysis in human cells, Doa1 posesses two 
ubiquitin binding domains, and Ubc4 directly ligates ubiquitin onto protein targets in its role as 
an E2 ubiquitin conjugase (Pashkova et al., 2010; Ruan et al., 2009; Stoll, Brzovic, Davis, & 
Klevit, 2011). The target(s) of Ubc4-mediated ubiquitination event(s) are currently unknown, 
though ribosomal proteins are obvious candidates. One possibility is that Asc1 itself is 
ubiquitinated. Future characterization of the 18S NRD pathway should include the identification 
of the target proteins. The method used in Fujii et al. 2009 could be instrumental in this regard. 
Briefly, they expressed FLAG-tagged ubiquitin in WT cells, and cells deficient for an E3 
ubiqutin ligase implicated in ribosomal protein ubiqutination in 25S NRD. They isolated 
ribosomes from cells expressing WT or mutant 25S rRNAs and ran western blots against FLAG 
in order to detect ubiquitinated ribosomal proteins. Using this method, they identified two 
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distinct bands at roughly 40 and 50 kd. Mass spectrometry analysis could potentially identify 
such proteins in an analagous experiment to identify ribosomal proteins that are ubiquitinated 
during 18S NRD (Fujii, Kitabatake, Sakata, Miyata, & Ohno, 2009). 
 
 The role of Ubc4 as an E2 conjugase, is well established, suggesting that it functions in 
the same role in NRD. Ubc4, like other E2 conjugases, binds a number of E3 ubiquitin ligases, 
including Pex2, Not4, and the essential protein Rsp5. We did not observe any loss of 18S NRD 
in the absence of NOT4, or PEX2, increasing the likelihood that Rsp5, as the only remaining E3 
ligase reported to interact with Ubc4, is indeed the E3 that works with Ubc4 in NRD. Previous 
studies have already implicated Rsp5 in affecting ribosome stability. Though the Scherbik et  al. 
2011 dataset indicated that Rsp5 promotes ribosome stability, which would argue against a role 
for Rsp5 in ribosome destabilization, their data do not preclude the possible that Rsp5 could also 
function to destabilize ribosomes in NRD by ubiquitinating a different target on the ribosome. It 
is possible to test the involvement of Rsp5 in NRD in two ways: 1) Assay the ability of UBC4 
RING or HECT binding mutants to complement ubc4∆ for its ability to conduct NRD (Stoll et 
al., 2011). 2) Test the effects of a dominant negative Rsp5 protein on the steady state levels of 
mutant or WT 18S rRNAs over time (Shcherbik et al., 2011). 
 
A potential role for Rps3 in NRD 
 Though the 18S NRD pathway includes parallel, independently functioning branches, it 
is possible that both branches could be coordinately regulated. The recently released crystal 
structures of the eukaryotic ribosome, and the bound Dom34:Hbs1 heterodimer, have provided 
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insight into the potential role for Rps3, which touches both Hbs1 and Asc1 (Becker et al., 2011; 
Ben-Shem et al., 2010). Rps3 is positioned at the mouth of the mRNA channel, and interacts 
directly with the mRNA. Given these three interactions, Rps3 is perfectly situated for sensing 
ribosome translocation along the mRNA, and to regulate both Asc1 and Hbs1. Moreover, it 
appears that the length of mRNA sequence present downstream of the P-site of a stalled 
ribosome determines whether or not Dom34:Hbs1 will dissociate the subunits (Pisareva et al., 
2011). The addition of more than 9 nucleotides will simultaneously position the mRNA 5` end in 
the vicinity of Rps3, and lead to the inhibition of Dom34:Hbs1 mediated dissociation of the 
ribosomal subunits. (Importantly, thought the effect of downstream mRNA length on subunit 
dissociation is known, its effect on rRNA degradation is not.) This raises the possibility that 
normal and Non-Stop mRNAs could be distinguished by Rps3, leading to the activation or 
inhibition of Dom34:Hbs1-mediated ribosomal subunit dissociation. Whether Rps3 actually 
possesses these activities remains to be seen. To test the possible regulation of Asc1 by Rps3, we 
attempted to remove the long c-terminal tail of Rps3. Despite the detection of recombination by 
our truncated RPS3 construct at the RPS3 locus, and confirmation that our PCR product encodes 
the truncated form of the RPS3 gene as expected, all of the recombinant strains still possessed 
the wild type RPS3 gene. This suggests that truncation of the RPS3 tail is harmful to the cell. We 
also attempted this truncation in an asc1∆ strain to avoid the possibility that misregulation of 
Asc1 in a truncated RPS3 strain was leading to toxicity. Again, we were not able to truncate the 
RPS3 gene, raising the possibility that its c-terminal tail is necessary for stability of the small 
subunit. In the future, an alternative approach could be attempted: instead of truncating RPS3, 
the N-terminal domain of Hbs1, or the WD4 wedge of Asc1 could be removed. These 
truncations would have the effect of ablating contacts with Rps3 and should not affect cell 
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viability. However, the major alterations in the structures of Asc1 and Hbs1 could simply lead to 
widespread misfolding and/or proteolysis. Hence these experiments would serve primarily to 
allow a positive result to disprove the Rps3 interaction hypothesis. 
 
The potential function of NRD in the clearance of damaged RNAs 
 Though the 18S NRD pathway is incompletely characterized, we were able to reduce the 
activity of the off the NRD pathway to undetectable levels by deleting both DOM34 and ASC1, 
or by deleting UBC4. This allowed us to begin testing our hypothesis that one of the functions of 
18S NRD is to rid the cell of damaged RNAs. We hypothesized that chemically damaged bases 
in an mRNA could lead to translational stalling, necessitating intervention by NRD/NGD, and 
leading to the removal of the mRNA. As such, we expected that NRD deficient strains would 
show sensitivity to genotoxic chemicals shown, or expected to damage RNA. Our results showed 
that dom34∆asc1∆ cells were synthetically sensitive to 4-nitroquinoline, but unexpectedly, they 
were not sensitive to alkylation, or oxidation. Though 4-nitroquinoline may be capable of 
damaging DNA, protein, and lipids, in addition to RNA, the established activity of Dom34 on 
translation surveillance suggests that the synthetic sensitivity seen in its absence is due to 
damaged translation components that would otherwise be remediated by NRD/NGD/NSD. 
Further studies are needed to confirm and characterize the effects of 18S NRD on the clearance 
of 4-nitroquinoline-damaged RNAs. 
 As a whole, these studies serve to update our understanding of the 18S NRD pathway in 
terms of the factors that promote it, and the degree to which NRD overlaps with the other 
ribosome degradation and translation surveillance pathways. We now know that ubiquitin 
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ligation is likely to play a part in small subunit degradation, as it does in 25S NRD, ribophagy, 
and the degradation of aberrant nascent peptides. Our model for 18S NRD suggests a regulatory 
role for an additional protein, Rps3, which could function as a sensor of ribosome stalling, and as 
a regulator of both branches of the NRD pathway. We also know that the Ribophagy pathway 
has implications for NRD, raising the possibility that NRD substrates may localize to the 
vacuole. Finally, we offer preliminary evidence that NRD could function as a detection and 
degradation mechanism that rids the cell of damaged RNAs. These data offer tantalizing clues 
about a number of functions for NRD, and suggest a direction for future studies on general 
ribosome function,  and translation quality control. 
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Appendix: 
Global ribosome footprinting analysis in a upf1∆ strain 
 
Introduction 
 In eukaryotes, translation is monitored by the Nonsense Mediated Decay (NMD) pathway 
which serves as a post-transcriptional mechanism for regulating gene expression, and also as a 
quality control device that degrades mRNAs encoding a termination codon in an unfavorable 
context (Amrani et al., 2006). For example, DNA mutations or transcription errors may produce 
premature termination codons (PTCs) upstream of an mRNA's standard termination codon. Such 
transcripts are detected by NMD. Following detection, such transcripts are translationally 
silenced, then degraded (Muhlrad et al. 1999). In its role as a modifier of gene expression, NMD 
may also repress the translation of up to 3-10% of the transcripts produced in S. cerevisiae (He et 
al., 2003; Lelivelt et al., 1999). This regulatory activity of NMD occurs both directly, and also 
indirectly, by modulating the translation of regulatory factor mRNAs. Together, these activities 
of NMD regulate the expression of a large percentage of the yeast genome, and also protects the 
cell from the potentially deleterious effects of truncated peptides that would otherwise be 
produced by PTC containing transcripts (Rebbapragada et al., 2009).   
 NMD is promoted by a number of proteins including Upf1, Upf2, and Upf3, as well as 
the Smg proteins (suppressor of morphological defects on genitalia) Smg1, Smg5, Smg6, and 
Smg7 (Czaplinski et al. 1995; Kashima et al., 2006; Singh et al., 2008). The Upf proteins 
represent the functional core of the NMD machinery. All three proteins, Upf1, Upf2, and Upf3 
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are essential for NMD in yeast (Culbertson et. al, 2003; Czaplinski et al., 1995; Leeds et al., 
1991). Smg1 phosphorylates Upf1 at several different locations, altering its activity, and creating 
binding sites for Smg5:Smg7 (Okada-Katsuhata et al., 2011). These events precipitate two major 
downstream consequences for the mRNA:  1) the Smg6-mediated endonucleolytic cleavage of 
the mRNA, and 2) the deadenylation, decapping, and Xrn1-mediated exonucleolytic decay of the 
mRNA. These two outcomes may not be decoupled (Nicholson et al., 2010). 
 In yeast, NMD is activated or repressed on a given mRNA through a competition 
between Upf1, and Poly(A) binding protein (PABP) (Singh et al., 2008). During canonical 
translation termination, the release factors eRF1:eRF3 bind the ribosomal A-site, recognize the 
stop codon, and promote ribosome release. When a PTC is present, the downstream sequence 
previously representing the 3` portion of the open reading frame becomes incorporated into the 
3` UTR, and increases the distance between the terminating ribosome and PABP. This is thought 
to lead to a decrease in the interaction between PABP and eRF3,  and allow for increased 
association between eRF3 and Upf1. This has the effect of stimulating NMD (Singh et al., 2008).  
 NMD also has effects on the ribosome and general translation. In vitro, the Upf proteins 
have been shown to promote the downstream reinitiation of ribosomes that reach a PTC. 
Conversely, Upf1 has been shown to repress translation of a PTC containing mRNA, presumably 
as an intermediate step before mRNA degradation (Ghosh et al., 2010). In a third study, Upf1 
appears to be important for the effective translation of non-abberant transcripts (Muhlrad & 
Parker, 1999). 
 Substrate definition is of particular interest to the field due to the observed effects of the 
NMD proteins on both PTC containing and wild type transcripts. Examples of both wild type and 
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PCT containing transcripts have been shown to increase in abundance when NMD is ablated 
(Johansson et al., 2007).  The effects on certain wild type genes may in fact represent indirect 
effects of UPF1 loss rather than loss of degradation by NMD (He et al., 2003; Johansson et al., 
2010). In yeast, UPF1 loss can yield indirect effects on translation through an increase in the 
level of Alr1 protein which serves as a Mg++ transporter. The added Alr1 proteins cause an 
increase in cytoplasmic Mg++ concentration, thereby affecting canonical termination by the 
ribosome (Johansson et al., 2010). 
 Given the ability of NMD to regulate gene expression both directly and indirectly, it is 
not surprising that the NMD machinery has been implicated in a variety of genetic diseases, and 
certain forms of cancer (Frischmeyer et al., 1999; Ionov et al., 2004). In human cells, NMD plays 
a part in regulating the levels of the spliceosomal protein SC35 (Sureau et al., 2001). If SC35 
levels are increased, this splicing regulator promotes its own alternative splicing, leading to the 
formation of an SC35 transcript that contains a PTC. This splice variant is then targeted by 
NMD, bringing down the levels of the protein, and restoring the normal splicing pattern (Sureau 
et al. 2001). Certain reports have also indicated that the protein Tdp-43, a gene which is 
implicated in both alternative splicing and the onset of amyotrophic lateral sclerosis (ALS), is 
also regulated by this mechanism (Dreumont et al., 2010; Sureau et al., 2001). In certain forms of 
cancer, a properly functioning NMD system can sometimes promote oncogenesis (Karam et al., 
2008). In the example of gastric cancer, a large number of germ line mutations in the gene 
encoding the tumor suppressor protein E-cadherin, can lead to the formation of nonsense codons. 
The resulting transcripts are targeted for degradation by NMD, suggesting that NMD could be 
inhibited as a form of therapy (Karam et al., 2008). Accordingly, drugs that promote the read 
through of PTCs, including the aminoglycoside antibiotics, are expected to represent good 
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candidates for bypassing NMD mediated quality control, and thereby treating certain illnesses 
(Floquet et al., 2011). 
 The literature has demonstrated effects of the NMD pathway on both PTC containing and 
normal transcripts, leading to physiologically relevant outcomes in both humans and yeast. The 
ability of Upf1 to affect ribosome translocation, or to repress translation of certain mRNAs, also 
suggests that Upf1 has functions outside of its promotion of mRNA degradation. These subtle, 
variegated effects on ribosome function have made it difficult to clearly define the full behavior 
of Upf1. Here we investigate for the first time, the effects of UPF1 loss on global ribosome 
positioning in S. cerevisiae. 
 The UPF1 family of helicases also includes the protein Mtt1, which has been shown to 
bind to eRF1:eRF3 and to associate with polysomes, similar to the observed behavior of Upf1 
(Czaplinski et al., 2000). When overexpressed, Mtt1 suppresses nonsense read through, 
suggesting again that like Upf1, Mtt1 may have a role in termination(Czaplinski et al., 2000). 
Moreover, mtt1∆ cells are sensitive to hygromycin B, which negatively affects the proofreading 
function of the ribosome, potentially allowing for misincorporation of tRNA into the P-site, and 
triggering additional proofreading functions that could halt ribosome elongation (Czaplinski et 
al., 2000).  Despite these similarities between Mtt1 and Upf1, no mRNAs have been shown to 
either increase or decrease in abundance in the absence of MTT1, arguing against a role in 
mRNA decay. To date, its function in the cell has not yet been full determined. Below we present 
an investigation into the effects of Mtt1 on global ribosome position in S. cerevisiae. 
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Results: 
In the absence of UPF1, a subset of genes display both decreased overall ribosome occupancy 
with preferential start codon occupancy. (Preliminary Data) 
 
To elucidate the effects of Upf1 on translation with greater clarity, we conducted global 
ribosome footprinting in S. cerevisiae. Global ribosome footprinting allows us to determine the 
position of a large number of the ribosomes in the cell, leading to the production of a highly 
accurate depiction of the translational profile for a given strain. We developed a global ribosome 
footprinting model for a WT, upf1∆, and mtt1∆ strains, allowing us to identify disparities 
between the ribosome positions in these strains. These data were produced using an N of 1 for 
each of the three strains tested, and have yet to be repeated. As such, this data set should be 
regarded as preliminary evidence. 
 To accomplish this, wild type and upf1∆ cultures were grown to mid-log in YPD medium 
and treated with 100 µg/ml cycloheximide (CHX). Cells were then harvested by vacuum 
filtration on a nylon membrane. Dry cells were then resuspended in a small volume of lysis 
buffer containing CHX, and flash frozen in liquid nitrogen. Frozen cell suspensions were then 
lysed on a Retsch ball mill for 3 min at 15 Hz, in canisters cooled in liquid nitrogen. 70 units of 
RNAse1 was added, and lysates were incubated at room temperature for 1 hour. RNAse 
digestion serves to cleave cellular RNAs, including the mRNA fragments exposed between 
translating ribosomes (Ingolia et al., 2009). This collapses polysomes into monosomes, and 
produces the roughly 30 nucleotide mRNA fragments representing the "footprint" of each 
ribosome in the cell (Ingolia et al., 2009). RNAse-treated lysates were then layered on 5-50% 
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sucrose gradients, and spun at 35k rpm for 2:40 at 4o. Sucrose gradients were separated into 0.5 
ml fractions on a fraction collector, and simultaneously analyzed in real-time by UV-vis. A260 
measurements were graphed with the corresponding fractions to allow for the identification of 
individual ribosomal subunits and 80S monosomes within the collected fractions. To isolate 
ribosome footprints, only the fractions corresponding to the monosome peaks were pooled and 
subjected to phenol:chloroform extraction and ethanol precipitation. Total RNA preps were then 
passed over a YM-10 microconcentrator column to decrease the sample size. The resulting 
samples were then subjected to RNaseH digestion using oligos complementary to rRNA 
fragments previously observed to be at high abundance in previous libraries. Following another 
phenol:chloroform extraction to remove the enzyme and buffer, samples were separated on 15% 
acrylamide gels and stained with Sybr Gold. Samples at the 28-30 nt range were excised and the 
RNAs were extracted from the gel piece via overnight incubation at room temperature in 
aqueous solution in the presence of RNase inhibitor. The gel pieces were removed by passing the 
sample over a Corning Spin-x column, leading to isolation of the final RNA samples. T4 
polynucleotide kinase was used to remove phosphate from the 3` end of sample RNAs, and also 
to transfer phosphate from ATP to the 5` end of the RNAs in the sample. 1 ul from each pre-
treated RNA sample was separately treated with radiolabelled phosphate, and separated on a 
15% acrylamide gel along with defined quantities of radiolabelled oligo. These oligos were used 
as a standard to measure the amount of RNA in 1ul of each sample. From each sample, 1 ng of 
phosphatased and kinased RNA was used as input into Applied Biosystems Small RNA 
Expression Kit. This protocol entails the ligation of DNA linker oligos onto the sample RNAs, 
their reverse-transcription, and subsequent bar-coding to allow for multiplexing in subsequent 
sequencing reactions. Samples were sequenced on an Applied Biosystems SOLiD machine, 
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yielding  10-100 million reads. Data output in the form of bed files was then aligned to the S. 
cerevisiae genome and uploaded into the UCSC genome browser. By comparing the histograms 
derived from the bed files, we were able to directly observe the ribosome occupancy on RNAs 
derived from any location in the genome.  
 We first attempted to validate our data set by looking for anticipated differences and 
similarities between the WT and upf1∆ data sets. First, we examined the UPF1 ORF to look for 
loss of ribosome occupancy in the upf1∆ strain. As anticipated, we observe ribosome occupancy 
in WT and mtt1∆ data sets, but not in the upf1∆ data set, suggesting that our data set accurately 
reflects dramatic differences in gene expression, and does not produce detectable non-specific 
signal. We also examined the ALR1 gene which is reported to increase in expression in the 
absence of upf1∆. In keeping with a previous report, we also observe a strong increase in 
ribosome occupancy in ALR1 ORF, again supporting the validity and sensitivity of our assay 
(Johansson et al., 2010). We then examined a number of candidate genes on each chromosome to 
establish the overall similarity between the three data sets. We observe that for most genes, the 
general pattern of ribosome occupancy is highly similar. When zooming the view to an entire 
chromosome, the two datasets are indistinguishable for many large regions. Next, we examined 
the ribosome occupancy at the CAN1 gene, which encodes a PTC in our strain - BY4741/S288c. 
This can1 allele is can1-100. Again, as anticipated, we observe a major difference in signal 
pattern within the CAN1 ORF in the upf1∆ data set, suggesting that the loss of UPF1 is 
specifically affecting a known PTC containing gene. Together, these data suggest that our data 
set is valid, and that only a subset of known genes, including a known NMD substrate, are 
subject to regulation by Upf1. 
156 
 
 To detect patterns in ribosome occupancy, as well as alterations in these patters in the 
absence of UPF1 or MTT1, we visually scanned each data set using the UCSC genome browser. 
Genes displaying differential patterns between the strains were identified and binned according 
to general pattern differences. The clearest pattern of change in the upf1∆ data set was dubbed 
"1/x" due to the resemblance the occupancy pattern bears for the graph of the equation y=1/x, in 
which a curved line asymptotically approaches both the y and x axes. The genes displaying the 
1/x phenotype, also display dramatically decreased overall signal. What signal remains for these 
genes is predominantly at the start codon. This pattern suggests that these genes may not be 
translated properly in the absence of UPF1. The 1/x genes are displayed in Table A1. 
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Figure A1. The 1/x phenotype as demonstrated by ribosome occupancy profiles of the CAN1 
gene. A. Graph of y=1/x. This shape is similar to that of the histogram for the upf1∆ data set for 
the CAN1 gene. B. Ribosome occupancy histogram for CAN1 in upf1∆ (top), WT (middle), and 
mtt1∆ (bottom). The size and orientation of the CAN1 open reading frame is depicted at the top. 
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C. Simplified approximation of the occupancy profiles of the CAN1 gene in upf1∆ (top), WT 
(middle), and mtt1∆ (bottom) strains. D. Ribosome occupancy of the REI1 gene demonstrating 
the 1/x phenotype in the upf1  and mtt1∆ strains (left). Occupancy approximations are shown on 
the right. 
 
 
SSH1 POP6 MDM34 PRM5 GAA1 LYP1 
CAN1 MUP1 ERG4 CBR1 YPS1 PSD1 
YBR13W ERG25 PMA1 SSM4 NHA1 YNL165 
YOL007C YGR106C STF2 PHO90 PEP3 YGP1 
UTP23 CRH1 YGR012W YJL200C MSS51 TOM70 
PHO89 PCM1 MSB2 ATG27 FRE1 TCB2 
CHS2 SPF1 YGR017W KRE9 YLR241W ALG11 
HXT3 GEA2 POP6 HAL5 EXG1 DSE4 
PHT2 YEL001C YGR031W KAR2 BUD5 ENB1 
ROT2 HEM14 GSC2 AVT1 FKS1 TAT2 
NUG1 CHO1 TFC4 GEL1 ORM2 YOL007C 
ERV46 CAJ1 MUP1 HOC1 SUR4 TCB1 
YBR159W FTR1 ERG25 MSN1 YLR413 YOR093C 
PCM1 UBP3 YGR106C YKL207W GAB1 LEU9 
SPF1 FET5 CRH1 LOS1 ERO1 SEC63 
YEL001C CAF16 YHL017W ZRT3 YML125 DIP5 
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HEM14 STE2 MRP4 RRN3 VAN1 RBD2 
CHO1 SMX2 LAG1 YKL077W TSL1 YPL221W 
CAJ1 HSP12 ERG11 YKL075C OST6 TPK2 
FTR1 SMC1 PPA1 LHS1 YML018C PET20 
UBP3 YFR016C DAP2 YKL065C HXT2 PEP4 
FET5 YFR018C MSC7 DCW1 ERG5 TIM50 
CAF16 SHE10 NCP1 PSR1 FET3 CWC27 
STE2 VRG4 KIC1 YII012W SWP1 SUR1 
YFR018C TPN1 TOM71 SMF3 ERG25 KTR6 
VRG4 YGL139W LSM12 YLR050c PFK2 SSN3 
STT3 OLE1 ECM14 ERG3 ZRC1 YME1 
MDM34 MIG1 WSS1 YLR065C SCW10 YPR028 
PMA1 SCW11 YIL130W MEF1 GAS1 YPR085 
MSB2 STT3 STH1 RAX2 EGT2 RPN7 
     
YPR114W 
Table A1. A comprehensive list of genes initially suspected to show the 1/x phenotype. For 
some of these genes, the signal to noise ratio is low due to low ribosome occupancy, raising the 
possibility of false positives.  
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 The group of genes displaying the 1/x phenotype predominantly encode proteins that 
localize to the plasma membrane, mitochondria, and golgi aparatus. Many of these proteins are 
exported from the cell via the secretory pathway, suggesting a possible link between them. This 
list is reported in Table A1. Two examples showing a strong 1/x phenotype are Can1, and Pma1 
(Fig. A1). 
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Table A2. The 1-x genes annotated by function and reported localizations of the respective 
protein product. Note: Some of these genes should not be on this list. Initial characterization was 
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overly sensitive, leading to a number of false positives, due to a certain individual's lack of 
experience with the program. 
 To examine the possibility that 1/x genes may be directly, rather than indirectly, 
regulated via Upf1, we cross referenced the list of 1/x genes to the previously published list of 
mRNAs known to immunoprecipitate with the Upf1 protein, and the list of mRNAs that 
increased/decreased in abundance in the absence of Upf1 (He et al., 2003; Johansson et al., 2007; 
Maderazo et al., 2003).  An annotated lists of the cross referenced genes are reported in Tables 
A3, A4, A5, and A6. 
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Comparison to the dataset reported in He et al. Mol. Cell, Vol 12. 1439-1452, December 2003. Table 2. 
      
RNA Type Description 
Gene 
Name upf1∆ CM Footprinting Data: 
Nonsense 
Containing YEL063C CAN1 9.7 Hit Differential occupancy. Decrease in signal.1/x 
 
YOR128C ADE2 42.2 -- Equivalent 
 
YDR007W TRP1 18.0 -- Equivalent 
Pre-mRNAs YJR021C MER2 10.1 Hit Major increase in pre-mRNA in upf1∆, but not mtt1∆. 
 
YDL115C Iwr1 7.2 Hit.  Increase in pre-mRNA signal in upf1∆, and mtt1∆.  
 
YGL251C MER3 5.7 -- Equivalent, very low expression in all strains 
uORF-containing YOR302W CPA1 5.0 Hit Increase in signal in the ORF in upf1∆  
 
YLR233C EST1 14.0 -- Equivalent 
 
YJL023C PET130 7.3 Hit Signal increase in upf1∆. 
 
YOL055C 
 
THI20 
 
8.0 
 
-- 
 
Equivalent. Potential signal in uORF in upf1∆.  
Potential spike difference in mtt1∆ 
Leaky Scanners YCR007C 
 
2.4 -- Equivalent, but signal spike in 5` UTR in Upf1 
 
YHL050C 
 
2.9 -- Very low signal but one is in intron. 
 
YIL107C PFK26 2.8 -- Equivalent 
Plus 1 
Frameshifting 
 
YIL009C-A 
 
EST3 
 
3.9 
 
Hit 
 
Signal increase in upf1∆, and possibly in mtt1∆. 
 Start codon enrichment upf1∆ 
 
YILWTY3-1 
 
6.5 -- Very low signal. 
Polycistronic YLR315W Nkp2 3.0 Hit Major change around start codon in upf1∆ and mtt1∆ 
 
YLR317W 
 
3.1 -- Very similar, some shifted peaks between strains. 
 
YMR181C 
 
2.9 -- Equivalent. 
 
YMR182C RGM1 4.4 -- 5` UTR signal in upf1∆ 
Pseudogenes YCR099C 
 
3.7 -- No signal in any strain 
 
YCR100C 
 
4.8 -- No signal in any strain 
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YIL164C NIT1 16.3 -- Very low signal 
 
YIL165C 
 
9.6 -- No signal in any strain 
 
YIR043C 
 
12.5 -- No signal in any strain 
Transposable 
Elements YDLWTAU1 
 
7.0 -- No signal in any strain 
 
YJLWTY4-1 
 
4.4 -- No signal in any strain 
 
YJLWTY4-1 
 
8.5 -- No signal in any strain 
 
YLRCDELTA27 4.5 -- No signal in any strain 
 
YNLWSIGMA2 3.7 -- No signal in any strain 
 
Table A3.. Comparison to the dataset reported in He et al. Mol. Cell, Vol 12. 1439-1452, December 
2003. Table 2. Transcripts reported to display altered mRNA levels in the presence or absence of UPF1 
were cross referenced with the current Global Ribosome Footprinting dataset and annotated subjectively 
according to the observed alterations. CM Dataset refers to the dataset produced by me in this experiment. 
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Gene 
name 
Up/Down 
Regulated 
(AJ) CM Data Set: 
   SET7 Up Overall similar. BIG loss of signal spike at start codon. 
CAN1 Up Differential occupancy. Major difference. 
REG1 Up Loss of 5`ORF signal spike 
TRP1 Up No major difference 
   RIB7 Up Minor difference 
SSN2 Up Decrease in Mtt1  Low signal overall. 
SPR6 Up Slight decrease in Upf1 
CIS1 Up Slight decrease in Upf1 
DLS1 Up Major increase in signal. Also 5` UTR signal 
AQY2 Up Low signal, but different. 
HAP5 Up Minor difference 
BUD4 Up Major decrease. Start codon spike decreased. 
TRM5 Up Potential signal increase.  
OAZ1 Up Minor difference 
CTL1 Up Low signal, but different. 
AMD2 Up Major spike in 5` UTR 
SLX1 Up 3` UTR signal 
PCK1 Up Small increase.  Also a signal spike. 
YBP1 Up Signal decrease, change in position. Upf1 looks like mtt1. both different than Wt. 
 
Up Major increase in signal. 
APL3 Up Low signal, but loss of start codon spike. Decreased signal. Mtt1 = Wt 
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SHU2 Up Potential increase in signal in upf1. Mtt1=Wt 
 
Up Increase in signal. No changes in profile. 
ADE2 Up Increase in signal. Subtle changes in profile. 
REC107 Up Signal in intron. Major increase in signal. 
 
Up 5` UTR signal. Possible decrease in number of tags. Mtt1 looks different. 
 
Up Almost no signal, but a couple tags in upf1 and mtt1. 
 
Up Very low signal in all 3. None in mtt1. 
 
Up Increase in signal Upf1, not Mtt1. 
GSC2 Up Differential occupancy upf1. Signal increase and loss of spike in upf1, mtt1 
HRT1 Up Increase in signal Upf1, not Mtt1. 
 
Up Major increase in signal in upf1. Moderate increase mtt1. 
 
Up Major increase in signal in upf1, not in mtt1. 
 
Up Increased signal upf1, possibly mtt1. Buildup at stop codon. 
 
Up Probably not a hit, but there's plenty of signal. All should be equal. 
ALR1 Up Major increase in signal in ORF and some in the 5` UTR 
 
Up Increase in upf1 not Mtt1. May be for YOR012W though (overlapping orf) 
CTL1 Up Low signal, but different. 
PEX10 Down 5` UTR Signal 
DAL5 Down 5` UTR signal 
PEX4 Down Increased signal 
PEX28 Down 5`UTR signal and Start codon spike 
CPA1 Down Increased signal 
JLP1 Down Increase 
 
Down Increase in signal 
SPR6 Down No differences but interesting 5` UTR Signal.  
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  Overall similar levels/patterns btw strains. 
TRP1 Down Potential decrease in signal. Low expression for Wt/mtt1. Hard to tell. 
 
Down Low signal. None in Wt/mtt1. Small signal Upf1 
 
Down Low signal, increase in Upf1, possibly Mtt1 
ARN2 Down Decrease in signal in upf1. 
 
Down Potential increase in upf1 and mtt1. 3` UTR signal. 
FRT2 Down Decrease in signal in Upf1. Wt same as Mtt1. 
 
Down Low signal but decrease in Upf1. 
PIN2 Down Low signal but decrease in Upf1. 
CIS1 Down Increase in Upf1. 
 
Table A4. mRNAs previously shown to be up/down regulated (Maderazo et al., 2003) in the absence of 
UPF1, and which also show a differential phenotype in the absence of UPF1 in terms of ribosome 
footprinting. Alr1 and Can1, which are known to be affected by NMD are shown in bold. "CM data set" 
refers to primary data reported here. 
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PEX32 YOR203W YHR033W NCR011C 
PAU4 YER066W YHL026C YEL074W 
DAN3 YER187W ICE2 YOL106W 
SSD1 YOR084W NER031W YCR025C 
ICE2 YGLWDELTA4 YDR438W NNL075C 
HIS3 YGR127W NDL035C PAU1 
PAU1 PET18 NHL005C YLL025W 
MED1 YOL029C NNL031C YAR068W 
PAU4 PAU6 YIR043C NHR009C 
PRM10 NPL007W NDR057W YLR046C 
ICL1 YOL162W YBR219C YEL020C 
CST9 YIL024C PAU4 YPL056C 
PGS1 YHL037C NIR001C KIP2 
GAS2 YHL048C-A YGLWTAU2 SSY5 
CSM2 NHR015C CST9 
 CTA1 YERCTAU3 PAU1 
 DAN3 YAR029W YIR016W 
 SDL1 YOL163W YLR122C 
 ISC10 YHR032W-A NER034C 
 YBR063C DAN3 YLRCDELTA27 
  
Table A5. mRNAs previously shown to be up regulated (Maderazo et al. 2003) in the absence of UPF1, 
but do not show a differential phenotype in the absence of UPF1 in terms of ribosome footprinting. CM 
dataset refers to data produced in the current data set.  
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MOG1 NDR012W YLL025W NJR012W HMRA2 NKL034C 
FAR7 YDR438W YEA6 YPL257W VBA2 NGR042W 
THI21 gEL01_1 AAD14 YJL213W YIR042C SPO1 
YOL106W NCL011C NER017W PAU3 NGL040C YNRCTAU3 
YLR164W GPX1 SNF11 YER185W YHL048C-A NPR004C 
AYT1 YGLWDELTA6 YOL159C YDR459C PDR8 
 
YGR066C YNL063W YAL063C-A YBLWDELTA1 YPL277C 
 
YPRCTAU3 YEL023C KAR5 YHL037C YOL162W 
 
 
  
  
 
Table A6. mRNAs previously shown to be down regulated (Maderazo et al., 2003) in the absence of 
UPF1, but do not show a differential phenotype in the absence of UPF1 in terms of ribosome footprinting. 
 
 Another trend in signal alterations between the two data sets is start codon enrichment. 
Among the few genes that noticeably displayed strong start codon enrichment, several were 
linked to metabolism and ribosome synthesis, suggesting that Upf1 could potentially control the 
rate of cell growth through these genes. Two representative candidate genes showing start codon 
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enrichment in the upf1∆ background are depicted in Figure A1. A comprehensive list of these 
genes is reported in Table A1. Interestingly, mtt1∆ and upf1∆ data sets show similar changes in 
ribosome occupancy in the form of start codon enrichment in Hxt3, Rei1 (which overlaps with an 
antisense transcript encoding the YBR266C gene), Ubx7, Rsc3, YDR179W, and Cft1 mRNAs. 
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Figure A2. Genes for four candidate mRNAs displaying start codon enrichment in the absence 
of UPF1 or MTT1, or both. A. HXT3 (oriented 3` to 5`), B. REI1 (5` to 3`), C. UBX7 (3` to 5`), 
and D. YDR179W (5` to 3`). Some genes in this category could also be considered to be in the 
1/x category. 
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Gene Name: Annotated Function: 
CFT1  RNA-binding subunit of the mRNA cleavage and polyadenylation  
factor; involved in poly(A) site recognition and required for both pre-mRNA cleavage 
and polyadenylation, 51% sequence similarity with mammalian AAUAA-binding subunit 
of CPSF 
HEM1  5-aminolevulinate synthase, catalyzes the first step in the heme  
biosynthetic pathway; an N-terminal signal sequence is required for localization to the 
mitochondrial matrix; expression is regulated by Hap2p-Hap3p 
HXT3  Low affinity glucose transporter of the major facilitator superfamily,  
expression is induced in low or high glucose conditions 
REI1  Cytoplasmic pre-60S factor; required for the correct recycling of  
shuttling factors Alb1, Arx1 and Tif6 at the end of the ribosomal large subunit 
biogenesis; involved in bud growth in the mitotic signaling network 
ROT2  Glucosidase II catalytic subunit required for normal cell wall  
synthesis; mutations in rot2 suppress tor2 mutations, and are synthetically lethal with rot1 
mutations 
RSC3  Component of the RSC chromatin remodeling complex; essential  
gene required for maintenance of proper ploidy and regulation of ribosomal protein genes 
and the cell wall/stress response; highly similar to Rsc30p 
UBX7  UBX (ubiquitin regulatory X) domain-containing protein that interacts  
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with Cdc48p 
YPRO85C Putative protein of unknown function; subunit of the ASTRA complex  
(Rvb1p, Rvb2p, Tra1p, Tti1p, Tti2, Asa1p and Tra1p) which is part of the chromatin 
remodeling machinery. Essential. 
YDR179W Putative protein of unknown function  
 
Table A7. Genes displaying strong start codon enrichment in the absence of UPF1 or MTT1.  
 
Deletion of MTT1 does not affect ribosome occupancy for most genes 
  To detect redundant roles for Mtt1 and Upf1, we also conducted global ribosome 
footprinting in an mtt1∆ strain, in parallel with the WT and upf1∆ strains. Cells were prepared in 
an identical fashion and subjected to visual analysis in parallel with the WT and upf1∆ data sets. 
This data set was highly similar with the other two data sets, essentially reiterating the WT 
dataset with the exception of four mRNAs: CFT1, REI1, UBX7, and YRD179W. These data are 
included below. 
 
Discussion: 
 The previously published studies examining the changes in global mRNA levels in the 
absence of UPF1, and the direct association of UPF1 with various mRNA transcripts, produced 
partially overlapping data sets (Maderazo et al, 2003, He et al. 2003). Likewise, our data set 
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demonstrates that the loss of UPF1 leads to specifically altered ribosome occupancy profiles in 
several genes identified as NMD targets, as well as several targets not previously known to be 
affected by Upf1. The genes displaying altered ribosome occupancy do not fully overlap with 
either of the two previous data sets, suggesting that UPF1 deletion may cause changes in 
ribosome behavior both directly, as with NMD targets, and indirectly. Moreover, Upf1 may 
function as a modifier of ribosome function independent of its function in mRNA degradation. 
Interestingly, the CAN1 gene, can1-100 ,which is known to contain a PTC, also shows the 1/x 
phenotype when UPF1 is absent, suggesting that the Upf1 promotes ribosome occupancy of 
Can1, despite its additional promotion of Can1 mRNA degradation via NMD. On the surface this 
would seem to be contrary to the previously proposed hypothesis that Upf1 discourages the 
translation of NMD targets as part of its role in NMD. 
 Of particular interest is the link between the 1/x genes. What common features link them, 
and is the 1/x phenotype a direct or indirect result of UPF1 deletion? There are certain 
connections between them, evident in common functions shared amongst different subsets of 
genes. These include chitin synthesis, glucose metabolish, membrane assoication, mitochondrial 
localization, and ER/golgi localization. The latter two categories suggest that Upf1 may regulate 
a subset of proteins that are sent to the secretory pathway.  
 One particularly interesting finding is that translation of CPSF, the cleavage and 
polyadenylation signal factor is apparently altered in the absence of the Upf1 protein. Given the 
strong data supporting a kinetic competition model between Upf1 and PABP, it is interesting to 
note this additional connection between Upf1 and poly(A) tail formation. Based on this finding, 
it is certainly possible that CPSF levels may be regulated by Upf1, increasing the number of 
mechanisms by which NMD could modulate gene expression. 
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 Among the simplest explanations is the possibility that many of the genes display an 
altered ribosome occupancy pattern in the absence of Upf1 due to increased Mg++ concentration 
(M. J. O. Johansson & Jacobson, 2010). For the 1/x genes previously reported to represent NMD 
targets, it will be interesting to elucidate the mechanism by which Upf1 promotes the normal 
translation pattern. It is somewhat counterintuitive that in  the presence of Upf1, the PTC 
containing NMD target CAN1 mRNA actually displays increased ribosome occupancy 
downstream of the PTC. One possible explanation for this is that Upf1 is promoting re-initiation 
downstream of the PTC, as recently described (Ghosh et al., 2010). This possibility is supported 
by the Can1 occupancy data in the upf1∆ strain, in that the signal downstream of the PTC is 
greatly diminished. The function of Upf1 in re-initiation could also serve to explain the higher 
levels of ribosome occupancy upstream of the PTC in the WT strain. If this is correct, then the 
explanation for the 1/x phenotype in the Can1 gene in the upf1∆ data set, is simply that 
ribosomes are translating the mRNA normally, using the PTC as the stop codon.   
 The mtt1∆ strain showed few differences in ribosome occupancy compared to the WT 
strain. The lack of effect on Can1 argues against a role for Mtt1 in NMD. Moreover, the general 
lack of effect on ribosome positioning in nearly every gene in the genome, also argues against a 
general function for Mtt1 in translation. However, the ribosome occupancy profiles for CFT1, 
REI1, UBX7, and YRD179W mRNAs in the area of the start codon suggest that Mtt1 could be 
regulating, either directly or indirectly, the translation of certain genes. Interestingly, these are 
the only four genes for which a difference in profile was noted for the mtt1∆ data set, and they 
appear to coincide in all four cases with differences in the upf1∆ data set. This suggests that Mtt1 
and Upf1 may have overlapping functions. Interestingly, Cft1, and Rei1 are involved with 
mRNA maturation and ribosome maturation, respectively. Likewise, Ubx7 interacts with Cdc48, 
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a protein known to be involved in ubiquitin mediated proteolysis, and ribosome degradation. The 
protein product of YDR179W is uncharacterized, however, the data suggest that involvement in 
translation would not be unlikely. These data, if repeated, suggest that a more thorough 
investigation of CFT1, REI1, UBX7, and YRD179W in either the upf1∆ or mtt1∆ strains is 
warranted.  
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